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Abstract
Background
Anecdotal evidence suggests that at least 8 young people (aged 14-35) die of 
undiagnosed cardiac conditions every week. Cardiac screening will detect the majority 
of cardiac conditions that could lead to a sudden cardiac death (e.g. Hypertrophic 
Cardiomyopathy, long QT syndrome, Wolff-Parkinson-White syndrome). However, 
screening of apparently healthy young people may have adverse psychological 
consequences on those who have negative test results.
Objectives
The objective of the current research was to evaluate the psychological effects on 
young people of screening for cardiac conditions that are partly genetic.
Methods
The current study (N=746) was a prospective investigation of psychological responses 
to screening, involving assessments at the time of invitation (T1), immediately before 
testing (T2), and 2-3 weeks later (T3), following receipt of results. It was carried out in 
the context of an innovative screening programme being developed by the charity 
Cardiac Risk in the Young (CRY). All participants were healthy individuals who had 
consented to cardiac screening in two different contexts, community (N=303) and 
school (N=443). Anxiety and self-rated health were evaluated using standard 
measures, and illness representations were assessed with the revised Illness 
Perception Questionnaire (IPQ-R). Between group analyses were performed for each 
of the key factors, gender, age, and number of symptoms at the time of screening. Two 
groups of young people - adolescents (14-19) and adults (20-35) -  were compared. 
Comparisons were also made with an adolescent age-matched control group not 
offered screening.
Results
Anxiety levels in the screening participants were significantly lower than those of the 
control group (not offered screening) and population norms. There were no changes in 
anxiety between T1 and T2, but at T3 (after receiving a negative result) anxiety levels
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significantly declined. Participants with symptoms were more anxious. Similar results 
were reported for self rated health. Patterns of response differed between adolescents 
and adults. Cognitive representations of the cardiac conditions were not associated 
with anxiety during the testing programme. Emotional representations and genetic 
worries were associated with anxiety at T 1 and T2 and emotional representations 
predicted reassurance at the end of the programme. A small number of participants 
had positive results in response to screening, and their experiences were also tracked. 
Discussion
This research provides strong evidence that the tests were acceptable to the 
participants. The levels of anxiety reported in this study, and the impact on self rated 
health, are not excessive. They were reassured after the testing; satisfied with the 
information they received; reported qualitative responses that were positive; and 
showed they had understood the process that they were engaged in. Selection factors 
were probably responsible for the lower levels of anxiety in participants than controls. 
These results suggest that screening apparently healthy young people (both 
adolescents and adults under the age of 35) for potentially serious cardiac conditions 
does not have adverse psychological effects.
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Overview of the thesis
In Chapter 1 I give an overview of cardiac conditions that can lead to a young sudden 
cardiac death. Chapter 2 reviews the issues relating to the current cardiac screening 
policies and the issues that guide policy in the UK. It also addresses how patients who 
are diagnosed with these conditions are managed and the psychological impact of 
living with a cardiac condition. In chapter 3 I discuss the issues relating to the 
psychological impact of screening in general populations as well as young people. I 
appraise various aspects of the screening process and different types of screening 
programmes. Much of this focuses on the issue of anxiety, however, I also look at the 
literature relating to general perceptions of health. In chapter 4 I discuss the theoretical 
background of the cognitive representations of illness, and the application of this theory 
to cardiac screening in adolescents, as well as the important relationship between 
anxiety and illness representations. In chapter 5 I give a brief summary of the literature 
review and in chapter 6 I outline the hypotheses driving this research. Chapter 7 
outlines the general methods that were adopted in this thesis, including two different 
testing scenarios, how the data was collected, the different measures that were used 
(both medical and psychological), and the way in which the cross-sectional and 
prospective data were analysed. Chapters 8-10 present the prospective analyses of 
anxiety and self rated health in adolescents and also in adults, in which the pattern of 
response for each of these is discussed in relation to gender, study type, symptoms 
and population norms. Chapter 11 starts by evaluating the factor structure of the 
revised illness perceptions questionnaire in this setting and compares the results I 
obtained with previously published reports in other illnesses. It then focuses on the 
relationship between anxiety and illness representations through the different stages of 
the screening programme and how illness representations relate to reassurance after 
the testing. In chapter 12 I give a qualitative analysis of the responses of those people 
who were called back for further tests after being told their initial results were abnormal. 
Finally in chapter 13 I bring the discussions from the previous chapters together. After
14
identifying some of strengths and limitations within my thesis, I identify some of the 
ways in which these results can be applied to policy.
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When the participants were asked why they agreed to be 
tested, here were some of their responses;
I have had chest pains for a number of years and the opportunity was a really good one to find 
out what my chest pains are or what has been causing them
to be sure of my health because I am an athlete
because I was worried that I had heart problems the same as some of my family and I don’t 
want to go through what they are experiencing
I had seen what can happen if I did have a heart defect and that it is so dangerous that I could 
die. I heard that if the defect was found something could be done about it.
I though it would be important not only to me but for the researchers as well. I thought that the 
more people who are screened the better the chance of finding something wrong before it is too 
late.
because I do a lot of sport and realised that I could be a high risk of having a problem with my 
heart I if carry on without knowing if I had a heart defect or not.
I decided to because I felt it would be better to know if I did have a defect so it could be dealt 
with. It is better to be safe than sorry
because mainly out of curiosity and also to check my health was okay
I thought it was a good idea and thought that if I had something wrong with me I would like to 
know about it. It was also for my own peace of mind
I decided to be tested because it was available
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I decided to be tested as there is a history of heart problems in my family, my dad recently had a 
heart attack recently also
Thank you so much. CRY is a great organisation and hopefully soon it will be recognised 
nationally as a fundamental test amongst young people just as it should be!
Because I had already heard of CRY and know of young people who have died suddenly 
through heart problems therefore I know that it can affect anyone my own age and know the 
importance of catching health problems early before they develop
My mother was keen to have it done, I would have been too scared otherwise
I felt it was important to be tested as it would tell me whether I had any heart deficiencies or not, 
and if I did, it would enable myself to take necessary precautions for the future in order to 
maintain satisfactory health status
Because it was free and a good opportunity to check if my heart was okay
I worry quite a lot about my health, and by being screened would put me at ease
I felt I needed to be screened ever since Richard died I have become more aware of my heart 
and have been concerned about the condition of me heart.
My mum bullied me
17
The psychological impact of cardiac screening 
Chapter 1. Introduction
The objective of the current research is to evaluate the psychological effects on young 
people of screening for cardiac conditions that are partly genetic. Anecdotal evidence 
suggests at least eight ‘fit and healthy’ young people die every week from undetected 
cardiac abnormalities. Some 80% of Sudden Cardiac Deaths (SCD) in the young are 
due to inherited/congenital structural or functional cardiovascular abnormalities 
(Sharma, Whyte, and McKenna, 1997).
The commonest cause of SCD is hypertrophic cardiomyopathy (Maron and 
Fananapazir, 1992), affecting 1 in 500 people (Maron etal., 1995). Other important 
causes of SCD include arrhythmogenic right ventricular cardiomyopathy (Corrado et 
al., 1990), anomalous coronary arteries, Wolff-Parkinson-White syndrome, long QT 
syndrome, Marfan’s syndrome, mitral valve prolapse, myocarditis, and premature 
coronary artery disease (Maron, Epstein, and Roberts, 1986). A brief description of the 
cardiac conditions under investigation is shown in table 1.1.
The cardiomyopathies are abnormalities of the heart muscle that are usually inherited. 
In hypertrophic cardiomyopathy (HCM) the muscle becomes excessively thick and the 
fibres are arranged haphazardly making the heart vulnerable to some dangerous and 
potentially fatal heart rhythms. In individuals who have high blood pressure or who 
have prolonged athletic training the heart muscle may also thicken. However, in HCM 
patients the muscle thickens without an obvious cause.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is one of the more common 
causes of unexpected sudden death in the young. The disorder is characterised by a 
progressive replacement of normal right ventricular muscle cells by fibrous tissue and 
fat. In dilated cardiomyopathy the main pumping chambers of the heart are dilated and
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contract poorly. This sometimes progressing to heart failure when the heart cannot 
meet the body's requirements.
Table 1.1 Incidence of Cardiac Conditions that may lead to a Young Sudden Cardiac Death (YSCD )
Condition
Hypertrophic 
cardiomyopathy 
(HCM / HOCM)
Wolff-Parkinson- 
White (WPW)
Long QT syndrome 
(LQT/LQTS)
Dilated
cardiomyopathy
(DCM)
Marfans
Description
Defined as ventricular hypertrophy (thickening) in the absence 
of cardiac or systemic cause (WHO, 1996) It is inherited at an 
autosomal dominant rate with a high degree of penetrance. 
The fibres in the heart are arranged haphazardly making it 
vulnerable to dangerous and potentially fatal heart rhythms 
(ventricular fibrillation / ventricular tachycardiac).
Characterised by an accessory conduction pathway (between 
the atria and ventricles) with a predilection to re-entrant 
supraventricular tachyarrhthmias which may precipitate 
ventricular fibriallation ((Dreifus et al., 1971 ;Gallagher et a!., 
1978)
Characterised by prologation of the QT interval on the ECG, 
with the propensity to syncope and fatal ventricular 
arrhythmias (Schwartz, Periti, and Malliani, 1975; Moss and 
Robinson, 1992) Genetic conditions that are caused by 
mutations of the DNA.
The main pumping chambers of the heart are dilated and 
contract poorly
Incidence
1/500 (Maron et al. 
1995)
1.5/1000
1/3,000 -10,000
1/3,000
1/5,000Characterised by skeletal, ocular, and cardiac abnormalities. It 
is an inherited connective tissues disorder.
Characterised by patchy fibrofatty replacement of the right 1/3,000 - 10,000 
ventricular myocardium which predisposes the heart to 
inhomogeneous and fatal re-entrant ventricular arrhythmias.
(McKenna et al., 1994)
Characterised by both the left and right coronary artery 
originating from the right side of the aorta. The second 
commonest cause of death in young athletes after the 
cardiomyopathies.
Characterised by an inflammation of the heart muscle. Viruses 
and occasionally drugs have been implicated in the cause 
(Virmani etal., 1988)
Common in the general population and its detection in SCD 4-20/1,000 
victims is likely to be coincidental rather than causal, or due to 
its association with other cardiac conditions.
Other conditions may include; Brugada syndrome, Lev-enegre’s syndrome, idiopathic ventricular fibrillations, 
catecholaminergic polymorphic VT, short QT syndrome, coronary artery disease, restrictive cardiomyopathy, 
Endorcardiac fibroelastosis.
Arrhythmogenic right 
ventricular 
cardiomyopathy 
(ARVC/ARVD) 
Coronary artery 
annomalies (CAA)
Myocarditis
Mitral valve prolapse 
(MVP)
Congenital heart disease includes abnormalities of the structure of the heart, which 
have been present since birth. Some of them may be inherited conditions. They include 
anomalous coronary arteries, a condition in which both arteries originate from the right 
side of the aorta. This anomaly or oddity is usually safe but can predispose to exercise 
related death making it one of the commonest causes of death in young athletes.
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The term myocarditis implies inflammation of the heart muscle. It is usually due to a 
viral illness. It is relatively common, though it rarely comes to the attention of the 
doctor. However, some cases are severe and lead to considerable impairment in the 
capacity of the pump efficiency resulting in severe heart failure.
Other inheritable conditions such as Marfan's Syndrome affect the structures that give 
support, strength and elasticity to the walls of the major blood vessels and the heart 
muscle. Sudden death can be caused by arrhythmias or due to the sudden rupture of a 
major blood vessel such as the aorta.
Mitral valve prolapse (MVP) is a condition where the mitral valve can sometimes be 
'floppy' in appearance. It is very common and affects around 5-10% of people. It is 
usually an asymptomatic and benign condition but in some rare cases it can be 
associated with arrhythmias and sudden death.
Conduction diseases include abnormalities in the way that the electrical impulses are 
conducted through the AV node. This is due to either a disease (for example as in 
myotonic dystrophy), or because there are additional or 'accessory' pathways as in 
Wolff-Parkinson-White (WPW) Syndrome. In WPW the extra or accessory electrical 
pathway is present in approximately 1.5 people per 1,000 people.
There is a group of diseases called ion channelopathies that affect the electrical 
functioning of the heart without affecting the heart's structure. They are conditions in 
which the sodium, potassium and calcium channels are affected. They include: Long 
QT Syndrome (LQTS), Brugada Syndrome, CPVT (catecholaminergic polymorphic 
ventricular tachycardia), PCCD (progressive cardiac conduction defect), IVF (idiopathic 
ventricular fibrillation), and sodium channel disease.
The most common is Long QT Syndrome (LQTS) is which the potassium channels do 
not behave as efficiently as normal or the sodium channel over-activates. This results
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in an electrical disturbance in the cell and is reflected on the ECG as lengthening of the 
time period known as the “QT interval”.
Brugada Syndrome was first identified in the early 1990s. The sodium channel behaves 
abnormally in that movement of sodium ions into the cells is restricted. This results in 
changes on the ECG, but no abnormalities in the structure of the heart.
Table 1.2 compares the incidence of diagnosis and annual deaths of cardiac conditions 
in young people with a number of cancers for which cancer screening programmes are 
currently in place.
Table 1.2 The incidence of cardiac conditions and cancers that are currently screened
Condition 
Cervical Cancer 
Breast Cancer 
Colon Cancer 
Cardiac conditions*
Deaths Annually 
2,000
15.000
16.000 
400+
Diagnostic rates 
11.7/100,000 (Tomatis, 1990)
5.9/1,000 (Blarney, Wilson, and Patnick, 2000)
3.5/1,000 (Atkin et al., 2002)
1/54 - 3/1000 (Corrado et al, 1998; Wilson et al., 2007)
*YSCD aged 14-35
Systematic screening programmes are needed to establish the prevalence of these 
diseases in the young. The aim of a screening programme is to detect a disease, or its 
risk factors. Once detected, preventative or therapeutic interventions can be 
implemented earlier and the disease can be treated when it is less advanced. In the 
case of cardiac conditions, the aim is to put in place treatments and lifestyle changes 
that will minimize the risk of a sudden cardiac death. These preventative actions may 
include medications, surgery or lifestyle changes. In some cases the condition will be 
cured with the risk of sudden cardiac death removed.
Nationwide cardiovascular screening has not been adopted due to the lack of empirical 
data to support the efficacy of screening and the associated costs. In evaluating the 
costs, it is important to know the psychological impact of the screening on those tested.
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Chapter 2. Cardiac conditions and Young Sudden Cardiac 
Death
2.1 Screening fo r card iac cond ition s
The sudden unexpected non-violent death in an apparently healthy young person is 
considered a rare event. However, its occurrence has a considerable psychological 
impact upon both those immediately affected and the wider community. Many studies 
have focused on sudden death in infants (especially on sudden infant death syndrome) 
and adults, but sudden death in children and adolescents has received little attention 
(Morentin etal., 2000).
Many sudden cardiac deaths occur with no prior symptoms. When symptoms do 
present they include chest pain, breathlessness, fainting, dizziness, and palpitations. 
Many of these symptoms are inherent in anxiety or other medical conditions, such as 
asthma and epilepsy. When presenting with these symptoms, there is currently no 
guarantee that the individual will be given the correct tests to identify an underlying 
cardiac condition. A new addition to the National Service Framework on Coronary 
Heart Disease is currently in its implementation stage. This aims to significantly reduce 
the number of SCDs by introducing the correct referral procedures for those people 
presenting with signs and symptoms of cardiac conditions.
Often SCD is the first symptom and specialist pathology is required to recognize the 
disease and bring the genetic implications of a potentially inherited disorder to the 
attention of relatives. Pathology and Coroner’s Court protocols are currently under 
review. However, rather than providing the cause of death when faced with SCD in a 
young person, the coroner’s mandate has been to exclude foul play. Subtle conditions 
may not be detected because an expert pathologist with experience of conditions 
causing SCD is often not responsible for performing the post-mortem examination. In 
conditions predisposing to fatal cardiac arrhythmias and SCD in the absence of
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structural cardiac abnormalities (such as long QT syndrome) the cause of SCD is 
difficult to ascertain. In all of these circumstances the cause of death is attributable to 
‘natural causes’ thereby producing a falsely low estimate of the incidence of SCD in the 
young (Sharma, Whyte, and McKenna, 1997).
When arrhythmias produce sudden death in patients with hearts without structural 
abnormalities, it is usually in patients with no previous electrocardiogram (ECG) 
investigations (Myerburg etal., 1997). If ECGs were routinely taken in adolescence it 
would be possible to determine the true incidence of cardiac conditions in young 
people, without having to speculate about potential misdiagnosis.
The ECG is abnormal, but not diagnostic in almost all cases of hypertrophic 
cardiomyopathy, and 90% of arrhythmogenic right ventricular cardiomyopathy 
(Sharma, Whyte, and McKenna, 1997), It will also identify the presence of a long QT 
interval or an accessory pathway in the case of Wolff-Parkinson-White prompting the 
need for a referral to a specialist cardiology unit for further evaluation.
Some evidence of the importance of routine ECG examinations has been obtained in 
Sweden (Wisten etal., 2004). Sixty-six of 162 individuals suffering a sudden cardiac 
death between 1992-1999 in Sweden had ECG’s prior to their death. The ECGs were 
identified from military conscription and medical records, re-analysed and classified 
according to the Minnesota code criteria. Pathological ECGs were common in young 
SCD victims, in spite of being taken many years before death (major or minor ECG 
abnormalities in 82% of the subjects) and were important in helping to identify 
prospective victims of SCD. The authors compared this data to a population study by 
Atterhog etal., (1980) of 18-19 year old Swedish military recruits at conscription who 
showed a prevalence of 2.5% of pathological ECGs. Wisten and colleagues did not find 
any systematic comparisons of ECG recordings and findings at autopsy and it was 
therefore only possible to relate their results to facts about the different cardiac
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diagnoses. However, with 50% of ECGs being pathological, they identified that 
pathological ECGs were 20 times more likely in SCD cases, as compared to the results 
of Atterhog et al., and other similar studies. The authors provided support for ECG 
screening, especially in athletes, and noted that taking an ECG test is clearly risk-free. 
Although the cost of screening an entire population could be substantial, the actual 
individual cost of an ECG is quite low. Wisten and colleagues (2004) suggested that 
further prospective and cost-effective studies should be performed to determine if 
routine ECG screening should be considered as a public health measure.
There is a need to screen large samples before true benefits can be established. 
Evaluating the benefits of cardiac screening is extremely difficult, with the incidence of 
sudden cardiac death believed to be rare, affecting approximately 1 in 100,000 people 
per life year in the general population. It should be noted that the use of the term “ per 
life year” or “person years” can be misleading or is misrepresented. Often it is 
construed as 1 in 100,000, and the “per life year” is excluded. In the important research 
into athletes carried out in Italy, it was estimated that the incidence of YSCD in athletes 
was 1.6 per 100,000 person- years, and 0.8 per 100,000 person-years in the general 
population, for the period 1979-1996 (Corrado et al., 1998). These figures equate with 
49 athletes out of 33,735 dying suddenly in the athletic population, compared to 269 
out of 2,009,600 in the general population (athletic population included). When the 
athletic population is excluded this is 220 in 1,975,865 population, 0.75 per 100,000 per 
year. This corresponds to 1 death per every 8,981 people.
The intention of a screening programme of this nature is to identify people with 
underlying cardiac conditions that could, at some point in time, kill them if not 
diagnosed and treated. It is immaterial whether the SCD occurs at the age of 15 or 34. 
Therefore it may be argued that an alternative, and more appropriate, method of 
evaluating the true incidence of the sudden deaths of these conditions is to look at the 
sample as a whole and how many of the population screened in this sample actually
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died, regardless of the study duration. This approach to reporting incidence is also one 
that can be easily understood across various professions, and less prone to 
misrepresentation.
Although the focus in this thesis is on young sudden cardiac death. It is important to 
note that the majority of sudden arrhythmic deaths occur after the age of 35 (Behr et 
al., 2007). Behr etal., estimated that over two thirds of the Sudden Arrhythmic Death 
Syndrome deaths occur between the ages of 35 and 64. Sudden Arrhythmic Death 
Syndrome is a term that is used to categorise sudden deaths that occur that are 
unexplained after post mortem, often using terms such as “natural” or “unascertained” 
death. Although these deaths are usually cardiac in origin, unless other family 
members are identified with a genetic condition it can be impossible to know the true 
cause of death due to a lack of evidence at postmortem. This lack of evidence or 
inappropriate evaluation of other family members of the deceased is part of the 
challenge in gaining accurate statistics on these conditions and is related to many 
misspecifications within the Office of National Statistics classifications of these deaths, 
highlighted in this study. Although screening will lead to a reduction in young sudden 
cardiac deaths, it is reasonable to suggest that it will also have a considerable impact 
in reducing those deaths that occur after the age of 35 by identifying those cardiac 
conditions that not only cause sudden deaths in young people, but also older 
populations.
There is some supportive evidence of the positive impact of cardiac screening of 
athletes in Italy. Italian law mandates that every competitive sportsperson must 
undergo clinical evaluation and obtain eligibility. Corrado etal., (1998) showed that, 
although hypertrophic cardiomyopathy was an uncommon cause of death in young 
competitive athletes, the identification and disqualification of affected athletes at 
screening, before participation in competitive sports, may have prevented sudden 
death. In the Italian work 1 in 54 people were identified with an underlying cardiac
condition that required them to stop participating in competitive sport. This appears to 
be a higher incidence than currently reported in the UK, with rates that are nearer to 1 
in 300 when the most common causes of SCD in the young are collated (Wilson et al,, 
2007). In 2005, Sharma presented statistics identifying that around 120,000 people in 
the UK, under the age 35, have a potentially fatal cardiac condition.
Much of the research in this area has focused on sport. The devastating impact of even 
infrequent fatal events in a young athletic population justifies appropriate restriction 
from competition (Maron and Zipes, 2005). The current position is that sports activity is 
not per se a cause of increased mortality. However, it acts as a trigger of cardiac arrest 
upon those with an underlying cardiac disease predisposing to life threatening 
ventricular arrhythmias. This is because the heart is more vulnerable to life threatening 
arrhythmias when it is stressed and athletes, compared to non-athletes, exert more 
stress upon their heart during training and competition.
The Sport Cardiology Study Group of the Working Group of Cardiac Rehabilitation and 
Exercise Physiology and the Working Group of Myocardial and Pericardial Disease of 
the European Society of Cardiology recommend systematic pre-participation 
cardiovascular screening of young competitive athletes to detect cardiovascular 
abnormalities (Corrado etal., 2005). The panel suggests a European standard for 
medical evaluation of competitive athletes with a protocol that includes a 12 lead ECG, 
on the grounds that this is the only screening modality proved to be effective in 
identifying athletes with hypertrophic cardiomyopathy, and preventing sudden death 
(Pelliccia etal., 2006). No deaths occurred in the long term follow-up in those athletes 
identified with hypertrophic cardiomyopathy and disqualified from competitive sport 
(Corrado etal., 1998).
Implicit within the recommendations to screen competitive athletes is the wider notion 
that testing high-risk populations will increase the chance of preventing SCD from
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occurring. In the case of sport, young people are making a lifestyle decision (sports 
competition) that will put them at an increased risk of SCD. Many young people will 
occasionally fit into a high-risk group, albeit not necessarily for prolonged periods of 
time or on a regular basis, as in the case of competitive athletes. However, on the 
presumption of screening athletes to reduce SCD risk, it may be reasonable to 
advocate screening of other groups.
For example, Nistri etal., (2003) described the ECG screening of 34,910 male military 
conscripts in Italy. Of these, 2,766 were referred from more detailed echocardiography, 
and 19 recruits with hypertrophic cardiomyopathy were identified and excluded from 
military service. Similarly, Sorbo et al., (1995) reported that 173 cases of Wolff- 
Parkinson-White syndrome were identified in 116,452 18-year old boys screened in 
North-East Italy. In both of these studies, the vast majority of the young men were 
asymptomatic. The authors argued that if the ECG screening had not been done, these 
cardiac diagnoses would not have been identified.
It is also difficult to know if the early detection of a condition will prolong a life. Unless a 
randomized trial is carried out it will be impossible to know what the lifespan would 
have been if the condition was not detected. However, a recent publication on how 
screening affects athletes goes some way to address this.
The strongest evidence to date in favour of preparticipation screening comes from an 
observational study carried out in the Veneto region of Italy and reported by Corrado et 
al., (2006). Since 1982 when ECG screening was introduced, the annual incidence of 
sudden death among athletes aged 12-35 years decreased from 3.6 to 0.4 deaths per 
100,000 athletes, a decline of 89%. There was no change in death rates among 
nonathletes, suggesting that the screening was responsible for these avoidable deaths. 
Although these results are compelling, they have limitations. The study did not 
compare screened and nonscreened athletes, but was a comparison with the general
population. Other changes in the management of health among athletes could have 
contributed. Additionally, all the athletes were screened at a centre in Padua, whereas 
the comparison population came from a wider region, so there could have been 
unmeasured differences between the two populations (Thompson etal., 2007).
The unique structure and pressures of organized sports means that athletes with heart 
disease engaged in competition may not always use proper judgment in prudently 
extricating themselves immediately from vigorous exercise, not recognizing the 
potential medical need to terminate the activity. It may be difficult to reliably distinguish 
symptoms such as dizziness, palpitations, fatigue, excessive dyspnea, or chest 
discomfort (or any other potential warning sign of cardiovascular disease) experienced 
during competitive sports from those innocent sensations that can normally accompany 
intense and extreme exercise, mimicking symptoms of cardiac disease (Maron et al., 
2004J.
These considerations are not generally part of truly recreational sports activity. 
Participants in recreational physical activities have greater opportunity to exert 
reasonable control over their level of exercise and therefore are more likely to reliably 
detect cardiac symptoms and willfully terminate physical activity. However, it is 
acknowledged that in some recreational sports (eg, soccer, tennis, squash and 
racquetball), participants can become truly competitive, largely owing to the style of 
play and participants’ attitudes (Northcote, Evans, and Ballantyne, 1984).
In Kagoshima, Japan, both athletes and non athletes were screened using an ECG for 
cardiovascular disease between 1989 and 1997 (Tanaka etal., 2006). 68,503 children 
were initially screened, 30,696 moved away leaving 37,807 who were followed up over 
6 years. Of these 632 were excluded from the study as they were previously diagnosed 
with cardiovascular disease. 99% of the population of seventh graders participated with 
nine high risk subjects identified. The authors suggested that this screening system
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might be helpful to prevent nonathletes from participating in competitive exercise in the 
future. Their findings clearly indicate the importance of identifying high risk subjects in 
both athlete and non athlete populations to decrease young sudden cardiac death.
They also identified that the screening system is cost effective and therefore 
considered appropriate. Two deaths did occur in boys aged 13 and 16 with normal 
ECG findings and they did raise the concerns that the ECG may be limited.
Furthermore one 14 year old boy was identified with hypertrophic cardiomyopathy 
during screening and died while jogging. He was a kendo player who had been 
disqualified from competitive sports.
The focus has so far been on conditions related to adolescents. Although the focus has 
been on a post-puberty age group, some cardiac conditions can be diagnosed prior to 
puberty and are implicated in sudden death from birth. QT prolongation in the first week 
of life has been shown to be a major risk factor of sudden infant death syndrome 
(SIDS) (Schwartz etal., 1998) in a prospective ECG study of 34,000 infants. Initially 
anecdotal evidence (Schwartz et al., 2001; Schwartz etal., 2000), which has now been 
shown at a molecular level in two recent studies of 93 and 201 SIDS victims (Tester 
and Ackerman, 2005; Crotti et al., 2005) has shown that 10% of SIDS cases are 
actually due to long QT syndrome. When patients with long QT syndrome are properly 
treated there is a very low mortality (<2%) (Moss et al., 2000; Priori et al., 2004; 
Schwartz etal., 2004). This research has raised the controversial question of the 
importance of neonatal ECG screening as a tool to identify and treat patients with this 
condition (Lucey, 1999). Some European countries are considering this possibility as 
part of their National Health Services while evaluating the appropriate expertise 
necessary in interpretation of neonatal ECGs. The Italian Ministry of Health is engaged 
in a pilot study to evaluate this nationally with interesting early findings of asymptomatic 
life threatening congenital heart diseases being identified which were not detected in 
initial medical visits.
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One of the key issues in introducing screening programmes is the cost effectiveness of 
the appropriate strategy. Quaglini etal., (2006) showed that neonatal screening is 
highly cost effective and that a significant number of lives can be saved for an 
objectively small cost. The authors state that their direct experience with their large 
pilot study of 45,000 infants has shown “complete and favourable acceptance by the 
families”. The significance of this research is in taking forward the debate surrounding 
the cost effectiveness of an ECG programme and primarily in disputing the common 
misconception that screening is not cost effective. However, there were some 
limitations in their analysis that need to be considered, since the cost of training 
cardiologists to read the ECGs was excluded.
It is reasonable to propose that screening in adolescents is a more cost effective 
strategy, compared to screening in the first weeks of life, on two premises. Firstly that a 
number of the cardiac conditions that can present as sudden cardiac death are not 
detectable prior to puberty. Therefore any screening programme that is introduced after 
puberty will have greater sensitivity and specificity. Secondly, the parents of those 
infants at risk of SIDS will already be aware of any potential risks their infant may face 
due to their prior diagnosis, and therefore screening after birth could be targeted at 
those who are known to be at higher risk.
Another group at increased risk is people with potentially cardiac related symptoms. 
How far should testing go in assessing symptoms? The new 2005 NSF guidelines 
(NSF Coronary Heart Disease, Chapter 8 Arrhythmias and Sudden Cardiac Death, 
2005) recommend that people experiencing various syncope associated symptoms 
should be referred to a heart rhythm specialist for evaluation. However, up to one in 
five of all adolescents suffer from an episode of syncope before adulthood (Ross and 
Grubb, 1998). Although the majority of syncope is benign, sometimes it is caused by an 
underlying life threatening condition. When syncope presents, the most useful 
investigation is a 12 lead ECG, primarily to exclude a long QT interval (McLeod, 2001).
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Furthermore, the incidence of reported unexplained sudden death is almost certainly 
an underestimate, as some of the deaths which would more accurately be described as 
being unexplained by findings at necropsy are attributed by the coroner’s pathologist to 
epilepsy or respiratory infection (Wren, O'Sullivan, and Wright, 2000). Should an ECG 
be routine in all diagnoses of asthma and epilepsy to rule out a cardiac cause of 
symptoms? It is estimated that one third of those diagnosed with epilepsy have an 
underlying cardiac abnormality (Boyle, 2005). If a symptom is caused by an underlying 
cardiac condition, not asthma or epilepsy, the prescribed medication may cause further 
cardiac complications, and further increase the risk of SCD.
There are several situations where a personal knowledge of an underlying cardiac 
condition may help a person make a decision about lifestyle that limits their risk of 
suffering a sudden cardiac death. These include not running a marathon, not taking 
certain medications, and not pursing a career in competitive sports.
The current screening programme under evaluation has been developed from the 
premise that young people can die without being aware that they are at risk of SCD.
For many of the instances of SCD the first symptom is sudden death. In a recent 
survey by Cardiac Risk in the Young (currently unpublished) over 60% of the deaths 
were asymptomatic. The only way to detect people who are asymptomatic, with no 
family history, is through proactive screening.
2.2 The management of cardiac abnormalities in youth
In 2002 the European Society of Cardiology convened a Task Force on Sudden Death 
and published recommendations for risk stratification and for prophylaxis of SCD (Priori 
et al., 2002). Within this article they addressed the issue of SCD occurrence as a 
consequence of inherited genetic abnormalities and discussed the most common 
conditions that can lead to SCD.
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Once a condition is identified, risk stratification is evaluated, with treatment options 
varying depending on level of risk. At one extreme, a patient may only require ongoing 
monitoring of their condition or minor lifestyle changes. At the other extreme, an 
implantable cardioverter-defibrillator (ICD) or even a heart transplant may be required. 
The ICD is a battery-powered device that has significantly improved the chances of 
survival in individuals at high risk of SCD.
The ICD is currently the most effective long-term treatment available for SCD, and is 
the primary therapeutic approach in the treatment of individuals at high risk of SCD. It 
is generally more effective than drug-based treatments (such as beta-blockers and 
amiodarone). However, it has not been internationally adopted, arguably because of 
differing medical priorities in communities with limited resources (Priori etal., 2002). It 
is important to note that currently the ICD is not proven to be superior to all other 
treatments in all conditions, and complications can occur with young children (due to 
issues such as physical growth or young people not adhering to lifestyle advice 
resulting in damage to the device).
Once a cardiac arrest has been survived or syncopal / hypotensive ventricular 
tachycardia has been experienced, the person will usually be considered at high risk. In 
the case of hypertrophic cardiomyopathy considerable progress has been made in 
establishing levels of risk. In this condition the implant of an ICD is most strongly 
warranted for those with a prior cardiac arrest or when two or more risk factors (such 
as previous cardiac arrest or ventricular fibrillation, syncope, reactions to exercise) 
have been identified (Priori etal., 2002). Sometimes, especially in young people where 
ICD implantation is complicated, home defibrillators are recommended, or ‘buddy’ 
systems are adopted where people at high risk of SCD are always accompanied. In 
some selected patients, treatment (such as amiodarone) may represent a 
pharmacological alternative to the ICD (McKenna etal., 1995). When the conditions
are considered at low risk of causing SCD, an ICD may not be recommended. This is 
usually when patients have not yet suffered a life threatening ventricular arrhythmia, 
but are at risk of such an arrhythmia.
Exercise appears to increase the risk of SCD. Therefore, people with these conditions 
are usually advised to avoid competitive sports and unrestricted severe exertion. 
Furthermore, a person with a cardiac condition that can cause SCD needs to take care 
when taking medication. Some drugs can stimulate and irritate the heart by causing 
adrenaline-like effects and should be avoided. In the case of long QT, specific 
medications can have a serious effect by further prolonging the QT interval (Schwartz 
et al., 2000). In some of conditions, less is known about the effects of a range of drugs 
and patients should always be cautious. In Brugada syndrome, antiarrhythmics, beta- 
blockers and some antidepressants are known to interact badly.
Although the majority of cardiac conditions will require ongoing cardiac treatment or 
surgery to minimize risk, sometimes corrective surgery is possible. When a patient with 
Wolff-Parkinson-White syndrome is at risk of SCD, catheter ablation is recommended, 
especially for those who have been resuscitated from ventricular fibrillation or had 
clinical atrial fibrillation with rapid ventricular responses (Zipes etal., 1995). This 
operation is highly effective and results in the elimination of SCD risk in the majority of 
cases.
It is not possible to go into the full details of all potential SCD conditions, as each have 
specific characteristics, which require specialist knowledge in diagnosis, assessment of 
threat, and treatment. Most of the work has so far been carried out in patient groups 
with considerable pre-existing cardiac disease. More work is needed in larger 
populations with less or no apparent heart disease. Effective identification and 
treatment will lead to a substantial reduction in SCD in the general population (Priori et 
al., 2002).
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2.3 The psychological impact of being identified with a cardiac condition in 
children and adolescents
A key debate in each screening programme is the psychological impact on those 
identified with a cardiac condition. The psychological consequences must be evaluated 
against a range of factors, including the characteristics of the illness and its 
implications for a person’s lifestyle, as well as the impact of genetic predisposition on 
the whole family. For instance, hypertrophic cardiomyopathy is a chronic condition. 
Patients are confronted with a potentially life threatening problem and may have the 
perception that their levels of physical activity is severely curtailed. Hypertrophic 
cardiomyopathy is familial in a substantial proportion of cases (McKenna, 1996), this 
can give rise to the fear of transmission and other issues surrounding genetic 
counseling. The few studies that examined the consequences of living with the 
diagnosis of a genetic cardiac condition seem to indicate that, on the whole, people 
diagnosed and treated are able to lead a relatively normal life, though some age- 
related differences were detected.
The first study to look at the psychological response to living with hypertrophic 
cardiomyopathy was a cross-sectional investigation of 171 patients (aged over 14 
years) that I carried out several years ago (Cox et al., 1997). 137 agreed to participate 
with a response rate of 80.1%. This showed that diagnosis of the illness negatively 
impacts upon the perceived quality of life of a patient, but that there were wide 
variations in reported symptoms, adjustment to the condition, and the perceived quality 
of interactions with clinical staff. Patients had severe limitations in all of the dimensions 
of quality of life measured including physical functioning; role limitations owing to 
physical problems and emotional problems; social functioning; mental health; general 
health perceptions; vitality and bodily pain. The quality of life was particularly impaired 
in those patients with chest pain and dyspnoea, but less consistently related to clinical 
cardiological measures. Ratings on the Hospital Anxiety and Depression Scale (HADS) 
(anxiety) scale averaged 8.23 (S.D. 4.3) with 21.2% of patients classified as possible
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and 28.5% as probable cases of clinical anxiety. These scores were not only 
significantly higher than population norms but also those reported by patients with 
cancer who were assessed at the time of the initial diagnosis or first relapse.
Few other studies have explored the psychological costs of living with these conditions 
in young people. In the case of children and adolescents being treated with ICDs, there 
is evidence from one study to suggest that although they experience significantly lower 
physical functioning compared with a normative US sample, their psychosocial 
functioning is not impaired (DeMaso etal., 2004). The authors suggested this could be 
a reflection of “denial-coping strategy” on the part of both the parents and patients. 
However, the study had major limitations in that it drew its conclusions from a sample 
of just 20 respondents (mean age 14.8 years; age range 9-19 years).
There is some evidence that once a condition is detected, and the necessary treatment 
is given, patients experience improvements in psychological well-being (DeMaso etal., 
2000). Patients (N=38, range 6-18 years) with recurrent arrhythmias who underwent 
radiofrequency catheter ablation of ectopic myocardial foci, resembled a normal 
population in anxiety or depression. After they had had the ablation, the patients 
showed reductions in the "fear of their heart problem" and an increase in "the things 
that they enjoy".
Although some patients will understandably experience difficulties in response to the 
diagnosis of a life threatening cardiac condition and subsequent treatment, they appear 
to have normal psychological functioning.
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2.4 National screening policy and its application to young sudden cardiac 
death
In this section I will present the 22 criteria that the UK National Screening Committee 
(NSC) adopt when appraising the viability, effectiveness and appropriateness of a 
screening programme (www.nsc.nhs.uk/pdfs/criteria.pdf). The committee states that 
ideally all of the criteria should be met before screening for a condition is initiated.
When conditions are sometimes asymptomatic prior to a first presentation of sudden 
death it is reasonable to suggest that the only means to furthering our knowledge is 
through research programmes or screening.
I italicise the word screening because the word itself is used in different contexts that 
need clarification. For instance there is screening of a family for an inherited condition 
after a family member is identified, there is screening of a subset population who are 
identified as at increased risk (as is the case in Italy where there is mandatory 
screening of their athletes), or there is the offer of a test to the public to have a test if 
required. This is not a conclusive list, however, even in this final option of offering to the 
public, a screening test is not necessarily automatically offered to all people. Mitigating 
circumstances may occur where people are not offered tests even when a national 
screening programme is in place with the authority of the National Screening 
Committee.
The reason this issue is raised is because it is questionable whether the current 
programme under study is a screening programme or a testing programme. Arguably it 
is a testing programme, however, if implemented on a wider scale it would be a 
screening programme. This would appear to be a relative discussion as in this study an 
ECG was offered to the complete population of defined age groups within schools and 
taken up by approximately a third of the population in each case.
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One of the considerable difficulties in appraising the current programme with the 
national screening committee criteria is the significant potential for incidental findings. 
Instead of looking at conditions that can lead to YSCD in general, it should be 
conceptualised as screening for common conditions, with uncommon conditions being 
incidental findings. The reason for this distinction is that it is reasonable to expect 
screening for a condition that is less common like Brugada syndrome or 
arrhythmogenic right ventricular cardiomyopathy, to fall short on some of the criteria 
identified by the NSC. Due to the small numbers of living people identified with these 
rarer conditions, the research is still in its infancy.
I will now address each of the criteria set out by the NSC in relation to screening for 
conditions that can cause YSCD, with a primary focus of answering the questions in 
relation to screening for hypertrophic cardiomyopathy and Wolff-Parkinson-White. 
Wilson has also presented criteria that are adopted by the World Health Organisation. 
All of Wilson’s criteria in table 2.1 are included in the national screening committee’s 
criteria set out below.
Table 2.1 Wilson criteria for screening
• the condition should be an important health problem
• the natural history of the condition should be understood
• there should be a recognisable latent or early symptomatic stage
• there should be a test that is easy to perform and interpret, acceptable, accurate,
reliable, sensitive and specific
• there should be an accepted treatment recognised for the disease
• treatment should be more effective if started early
• there should be a policy on who should be treated
• diagnosis and treatment should be cost-effective
• case-finding should be a continuous process
2.4.1 Criteria for screening
The NSC guidelines state that ideally all the following criteria should be met before 
screening for a condition is initiated:
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2.4.1.1 The condition
1. The condition should be an important health problem
In 2005 the Department of Health produced the NSF chapter 8 arrhythmias and sudden 
cardiac death, a set of guidelines set out with the aim to “prevent some of these 
tragedies and ensure that there is appropriate support for the families of people who 
die unexpectedly, many of whom are young.” The Sudden Cardiac Death of a young 
person has a considerable impact on all those who are involved. It is difficult to 
determine the true impact of a young sudden cardiac death without research to identify 
how far the impact reaches, and what the impact is. On the basis that 400 young 
people die every year, this will have a direct and ongoing impact on a conservative 
estimate of at least 2,000 immediate family members (grandparents, parents, siblings 
and children). There will then be the further impact on friends and colleagues of the 
deceased.
2. The epidemiology and natural history o f the condition, including development from 
latent to declared disease, should be adequately understood and there should be a 
detectable risk factor, disease marker, latent period or early symptomatic stage 
The conditions are often genetic and asymptomatic. An ECG will identify an 
abnormality and in the majority of cases, this will prompt further tests that will confirm 
diagnosis and risk stratification.
3. All the cost-effective primary prevention interventions should have been 
implemented as far as practicable
Due to the conditions often being asymptomatic it is impossible to intervene in those 
cases where symptoms are not present. When symptoms are present referral to a 
specialist should take place, as identified in the NSF chapter 8 guidelines.
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4 If the carriers o f a mutation are identified as a result o f screening the natural history 
of people with this status should be understood, including the psychological 
implications.
Research has been published to identify prognosis of the most common conditions as 
well as the psychological implications of living with hypertrophic cardiomyopathy and 
dilated cardiomyopathy, as well as the role of the ICD in high risk patients and the role 
of ablation in Wolff-Parkinson-White.
2.4.1.2 The test
5 There should be a simple, safe, precise and validated screening test
The ECG is simple, safe, non-invasive and accurate when read by a specialist. The 
ECG has been identified by a working group for the European Society of Cardiology 
(ESC) as the only screening modality to affectively identify those at risk of hypertrophic 
cardiomyopathy. The ECG will identify Wolff-Parkinson-White in nearly all cases 
(Corrado et al., 2005).
6 The distribution of test values in the target population should be known and a suitable 
cut-off level defined and agreed
International criteria for identifying ECG abnormalities have been published (Corrado et 
al., 2005).
7 The test should be acceptable to the population
There is little evidence on this topic, and this was one of the reasons for carrying out 
this research.
8 There should be an agreed policy on the further diagnostic investigation o f individuals 
with a positive test result and on the choices available to those individuals.
Considerable research has been conducted into risk stratification of hypertrophic 
cardiomyopathy and Wolff-Parkinson-White. ESC guidelines were recently published
for competitive sport participation (Pelliccia et al., 2005) and general guidelines for 
SCD (Priori et al., 2002). Guidelines in the form of a National Service Framework have 
also been produced (March, 2005).
9 If the test is for mutations the criteria used to select the subset of mutations to be 
covered by screening, if  all possible mutations are not being tested, should be clearly 
set out
Not applicable
2.4.1.3 The treatment
10 There should be an effective treatment or intervention for patients identified through 
early detection, with evidence o f early treatment leading to better outcomes than late 
treatment
Early treatment will reduce the risk of suffering a sudden cardiac death, as noted in 
section 2.2.
11 There should be agreed evidence based policies covering which individuals should 
be offered treatment and the appropriate treatment to be offered
International recommendations for risk stratification and the preventions of SCD have 
been published (Priori et al., 2002). International recommendations have also been 
published for participation in competitive sports for athletes with cardiovascular disease 
(Pelliccia etal., 2005).
12 Clinical management of the condition and patient outcomes should be optimised in 
all health care providers prior to participation in a screening programme
Through a co-ordinated structure of specialist centres it will be possible to ensure that 
all health care providers have access to the specialist services required for ongoing 
management of these conditions. This service is currently being implemented 
throughout the UK.
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2.4.1.4 The screening programme
13 There should be evidence from high quality randomised controlled trials that the 
screening programme is effective in reducing mortality or morbidity.
No randomised controlled trial of cardiac testing has yet been carried out. However, 
Corrado etal., (2006) published a report identifying how screening in Italy significantly 
reduced mortality in the screened population. Prior to screening, deaths in athletes 
were significantly higher than the population, after screening the incidence of SCD in 
athletes were lower than population norms.
Where screening is aimed solely at providing information to allow the person being 
screened to make an “informed choice” (eg. Down’s syndrome, cystic fibrosis carrier 
screening), there must be evidence from high quality trials that the test accurately 
measures risk. The information that is provided about the test and its outcome must be 
of value and readily understood by the individual being screened.
The informed consent requires that the participant is aware of the implications if a 
diagnosis is made, that the conditions may be genetic and have an effect on their way 
of life. It also states that the ECG will identify the majority of conditions that can lead to 
YSCD.
14 There should be evidence that the complete screening programme (test, diagnostic 
procedures, treatment/ intervention) is clinically, socially and ethically acceptable to 
health professionals and the public.
Clinically - the tests are painless and non invasive and so acceptable to the public. 
However clinical specialism is required to maintain quality control throughout the 
screening procedure. This thesis studied the psychological acceptability of the test to 
the public. Health professionals may dispute the utility of the service on the allocation 
of resources, and how they may have been better allocated. Ethically it is a difficult 
debate.
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15 The benefit from the screening programme should outweigh the physical and 
psychological harm (caused by the test, diagnostic procedures and treatment)
No physical harm is caused through the testing procedure (except some hair being 
removed from the chest!). The primary focus of this thesis is the important question of 
whether there is a psychological impact on those people who have participated in the 
testing and been given a negative diagnosis. The research to date in other conditions 
(such as cancer) will be discussed in the next chapter.
16. The opportunity cost of the screening programme (including testing, diagnosis and 
treatment, administration, training and quality assurance)should be economically 
balanced in relation to expenditure on medical care as a whole (ie. value for money). 
The study of screening new born babies for long QT syndrome has gone some way to 
show that ECG screening is highly cost effective in this population. It is reasonable, as 
has already been discussed, that screening in an adolescent population would be more 
cost-effective due to the increase in sensitivity of the test when conducted after 
puberty.
17. There should be a plan for managing and monitoring the screening programme and 
an agreed set o f quality assurance standards
A plan has yet to be established.
18. Adequate staffing and facilities for testing, diagnosis, treatment and programme 
management should be available prior to the commencement o f the screening 
programme
The clinical skills are available and therefore a programme would expand in 
accordance with demand for the screening service.
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19 All other options for managing the condition should have been considered (e.g. 
improving treatment, providing other services), to ensure that no more cost effective 
intervention could be introduced or current interventions increased within the resources 
available.
With an expanding number of people being tested and identified with the conditions, it 
would follow that there will be an increase in research which will enable new clinical 
initiatives to develop and optomise current treatment regimes.
20 Evidence-based information, explaining the consequences of testing, investigation 
and treatment, should be made available to potential participants to assist them in 
making an informed choice.
Currently, it states on the informed consent what the implications of being diagnosed 
with a condition are (i.e. life insurance and mortgage difficulties), as well as the clinical 
limitations of the ECG (i.e. not identifying everyone at risk).
21. Public pressure for widening the eligibility criteria for reducing the screening 
interval, and for increasing the sensitivity o f the testing process, should be anticipated. 
Decisions about these parameters should be scientifically justifiable to the public. 
Clinical criteria inform the age at which the screening can be implemented. Prior to the 
age of 14 the testing can be conducted but will be more sensitive if conducted after 
puberty. Currently the time interval for receiving results are reasonable (3 weeks). 
Furthermore, with an increase in research it is reasonable to expect the sensitivity of 
the testing to improve. This is exemplified by the work of Corrado et al., 2006. When 
they commenced their athletic screening programme 25 years ago, far less was known 
about arrhythmogenic right ventricular cardiomyopathy. Regardless of the screening, 
initially many people continued to die of this condition. In later years new guidelines 
were adopted which identified those at risk, and now the number of deaths has been 
substantially reduced (Corrado et al., 2006).
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22 If screening is fo ra  mutation the programme should be acceptable to people 
identified as earners and to other family members.
Not applicable
2.5 Conclusions
The cardiac conditions underlying YSCD occur with sufficient frequency to warrant 
screening. These conditions can be effectively treated to reduce cardiac risk. ECG 
screening of athletes appears to reduce risk of YSCD, although a definitive randomised 
controlled trial has not been carried out. An ECG testing programme for cardiac 
conditions underlying YSCD would appear to fulfil the UK National Screening 
Committee criteria for accepting a new screening programme.
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Chapter 3. Psychological impact of screening
Evaluation of the psychological costs of a screening programme is part of a larger 
debate as to the net benefit of a screening programme. Some have argued that the 
(relatively small) number of lives being saved through screening does not justify the 
anxiety raised through the procedure (Schmidt, 1990). In most cases the calls to 
establish new screening programmes are based on evidence of benefits to people who 
are found to have the disease. However, when conditions are rare, many hundreds or 
thousands may have to be screened to identify those affected. It is therefore of great 
importance to evaluate the full impact of the programme on the health and well-being of 
potentially healthy individuals, before it can be decided whether the programme is good 
for the public’s health. It is important to know the social and psychological costs of 
screening before deciding whether individual screening programmes should, or should 
not, be provided. The benefits of a small increase in life expectancy or reduction in 
disability for a small number of people needs to be weighed against a range of harmful 
psychological effects (Stewart-Brown and Farmer, 1997).
There are many potential costs of participating in a screening programme. Some of the 
suggested costs and benefits are shown in table 3.1. These range from the trauma of a 
symptom-free individual being identified with a disease, through to the stress for a 
healthy person in which a disease was suspected but later discounted. There are also 
the more subtle worries of participants during the screening process (Wardle and Pope, 
1992). It is necessary to examine and address the psychological consequences of an 
organised screening programme to prevent potentially negative consequences from 
occurring (Marteau, 1990).
Much of the research into the psychological impact of screening has focused upon
cancer. Cancer is probably the most feared disease in the Western world, and has had
significant screening programmes in place for a number of years. Although there are
many facets of cancer that differ from the currently examined cardiac conditions, it will
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provide a necessary insight into some of the potentially negative outcomes that can 
occur from engaging in a screening programme. It has been suggested that 
psychological distress can occur at each stage of the screening process from the initial 
invitation to the provision of the test result (Marteau, 1990). Research into breast 
cancer has also highlighted the need to examine the potential for psychological distress 
in those who receive a normal result as well as false-positives (Steggles, Lightfoot, and 
Sellick, 1998).
Cancer and lifestyle-related coronary heart disease are profoundly different from the 
cardiac conditions being screened for in a young age group. Although screening is 
predominantly carried out on older populations (i.e. over the age of 55), research in 
these areas is often mentioned in arguments debating the screening of young people 
on the ground of causing anxiety in participants. The impact of screening may be 
fundamentally different for the young, due to a number of factors including 
physiological differences and different prognostic implications, as well as psychological 
factors, such as the potentially different perspectives that the young may have of their 
health compared with older generations.
There are no systematic studies of the psychological impact of cardiac conditions in 
young people. Furthermore, there are very few studies of the psychological impact of 
any screening programme on young populations, let alone ones that have adopted a 
systematic robust methodological approach. It has therefore been necessary to look 
outside the realm of cardiac conditions in young people and draw conclusions from the 
literature of those conditions that have been well researched.
The screening programme under study is not strictly a genetic based screening 
programme. However, many of the conditions being screened for are genetic, such as 
hypertrophic cardiomyopathy, which is transmitted at an autosomally dominant rate 
(50/50 chance). The research into the psychological impact of genetic screening will
therefore also be informative. As in the case of this screening programme, many 
participating in genetic screening programmes are both ‘healthy’ and asymptomatic.
In the following sections, I will first review the available literature on screening for 
conditions in young age groups. I then go on to discuss the issues of screening in older 
age groups before providing a theoretical framework for this thesis.
3.1 The psychological impact of participation in screening for children and 
adolescents
The only study to look at the acceptability of ECG testing from a psychological 
perspective evaluated reactions to ECG screening to detect cardiac arrhythmias in a 
university dental school clinic (Little et al., 1990). 91 patients (in 8 age groups 11-20 
through to 81-90) were studied, of whom 71 completed the anxiety measures. The 
study found that the vast majority of those who participated indicated that the test was 
easy and did not intrude on the dental appointment. Most reported that the test was a 
valuable service, and none stated the tests should not be performed in the dental 
office. Only a few of the patients expressed any significant concern or anxiety about the 
test either before or after it was completed. It is important to note that there is no 
reference to age differences in this report, and only 24% of respondents (N=22) were 
between the age of 11 and 30. Conclusions were drawn from concurrent and
Table 3.1 Psychological costs and benefits of screening
Potential costs
Raised anxiety
Raised health preoccupation/ Medicalisation of society
False/ Inappropriate reassurance
False positive / abnormalities
Difficulties provoked if screened and found healthy
Psychiatric morbidity
Discrimination in employment and insurance 
Financial cost -  screening requires funding
Potential benefits
Reduced anxiety
Reassurance
Relief from uncertainty
Early identification of disease
Diminution of psychiatric disturbance
Assist lifestyle decisions
Individual autonomy
A
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retrospective non-validated anxiety measures. Respondents were asked 2 anxiety 
questions after receiving their results, one question asking about their level of anxiety 
just before the test was performed, and one question asking about their level of anxiety 
after the test was completed and they were informed of the result. This lack of a 
prospective base-line measure before the testing limits the possibilities for determining 
true shifts in anxiety across different stages of screening. The second question could 
also be interpreted as addressing two separate issues -  anxiety after test, and anxiety 
after result, further complicating the result interpretation. The use of a multi-item 
validated anxiety measure, instead of a non-validated single item anxiety measure, 
would have improved the study design. The low anxiety reported following the 
screening could well have been due to the nature of the screening procedure itself: 
only a three lead ECG was used and the patients were not required to disrobe, an 
aspect of the procedure often considered a potential cause of anxiety. Furthermore, the 
ECG test was taken at a time when there was less awareness of the cardiac conditions 
affecting young people.
There is a consensus that children should be offered genetic testing when conditions 
are treatable because the clinical benefits outweigh psychological problems (Reilly & 
Wertz, 1997). However there is little empirical data on the psychological impact of 
predictive testing in children (Michie & Marteau, 1996).
Michie etal., (2001) conducted two studies of predictive testing for familial 
adenomatous polyposis (FAP). One was a cross sectional study comparing the 
psychological impact of the testing in adults and children (age 10-16 years). The other 
was a prospective study comparing children’s psychological functioning before testing 
and at two time points following the testing. The cross sectional study comprised a 
sample of 148 adults and 60 children, recruited from seven UK genetics centres and an 
Australian genetics centre. They were sent a questionnaire after receiving their test 
result, although it was not clearly specified how long after. The adults were aged 17-67,
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125 tested negative and 23 positive. The children were aged 10-16, 29 tested negative 
and 31 positive. Well-validated measures were used, including the Spielberger State 
Trait Anxiety Inventory (shortened adult version and children’s version). They found 
that children receiving positive or negative results did not experience greater anxiety or 
depression than adults. The only differences were that children testing positive were 
less anxious than the adults and fewer children than adults testing positive had clinical 
levels of anxiety (19% vs. 43%). Children with negative results had anxiety scores 
significantly lower than US norms. Although children who tested positive were more 
anxious and depressed than those testing negative, their test results did not influence 
their perceived health. 26 (out of 29) negatives and 30 (out of 31) testing positive 
reported that their health was good or excellent.
The prospective study comprised 31 children from the cross sectional study who had 
completed additional measures (including anxiety) before testing and at a second point 
after the results. Time 1 - before testing, time 2 an average 8 weeks (range 1-43) after 
receiving test results and time 3 -  an average 33 weeks (range 20-77) after testing.
Children did not show any significant distress over the first year following the predictive 
test. Those with positive results were within the normal range for anxiety and did not 
change over time. Anxiety decreased over time for those receiving negative results. 
Both positive and negative groups worried less about their chance of getting polyposis 
after the testing.
The authors suggested that the age of the respondents may have influenced the low 
levels of anxiety since young people may have less understanding of the social 
implications of the test result (i.e. obtaining mortgage) and passing on the condition. 
Alternatively, it may well be that the threat is further in the future and therefore the 
children perceived this as less threatening.
49
The main limitation of this prospective study is that its conclusions were drawn from a 
sample of only 19 respondents who completed the anxiety measure at all time 
intervals. Furthermore, the timing of administration of questionnaires after the testing 
was very variable; there will have been some responses that will have completed the 
anxiety measure at time 2, yet within the time 3 range and vice-versa. In the light of the 
small sample size, it would have been useful to limit the variation in time intervals, with 
no time overlap, for administration of the questionnaires. Nevertheless, similar findings 
were identified previously in the genetic testing for FAP in 41 children (aged 6 to 16 
years) and their parents, showing that the testing of children at risk for FAP did not lead 
to clinically significant psychological symptoms in tested children or their parents 
(Codori etal., 1996).
Measuring adolescents’ attitudes to genetic screening should help understand the 
potential psychological implications of engaging in a screening programme. Harel e ta i, 
(2003) examined adolescents’ attitudes towards screening for Tay-Sachs disease, 
breast cancer and hypercholesterolemia. No screening was actually carried out. Their 
research indicated that many adolescents are interested in testing for possible 
hereditary disorders. About two-thirds of the adolescent girls wished to undergo genetic 
testing to detect inherited susceptibility to breast cancer. The main reason for not 
wanting genetic testing for breast cancer was anxiety. About a half of the study 
participants were willing to be tested for hypercholesterolemia, with a family history of 
high cholesterol making individuals significantly more willing to be tested. As pointed 
out by the authors, the study was limited by including a sample taken from only one 
school, but it does provide some insight into the ways adolescents think about testing 
for genetic illness.
The current literature indicates that although there is some evidence that adolescents 
may not respond well to learning of increased risk in some conditions, there is also 
evidence that adolescents often respond positively to the potential threats of a genetic
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disease, and that they show willingness to be tested. However, there are significant 
limitations to the research reviewed, which prevent extrapolation to cardiac screening 
in the young.
3.2 Predictive (genetic) screening
Other studies of predictive testing may provide further insight into the potentially 
harmful side effects of engaging in a screening programme, as many cardiac 
conditions are inherited at an autosomally dominant rate. The conditions under study 
(such as hypertrophic cardiomyopathy, long QT syndrome) may have an immediate life 
threat if undiagnosed and therefore differ from the situation in which the threat may of 
developing a disease in the distant future. However, there is an overlap in that both are 
testing a ‘healthy’ population and introducing a potential risk factor that will probably 
have a psychological impact.
Broadstock et al., (2000) conducted a literature review to describe the psychological 
consequences of predictive genetic testing. Fifteen papers included studies of 
predictive genetic testing for Huntington's disease, hereditary breast and ovarian 
cancer, familial adenomatous polyposis and spinocerebellar ataxia. None of the papers 
reported increased distress (general and situational distress, anxiety and depression) 
in carriers or non-carriers at any point during the 12 months after testing. Both carriers 
and non-carriers showed decreased distress after testing; this was greater and more 
rapid amongst non-carriers. Test result (i.e. being a carrier or non-carrier) was rarely 
predictive of distress more than one month after testing. The studies reviewed suggest 
that people undergoing predictive genetic testing do not experience adverse 
psychological consequences. It is important to note that most of the research was in 
testing for Huntington's Disease.
Having identified that the pre-test emotional state was predictive of subsequent distress 
in 14 of 27 analyses, the authors argued that testing protocols should include a pre-test
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assessment of emotional state so that post-test counselling can be targeted at those 
more distressed before testing.
3.3 False positives
A false positive in screening occurs when the test produces positive signs of the 
disease or condition that stimulates more detailed investigations, which indicate the 
disease or condition is not in fact present. Most screening tests are not completely 
specific, and there is a trade off between the sensitivity of the criteria used to interpret 
the test, and the specificity of the outcome. The present study also aims to gain a 
better understanding of those who require further tests to confirm a positive or negative 
diagnosis, and false positives inevitably arise.
Many studies have looked at the psychological impact of false positives, and most 
would acknowledge this to be at the very least an undesirable side effect of the 
programme (Meystre-Agustoni et a/., 2001) or the cause of short term distress (Gilbert 
etal., 1998; Ellman etal., 1989), and that programmes should ensure that steps are 
taken to minimise the number of people recalled for unnecessary investigations.
An article reviewing 10 studies that examined the psychological distress associated 
with organized breast cancer screening showed that anxiety appears to be the most 
prevalent consequence of mammography and seems to affect certain subgroups. The 
most significant effects are among those women requiring further investigation because 
of abnormal results (Steggles, Lightfoot, and Sellick, 1998). 496 women with false- 
positive screening mammograms were compared to a group of 496 women with normal 
screening mammograms in a large health maintenance organization in New England. 
The results from this showed that fifty (10%) of those with false-positive mammograms 
had documentation of breast-related concern during the 12 months after the 
mammogram, compared to 1 (0.2%) woman with a normal mammogram (P =0.001). 
The level of concern documented increased with the intensity of the recommended
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follow-up (P =0.009). It was also shown that the subsequent ambulatory visits, not 
related to the screening mammogram, increased in the year after the mammogram 
among women with false-positive mammograms, both in terms of breast-related visits 
and non-breast-related visits (Barton etal., 2001).
Psychological distress was examined as a consequence of mammography screening 
after adjusting for background, personality and prescreening distress, in subjects aged 
50 years (Aro et a/., 2000). Measurements were taken at one month before screening 
invitation with follow-ups at 2 and 12 months postscreening. At 2 months, there was a 
moderate multivariate effect of group on distress. Intrusive thinking and worry about 
breast cancer, in particular, were most frequent amongst the false positives (compared 
to those with normal findings). Intrusive thinking still prevailed at 12 months, as well as 
a higher perceived breast cancer risk and susceptibility. Although the distress related to 
screening and false-positive findings seemed to be moderate, the prevailing cancer- 
specific concerns called for improvements in screening programmes. In Shaw et a/’s., 
(Shaw et al., 1999) review of a number of screening studies they looked at the adverse 
consequences of positive test results. They found that in the majority of studies a 
positive test result was associated with depression, anxiety, poorer perceptions of 
health and psychological distress in the short term. But anxiety and depression levels 
were not significantly elevated in the longer term
Lerman etal., (1991) used telephone surveys to assess the psychological effects of 
breast cancer screening and concluded that some women with abnormal 
mammograms experience psychological difficulties after learning that their results are 
normal. Other studies go further, stressing the long-term problems arising out of false 
positives. Bloom and Monterossa (1981) found that patients who were told they were 
hypertensive but were later judged normotensive reported significantly more 
depressive symptoms, lower present health, and a worsening of their health over the 
next five years compared with a normotensive sample.
Gram etal., (1990) investigated mammography screening and found the prevalence of 
anxiety about breast cancer was significantly higher in the false positive group (29%) 
compared with the negative group (13%) 18 months after the test. Seven (5% of the 
false positive group) women described the false positive result as the worst thing that 
they had ever experienced. In retrospect, those with false positives regarded the 
experience as one of the many minor stressful experiences creating a temporary 
decrease in quality of life.
It is clear that the false positive rate represents a cost to the screening programme, 
which is in need of clarification. Currently, there is insufficient evidence to assess the 
size of the effect in a relatively well-researched condition like cancer. Although it does 
appear to have an effect in a number of studies, this appears to last only for a short 
time (Gram, Lund, and Slenker, 1990). It is therefore difficult to make assertions about 
less understood conditions such as the cardiac conditions researched in the current 
study.
3.4 Aspects of screening programmes relevant to the present study
3.4.1 Situational context of screening
Issues independent of the disease can cause concerns for participants in a screening 
programme. Prior information given to the participants and the attitude of the staff 
(Eardle & Elkind, 1990, Baines et al. 1990) are important in a well structured 
programme. In evaluating a screening programme, therefore, it is paramount to include 
measures of these factors.
3.4.2 Social context of screening
The current study explores two different programmes, a community based programme 
(publicly advertised) and a school based programme (participants invited by a mail shot 
within a closed community). The possible impact of publicity surrounding a screening
may be a source of anxiety (Skrabanek, 1985), although this has been disputed 
(Gregorio etal., 1990; Lane, Polednak, and Burg, 1989). The present consensus is that 
screening publicity is unlikely to be more than mildly upsetting and any disturbance 
caused through a direct invitation would appear to be transient (Wardle and Pope,
1992). Nevertheless, I have carried out comparisons between these two types of 
programme.
The key distinction between the two types of programme in this study is that one type 
of screening, community testing, was publicly promoted as part of a campaign that was 
started after a sudden death of a young person in the locality. They typically involved 
emotive visual images. The other type of screening, schools testing, was less emotive 
and more controlled, with the ECG testing was bought to the school. This made the 
testing process relatively easy to commit to with participants only needing to go to the 
school health centre, or designated location, on a given day, during school hours.
The community screenings occurred at weekends, at venues that people would have to 
reach (i.e. a local health centre). Usually participants were accompanied by at least 
one other family member. At the school screenings the children were taken out of 
class, usually in groups of 10. Therefore they did not attend with their parents, just with 
their other class/ housemates. It is reasonable to think that a person may feel 
differently if in the company of a friend or a parent.
3.4.3 Issues of self selection
The psychological effects of screening need to be interpreted in the context of selective 
participation. Those who participate in the screening procedure are self-selected and 
cannot be assumed to be identical to non-participants in respect of psychological state 
or disease risk.
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The results of comparisons of attenders and non-attenders have been inconsistent. A 
number of conclusions have been drawn: that non-attenders are more anxious (French 
etal., 1982); that attenders are more likely to have symptoms (Fink, Shapiro, and 
Lewison, 1968); that anxiety predicts reasons for contemplating the testing (Wroe et al., 
1998); that anxiety does not predict attendance (Sutton et al., 1995). These 
inconsistencies highlight the importance of incorporating comparison groups into the 
analysis of the psychological impact of a screening programme.
Due to the social context of the screening, with participants having to make greater 
effort to be tested in the community study, self selection was a stronger factor in the 
community study. If differences between the two types of screening are not observed, 
then self selection may not be very important. Additionally, I assessed anxiety level in a 
comparable group of adolescents who were not offered cardiac testing at all.
3.4.4 The role of reassurance and false reassurance
The reason why people engage in a screening programme may provide an important 
insight into their initial reaction to the screening as well how they manage subsequent 
information. Apart from engaging in a screening programme to detect abnormalities, 
and avoiding unnecessary anxiety throughout, there is the additional psychological aim 
of reassuring those in whom no abnormality is found while ensuring awareness of 
residual risk.
Marteau and Michie (1995) argued that screening programmes can also provide 
psychological relief from uncertainty (Marteau, 1995). Their position was that 
“knowledge can be a kind of cure” for parents of screened children. They also cited 
studies in which adults undergoing genetic testing for Huntington’s disease and breast 
cancer attested to the psychological relief they experienced when receiving test results, 
positive or negative (Wiggins et al., 1992; Lynch et al., 1993). It is important to note that 
Marteau and Michie stressed they were not arguing for clinicians to encourage parents
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to undergo predictive testing in their children. However, they were arguing for 
respecting parents’ wishes in the absence of evidence of harm and when there is 
potential benefit.
One of the problems that may follow the receipt of a negative test result is false 
reassurance where an individual believes that a low-risk result means no risk. This has 
been found in a number of conditions including those undergoing cystic fibrosis carrier 
testing (Axworthy etal., 1996), prenatal screening for Downs syndrome (Smith, Shaw, 
and Marteau, 1994), cervical screening (Marteau, Senior, and Sasieni, 2001) and 
cardiovascular disease risk (Marteau etal., 1996).
In the study by Tymstra and Bieleman (1987) of 428 men aged between 30-33 years 
screening for cardiovascular risk factors, more than half of the participants who replied 
(51%, n = 107) were found to have an 'abnormality' (scoring on one or more of 
cigarette smoking, overweight, hypertension, hyperlipoproteinaemia, albuminuna or 
glucosuria). The supplementary information provided on nutrition and smoking caused 
a large proportion of them to claim they had changed to a more healthy life-style after 
the screening test. However, those without 'abnormalities' did not lead significantly 
healthier lives than the rest in terms of exercise, smoking, diet and so on. For them the 
result might have a 'certificate of health' effect justifying their not always healthy 
behaviour (Tymstra and Bieleman, 1987). This concern of a ‘certificate of health’ effect 
is supported by Kinlay and Heller’s (1990) conclusion in a study of Australian men and 
women. They found that requiring everyone to be tested for high cholesterol 
concentrations might interfere with population strategies designed to reduce everyone's 
dietary intake of fat. Those people with borderline levels were significantly less likely to 
recall receiving recommendations about the need for cholesterol reduction and less 
likely to recall receiving dietary advice than those with high levels (Kinlay and Heller, 
1990).
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In the current study, it will be important for the participants to realise that apart from the 
potential for reassurance, there is also the potential for false negatives or instilling an 
overly optimistic view of their health because of a negative finding. Furthermore, a 
normal ECG result will provide a ‘certificate of cardiac health’, however, it has no 
predictive ability on premature coronary heart disease and other lifestyle related 
disorders.
3.4.5 Self rated health
The research evaluating the psychological impact of screening has primarily focused 
on anxiety. It is also important to know if a programme has an impact on a person’s 
perception of their health. In this study, the impact of cardiac testing on self rated 
health as well as anxiety was assessed. Self rated health is a simple but important 
health indicator. It is typically measured using a simple single item scale, asking the 
respondent if they regard their health as excellent, very good, good, fair, or poor. The 
reasons that it is a valuable indicator are that self rated health generally corresponds 
well with both physicians ratings to their health (LaRue etal., 1979; Maddox, 1964; 
Maddox and Douglass, 1973) and with longevity (Idler and Benyamini, 1997; Idler and 
Kasl, 1991; Kaplan and Camacho, 1983; Idler, Kasl, and Lemke, 1990; Menec, 
Chipperfield, and Perry, 1999; Mossey and Shapiro, 1982). For example, Idler and 
Benyamini (1997) reviewed 27 longitudinal community studies, the majority of which 
showed that a global self rated health measure predicted future mortality.
In 1958, the World Health Organisation developed a definition of health that included 
contributions from physical, mental, and social well-being. Lay definitions take a wide 
range of factors into account beyond this, including functional ability (Barsky, Cleary, 
and Klerman, 1992; Johnson and Wolinsky, 1993), lifestyle and preventative health 
practices (Krause and Jay, 1994; Ross and Bird, 1994) and socio-cultural constructions 
of specific health risks (Barsky, 1988). Health is also closely related to the experience 
of physical symptoms (Bailis etal., 2001; Garrity, Somes, and Marx, 1978). Ongoing
changes in the amount of distress or limitation associated with physical symptoms may 
also be expected to influence self rated health.
Vingilis etal., (1998) showed that in adolescents, higher income, good child parent 
relationship, higher interest and achievement in school, high self esteem, not smoking 
and being male were all positively and directly associated with higher self ratings of 
health. They noted that although these relationships were significant, they accounted 
for less than 17% of the variance, with all variables being modest predictors at best. 
They felt that in adolescents the major predictors of self rated health were not among 
the variables they had studied or identified in the literature (Vingilis, Wade, and Adlaf,
1998).
In 2006, Singh-Manoux et al., set out to identify what were the determinants of self 
rated health. Their data came from European cohort studies. The British Whitehall II 
study included 10,308 civil servants with office based jobs. The French Gazel cohort 
included 17,696 gas and electricity public utilities employees, many of whom were 
manual workers both skilled and unskilled. In both the age range was 35-55 with at 
least twice as many males. The categories that were considered were age, early life 
factors and family history, sociodemographic variables, psychosocial factors, health 
behaviour, and health. 36.1% (men) and 36.9%(women) of the variance in self rated 
health was explained by these factors in the Whitehall II data and 42.7% (men) and 
44.3% (women) of the variance in the Gazel data. Further analysis identified that five 
determinants in the Whitehall data and four in the Gazel data explained 34.7% and 
41.4% of the variance in the two studies. The key finding from their study was that self 
rated health was mostly a measure of health. In the Gazel data psychosocial factors 
were also important. Measures of early life factors, family history, sociodemographics 
and health behaviours only had a minor impact. In the Whitehall II data self rated health 
was predicted by measures of current health status, health over the past year, longer 
term health problems, and psychiatric morbidity. In the Gazel data, being “physically”
tired explained about 81.2% of the total variance. The authors gave two interpretations 
of this, firstly that it reflected the difference between the two working environments of 
the data sets, the Gazel being more physically demanding. The second being that 
physical tiredness was a good comprehensive measure of health (Singh-Manoux et al., 
2006).
Most literature in the field relating self-rated health with screening has tested whether 
participation in screening has an association with self rated health. Several studies 
show that people who take part in genetic or cancer screening have better self-rated 
health than those who don’t participate, but some show the opposite and others show 
no difference. In breast cancer screening in Sweden non attenders rated their health 
status as poorer than attendees (Lagerlund etal., 2000). Non participation was three 
times more likely among women with very poor self rated health compared to those 
reporting their health was very good. The authors felt that it was possible that those 
who refused to be interviewed had a worse sense of health, with more extreeme 
behaviours and living in worse social conditions. Non-attenders were also more likely to 
drop out of the study due to refusal, ill health and missing contact details.
Opposite was the case in the study of the patients of hemochromatosis, a treatable 
disorder with a major genetic predisposition. Anderson et al., (2005) showed that those 
people with higher self rated general health were less likely to accept the screening 
than those reporting lower scores. The authors felt that those with lower percieved 
health were possibly more motivated to seek care or explanations for health problems. 
Alternatively, the authors felt they may have been more familiar with medical tests 
(Anderson etal., 2005).
In 2007, Farmer et al., explored the psychological correlates of older women’s 
adherence to annual mammography screening. Self rated health, among other factors, 
did not differ in a comparison between those who either did or did not have a
mammogram in the previous year. It should be noted that almost half of those who had 
no mammogram in the prior year had one in the past two years, and a greater 
percentage of this group felt this is how often they should be done. The lack of 
difference is likely to be due to the study design, measuring how often people are 
screened and how often they believe they should be screened, rather than a difference 
between people who do or do not go to mammography screening (Farmer et al., 2007).
In a small number of studies, self-rated health has been used to assess the impact of 
screening on health, as in the present thesis. Patch et al., (2005) compared two 
pragmatic screening strategies, genotypic and phenotypic, for hemochromatosis. 939 
individuals aged 30-70 accepted the testing and were previously unaware of the 
condition. Self rated health, anxiety and depression were measured at invitiaton, 
testing, the time of results and 6 months later. They found that screeing did not lead to 
significant changes in self rated health, anxiety or depression (Patch, Roderick, and 
Rosenberg, 2005). In another study of 1256 elderly people (aged 71 and older) a 
number of factors including self rated health were examined to determine their 
association with health behavours such as cancer screening (Fillenbaum etal., 2007).
It was found that cancer screening had no population-level association with self rated 
health, whereas the practice of health behaviours did.
A variety of events can change a person’s perception of their health, such as the 
diagnosis of a chronic condition, or starting a new exercise regime. In these 
circumstances people are likely to need to re-evaluate their health and a variety of 
adaptive responses might depend upon the outcome of this evaluation. It has been 
argued that self ratings of health may be sensitive to and directly reflect the impact of 
information, behavioural or normative changes.
It has also been argued that perceptions of health may be driven by prior beliefs that 
people hold about themselves as a healthy or unhealthy people. People experience
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continuity in their health and there are many instances in which people’s self rated 
health does not reflect more objective indications of their health status (Borawski, 
Kinney, and Kahana, 1996; Litva and Eyles, 1994; Wilcox, Kasl, and Idler, 1996) 
(Chipperfield, 1993). There are many reasons why this occurs including people being 
overly optimistic (Chipperfield, 1993). There are also buffering mechanisms that protect 
the self concept from changing (Banaji and Prentice, 1994). It is considered that these 
buffering mechanisms ensure a degree of consistency that is broadly adaptive for 
human functioning (Ryff and Singer, 1998).
The superior predictive validity of self rated health, compared to the other health status 
indicators used in previous studies has been particularly emphasized by Idler and 
Benjamini (1997). Their research provides compelling evidence that people can and do 
synthesize a great deal of information in a single global assessment of their health.
Most of the research has adopted a view where changes in any component of health 
status should be reflected each time self rated health is assessed. In the case of this 
study, the impact of the offer of testing and potential threat this may have on a person’s 
perception of health may be reflected in changes in their self-rated health.
3.5 Conclusions
It is important to evaluate the psychological costs of a screening programme both for 
participants with positive and negative results. The evidence shows there are typically 
few significant adverse effects of participation for people who have a negative 
diagnosis after the screening test and the evidence about the psychological impact of 
screening for those with false positives is inconclusive. Little research has been carried 
out with young people, and none with the cardiac conditions being considered here. 
Most research on the adverse impact of screening has focused on anxiety, and there is 
a need to consider broader outcomes such as general perceptions of health.
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Chapter 4. Theoretical background
Much research on psychological aspects of screening has been pragmatic and 
atheoretical, addressing the practical issues of whether the costs of screening include 
psychological distress, and how persistent these responses are. However, it is 
important to have a theoretical framework in which to understand why participants 
respond in the ways that they do. It is important to have a theoretical background for 
studies such as these not only to ground the findings as part of a cohesive developing 
framework within health psychology but also to enable theoretically informed 
comparisons with other conditions,
Embedding research such as this within a well established theory helps to make sense 
of the experiences of the participants. A good theory enables generalisability of 
findings, providing a meaningful framework. In addition, it gives a better understanding 
of particular strategies that may be implemented in future interventions aimed to 
address factors that may be associated with negative health outcomes. It will also help 
to inform how these strategies would be used, when to use them and why they should 
be. In this thesis, I have used the Common Sense Model (CSM) of illness 
representations, part of Leventhal’s self-regulation theory, to structure the findings.
This chapter will discuss the theoretical foundations of illness representations, how this 
theory has been implemented and the important relationship between illness 
representations and anxiety.
4.1 The Common Sense Model (CSM)
The Common Sense Model proposes that schematic representations of illness and 
health-threatening conditions are constructed by individuals according to the concrete 
and abstract sources of information available to them (Leventhal et al., 1980). Sources 
of information include both health professionals (general practitioners, nurses, 
surgeons) and the general pool of information available from social sources and
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symptomatic experience with the illness itself (Leventhal et al., 1984). A coping 
response will be evoked if the individual’s representation of the illness is sufficiently 
threatening (Leventhal etal., 1984). The model is illustrated in figure 4.1.
Figure 4.1 Leventhal’s self regulatory model of illness behaviour 
(adapted from Ogden, Health Psychology)
Stage 1: 
Interpretation
• Symptom 
perception
• Social 
messages
The model proposes a processing system that consists of two parallel pathways. One 
pathway involves a cognitive representation of an illness and a coping response to 
manage the illness threat. The cognitive representations consist of:
Identity - the label given to the illness (diagnosis) and symptoms experienced.
Cause -  may be biological or psychosocial, and patient’s beliefs can reflect a variety of 
different causal models.
Consequences -  how the illness affects the patient’s life (physical, social, emotional 
and financial).
Time line - how long the illness will last, if it is acute (short term) or chronic (long term). 
Cure I control - whether the condition is curable or treatable and how controllable it is, 
either by the individual or by powerful others such as health professionals.
The other pathway involves an emotional response to the threat and a coping response 
to manage these emotions. The cognitive and emotional processes are highly
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Representation of health
threat
Identity
Cause
Consequences 
Time Line 
Cure/control
Stage 2: Coping
• Approach coping
• Avoidance coping
Stage 3: Appraisal
Was my coping 
Strategy effective?
Emotional response to
health threat
Fear
Anxiety
Depression
interactive, with bi-directional links. Cognitive representations and threat appraisal can 
shape anxiety and fear responses, and anxiety in turn can affect perceptions of threat 
cues, representation development, selection of strategies for coping, and selection of 
criteria for outcome appraisals.
The three components of the model, interpretation, coping and appraisal, have been 
shown to interrelate in order to maintain the status quo. The model proposes that an 
individual is motivated to regain the balance if their normal state of health is disrupted 
by illness (Leventhal and Diefenbach, 1991).
Health-related behaviour (such as attending a cardiac screening) is viewed as a coping 
response (Leventhal etal., 1997) and will therefore be influenced by the individual’s 
illness representations. Lazarus (1999) noted that people use all types of coping 
strategies in response to an encounter that is perceived to be stressful. Depending on 
the situation, these coping strategies may be maladaptive or adaptive.
Cognitive representations are involved in interpreting new symptoms and guiding 
people’s subsequent behaviour (Levanthal, Meyer and Nerenz, 1980; Weinman and 
Petrie, 1997). They help patients make sense of the symptoms and have been found to 
contain beliefs about etiology, how long the illness will last, the personal consequences 
of the condition and the extent to which the illness is amenable to control or cure 
(Hagger and Orbell, 2003).
Cognitive illness representations were initially elicited through semi-structured or open 
ended interview, but more recently self reported questionnaires have been developed, 
most notably the Illness Perceptions Questionnaire (Weinman etal., 1996). This 
questionnaire was developed to provide a quantitative assessment of the illness 
representations identified in Leventhal’s regulatory model. This questionnaire has been 
used in studies of illness adaptation in patients with a wide range of conditions. These
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include heart disease (Cooper etal., 1999; Petrie etal., 1996; Steed etal., 1999, Hirani 
etal., 2006), rheumatoid arthritis (Buick, 1997), psoriasis (Fortune etal., 2000;
Scharloo et al 2000a), chronic obstructive pulmonary disease (Scharloo et al., 2000b), 
chronic fatigue syndrome (Heijmans 1998; Moss-Morris etal., 1996), diabetes (Griva et 
al., 2000) and Addison’s Disease (Heijmans, 1999), people undergoing investigations 
such as coronary angiography and genetic testing and for spouses and carers of 
patients with major health problems (Hirani et al., 2006; Heijmans etal., 1999; 
McClenahan and Weinman, 1998; Weinman etal., 2000).
Hagger and Orbell (2003) performed a meta-analysis of 45 studies that used the CSM, 
and showed there was strong quantitative evidence for the structural relationships 
between the five components of illness representations and for associations between 
them and a range of psychological outcomes. These include coping (Heijmans, 1998; 
Heijmans and de Ridder, 1998; Moss- Morris etal., 1996, Scharloo etal., 1998, 2000), 
mood (Fortune etal., 2000; Murphy etal., 1999), functional adaptation (Heijmans,
1998, 1999; Moss-Morris, 1997; Petri eta., 1996, Scharloo etal., 1998), adherence to 
a range of medical recommendations (Cooper et al., 1999; Weinman et al., 2000;
Horne and Weinman, 2002), reassurance after testing (Donkin etal., 2006) emotional 
status (Hagger and Orbell, 2003; Edwards et al., 2001; Fortune etal., 2002, Steed et 
al., 1999) and ability to perform activities of daily living (Weinman et al., 2000). The 
IPQ has also shown the ability to differentiate between illness conditions. In 1996, 
Weinman demonstrated that patients with rheumatoid arthritis had higher scores on the 
identity and time-line subscales than chronic pain patients.
There is a limited amount of research that suggests patients’ illness beliefs may be 
important in the area of cardiac symptoms. One study found that patients with non­
cardiac chest pain have higher levels of disease conviction and engage in more cardio­
protective behaviour than patients with confirmed cardiac disease (Eifert et al., 1996).
A number of studies have found that cardiac investigations can foster patient’s illness
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beliefs, and encourage them to focus on cardiac symptoms and reinforce the belief that 
the complaints are serious (Howard and Wessely, 1996; Mayou, Bass, and Bryant,
1999).
Donkin et al., (2006) studied 62 patients who were being investigated for chest pain, 
assessing whether illness beliefs influenced measures of anxiety and reassurance after 
investigations were complete. They found that beliefs about consequences, illness 
identity, concerns, emotional effects and particularly timeline beliefs, were important 
correlates of reassurance. They suggested that timeline beliefs are likely to indicate 
how entrenched patients’ beliefs are that their current symptoms represent a significant 
long standing illness, illness understanding and health anxiety were not associated with 
reassurance at any time. Although state anxiety was not associated with reassurance 
immediately prior to or after the test, it was one month later.
4.2 Cultural and social factors
The self-regulation system is constantly shaped and reshaped by the social 
environment. The importance of both cultural and social factors in influencing self­
regulation of illness is depicted in the CSM (Brownlee et al., 2000; Leventhal et al., 
1998). Self-regulation is dependent on the input and expertise of others with individuals 
turning to medical practitioners for diagnosis and treatment when experiencing somatic 
changes that are novel, vague and/or unexpected in duration (Mora etal., 2002).
The internal processes and mechanisms within self-regulation occur within a 
sociocultural context. The importance of culture in self-regulation can be seen at a 
basic level in the use of different linguistic labels for categorizing the array of events 
that constitute illness. The way knowledge of an illness, health, and treatment is 
structured reflects experiences with the family, neighbourhood community and society 
at large (Jackson etal., 2000). Health behaviour is affected by both social and
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economic resources and will have an effect on the experience of dealing with and 
interpreting a health threat.
Social interaction and communication (e.g. the presence of others) may be a necessary 
condition for the successful self-regulation of both physical health (Berkman and Syme, 
1979; House, Landis, and Umberson, 1988) and psychological health (Thoits, 1983).
Virtually every care seeker will consult with a family member and/or friend before the 
formal use of medical care (Cameron, Leventhal, and Leventhal, 1993; Suls et al.,
1997). The social network is active throughout the care-seeking and treatment process 
(Pescosolido, 1992) helping to determine if the experience is normal, or helping to 
predict how one should expect to feel. As well as facilitating, social networks can also 
lead to inappropriate self management due to lack of trust of the health care delivery 
(Suls and Goodkin, 1994). Individuals often hold different views about their health 
situation to their family (Clipp and George, 1992; Hatchett et al., 1997; Peyrot et al.,
1998) and health professionals (Eichenberger and Rossler, 2000; Maddox and 
Douglass, 1973), and social influences may be rejected on the basis of their 
inconsistency with personal experience. The consequence of a strong social network 
can often have an undesirable effect, as it can lead to delays in seeking medical 
interventions (Berkanovic, Telesky, and Reeder, 1981). Many ignored symptoms could 
benefit from medical attention, and failure or delays in seeking care could be serious 
(Suls etal., 1997).
4.3 Message framing as a social influence
Interpreting the role of illness perceptions must incorporate the way in which the 
original health message was framed. The message framing will vary in its influence as 
a social message. This influence may depend on prior experience, and in some cases 
may be the only information in regard to the conditions that the participant has 
received.
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With message framing there appears to be a consistent pattern that a loss framed 
message is more effective when the threat is perceived to be risky, while a gain framed 
message is more effective when the threat is not perceived as risky (Rothman et al., 
1999; Apanovitch, McCarthy, and Salovey, 2003). In the case of screening, the 
detection behaviours are consistently described in terms of their ability to detect 
disease, and therefore screening behaviours automatically elicit images of illness and 
feelings of distress (Millar and Millar, 1995). Personal experience and beliefs about a 
particular health issue should also inform how a behavior is understood (Pearlman et 
al., 1997).
Rothman et al., (2003) identify two responses to a clear result in a screening procedure 
using the case of breast screening to illustrate their point,
1. feeling lucky and temporary relief from anxiety
2. feelings of reassurance and well being
The first response might characterise people who interpret the screening result as a 
sign of the absence of disease. This may reflect what Higgins (1998) has described as 
prevention-focused self-regulatory style. Screening remains a risky endeavour and the 
initial feeling of relief will dissipate as attention moves onto the next risk (loss framed 
appeals are more motivating). In the case of this study we might expect anxiety levels 
to reduce after receiving the results temporarily and then increase back to a normal 
level at some point in the future.
The second response, a feeling of reassurance, reflects a sensitivity to the presence of 
positive states. This is consistent with Higgins’s (1998) promotion-focused-self 
regulatory style. Participants ascribe a favourable cognitive and affective association to 
the process of screening, which is not seen as a risky endeavour. In the future, 
screening would be seen as an opportunity to affirm health (gain framed appeals are
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more motivating). In the case of this study, I would expect participants’ anxiety levels to 
reduce upon receiving the results and remain the same thereafter.
4.4 The common sense model and cardiac testing in young people
The pathways to cardiac testing of a young person are multifaceted, occurring for a 
number of different reasons, depending on each individual. They may be driven by 
perceived symptoms, personal experience of a friend suffering from a condition, 
concern after reading a story in the media, or general preventive health behaviour.
There are a number of ways in which self-regulation theory can inform the researcher 
and clinicians about the underlying psychological process involved in the cardiac 
testing of young people. Furthermore, it can aid in the development of public 
information services and counselling protocols after a diagnosis is made.
The common sense model (CSM) is suited for the application of cardiac testing of 
young people for a number of reasons, one of which is the five attributes of the threat 
or illness representation (Leventhal, 1970).
The identity attribute defines and labels the threat. This identification process may be 
triggered by an internal symptom such as chest pain, breathlessness, passing out, 
palpitations or a young unexplained sudden death in the family. It may also be set in 
motion by information from an external source, such as risk information given by a 
health care provider. It may have been prompted by the knowledge of an elite athlete 
dying, and after extensive media coverage. The individual may have had a friend or 
colleague who died suddenly from an unexplained or identified cardiac condition. Many 
of those engaging in the testing are too young to give personal consent and therefore 
the decision to be screened may have been prompted by a parent who is concerned for 
any of the reasons already mentioned. They may be keen to contribute to research in
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the area. It may also be a requirement of a sporting body that all their athletes be 
tested prior to engaging in competitive sport.
The use of an identity label often predicts subsequent attributes, such as timeline or 
duration, consequences, cause and controllability (Lau, Bernard, and Hartman, 1989). 
Each of these attributes can contribute to perceptions of risk and worries related to the 
conditions.
The timeline attribute addresses the perceived temporal progression so will relate to 
how long the cardiac condition will last. For some conditions that may be treated by an 
operation (i.e. ablation in the case of Wolff-Parkinson-White) the condition may be seen 
short term. However, if an ICD is required to treat the condition, this will remain for the 
rest of life and will not be something that will pass quickly. The majority of conditions 
are genetic and chronic and will require ongoing treatment regimes.
The consequences attribute defines the stimulus in terms of the potential impact it 
would have upon quality of life (emotional, physical and economic) and how others will 
perceive the person if diagnosed. If a person is told they will have to stop playing 
competitive sport or not participate in strenuous exercise, it may affect the way they 
feel others see them so will have an impact upon their identify. They may also have 
other lifestyle difficulties like in obtaining life insurance.
The cause attribute categorizes the stimulus in terms of the potential factors that may 
have led to the diagnosis. For example, this may be perceived as genetic (passed on 
by a family member) or due to lifestyle choices.
The controllability attribute addresses the question of whether the person feels 
anything can be done if he or she is diagnosed with a condition. This is separated into 
both treatment control and personal control. Some people may feel that the treatment
available will help if they are diagnosed. Others may feel that the condition is 
controllable by their own actions, such as changes in lifestyle.
These representations will often be highly individualized, and influenced by the 
person’s concrete-perceptual realities, and may not be consistent with medical 
knowledge. It is important to note that the conditions under study cover a broad 
spectrum; some will be less threatening than others, others more treatable. The reason 
for looking at them as a whole is that any one of the cardiac conditions is a potential 
diagnosis, and it is the personal experience of the testing procedure that is under study 
and not participants’ detailed medical knowledge. The CSM suggests that a 
consequence of the individualization of personal perspectives is that beliefs about 
cardiac conditions and associated expectation are extremely difficult to change. 
Therefore knowing how people perceptive the conditions prior to diagnosis may have 
implications for the illness representations that develop if a diagnosis is made.
The CSM also identifies the parallel processing of cognitive and emotional stimuli. The 
individual will be processing information in regard to the likelihood of being diagnosed 
with a cardiac condition and understand information related to its cause(s) and 
controllability. It may be reasonable to expect that they will respond emotionally to the 
potential threat of being diagnosed with a cardiac condition that will be life-altering by 
considering the potential causes and controllability of the disease. The parallel 
framework accounts for both the cognitive and emotional processing pathways, how 
they interact, and how they influence behaviour.
Another way in which the CSM can be applied to cardiac conditions is in understanding 
the role of threat evaluation and decision-making in influencing behaviour. A cognitive 
evaluation of the threat, the emotional impact of the threat, an interaction of the two, or 
motivations to achieve a personal goal can trigger the response to the health threat.
The personal goal may be the process of being screened for a condition to prevent a
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sudden death. If the individual (or their parent) is confident that engaging in the 
screening procedure is likely to progress them toward the achievement of the goal, it 
will be selected. If, on the other hand, the behaviour or coping strategy’s efficacy and 
availability is questionable, they will be less likely to participate. It may be reasonable to 
suggest that a potential participant who has personal knowledge of a young person 
dying who may have been saved if they had been offered cardiac testing, could have a 
heightened perception of personal risk. This may be amplified if they have one or more 
of the symptoms that are associated with cardiac conditions in young people. This type 
of information processing will lead to an evaluation of coping options. One of the 
options may be to consider engaging in the screening procedure to reduce the 
uncertainty about risk of suffering a sudden cardiac death.
The final stage of the CSM is appraising the situation in which the screening 
behaviour or coping response is evaluated for its effectiveness. If the coping response 
is successful, then no further change in behaviour is necessary and there will be no 
changes in further threat representations. However, if this is unsuccessful, the 
individual will engage in a different response and will review the existing threat 
representations. In the case of cardiac testing the individual will assimilate the 
information and decide whether the screening is an acceptable course of action, and 
seek to obtain the desired information about their future risk.
4.5 Illness Perception Questionnaire (IPQ)
In 1996, the illness perception questionnaire (IPQ) was developed to provide a 
quantative assessment of the five components of the illness representations in 
Leventhal’s Self-Regulatory Model (Leventhal, Nerenz, and Steele, 1984). In 2002, 
Moss Morris etal., recommended certain improvements to the scales. These 
improvements were realised in the development of the Revised Illness Perception 
Questionnaire (IPQ-R). The IPQ-R is divided into 3 sections, with the identity and 
causal dimensions presented separately from the remaining dimensions. The identity
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scale consists of 12 commonly experienced symptoms included in the original IPQ, 
with two additional symptoms of sore throat and wheeziness added. The causal 
dimension consists of 18 attributional items, in the original IPQ this was 10. The other 7 
dimensions consist of 38 items. The specific scales are discussed in chapter 11 in 
relation to the rewording of each item for this study. The Cronbach alpha’s for each of 
the scale ranged from 0.79 to 0.89.
The important component of emotional representation was one of the areas omitted 
from the original IPQ scale, and was included in the revised scale. The cure/control 
dimension was also revised into 2 separate dimensions personal control and treatment 
control. My study utilised the IPQ-R to look at how the emotional representations of 
cardiac conditions interact with levels of anxiety, self-rated health, and other cognitive 
factors.
The IPQ-R was designed in a way that lends itself to modification and application to 
different aspects of health and illness. Research using this revised instrument has 
indicated that the scales maintain adequate construct and predictive validity, test-retest 
reliability and internal consistency across a number of illnesses (Moss-Morris etal., 
2002). However, it has not previously been applied to a screening context for young 
people.
I have discussed the association between cancer screening and distress earlier in this 
thesis. A few studies have examined cognitions associated with the distress (Hagger & 
Orbell, 2003; Orbell etal., 2004). In 2006 Hagger & Orbell described a study of 660 
women who received abnormal cervical smear results and 701 men and women who 
received abnormal colorectal cancer screening results. Participants completed the IPQ- 
R prior to a follow up appointment, after receiving a positive test result at the initial 
screening appointment. In the cervical screening sample there were significant 
relationships between anxiety and the consequences, causes and illness coherence
scales that were mediated by emotional representations. In the colorectal screening 
sample a similar pattern of relationships occurred, though effects were less consistent.
A key component of illness representations is how individuals structure their causal 
beliefs. People report a wide range of beliefs about what causes their illness, so 
considerable attention has been given to identifying any underlying factors. Some 
research has suggested that causal beliefs can be categorized into internal causes (ie 
stress, and personality), and external causes (situational factors such as an accident or 
a virus) (Croyle and Barger, 1993). More recent analyses have suggested three broad 
domains of causal beliefs: psychological causes (i.e. stress, personality), behavioural 
causes (ie smoking, diet) and biological causes (i.e. pollution, viruses) (Heijmans,
1998; Heijmans & De Ridder, 1998; Heijmans et a i, 1999; Rutter and Rutter, 2002). 
The majority of research in self-regulation has focused on the importance of one or 
more of these causal dimensions or individual items. A more systematic approach, 
utilizing factor analysis in 8 chronic illness, extracted factors that were labelled 
psychological, risk factors and immunity attributions of cause (Moss-Morris et al.,
2002). These broadly replicated the psychological, behavioural and biological causal 
factors identified earlier. They also identified a fourth factor that they called “bad luck” 
or “chance”. Hagger & Orbell (2005) conducted a factor analytic approach of causal 
items in the context of a cervical cancer screening programme. Factors related to 
psychological stress, behavioral and biological causal attributions emerged as 
expected. Few studies have adopted this factor analytic approach to the IPQ-R causal 
scale and none have examined these causes in the context of young people 
undergoing cardiac screening. I therefore carried out factor analysis of causal beliefs in 
this thesis.
To understand illness representations in the context of explaining an emotional 
response to a health threat it is important to discuss some of the ways in which illness 
representations and anxiety interact.
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4.6 Influence of anxiety on construction of illness representations
This thesis evaluates anxiety responses to a screening procedure. Conclusions will be 
sought about the psychological impact of cardiac screening of young people. It is 
reasonable to suggest that people will not all react homogenously. This justifies the 
incorporation of an evaluation of illness representations to shed light on why 
participants respond to the health threat in different ways. Although it would be 
convenient to think that the relationship between illness representations and anxiety 
would be clearly causal, the complex interactions identified in the CSM between the 
cognitive and emotional processes shows this is not the case. This section will taker a 
closer look at the relationship between illness representations and anxiety and identify 
key issues that will be considered when drawing conclusions at the end of the thesis.
The arousal of anxiety is likely to influence the formation of the key attributes of illness 
representations in a number of ways.
1. Influencing perception and attention
2. Influencing information processing strategies and concrete strategies
3. As information about health threat attributes
(Cameron, 2003)
4.6.1 Anxiety, perception and attention
Anxiety increases perceptual sensitivity and attention to threatening stimuli (Ohman, 
Flykt, and Esteves, 2001). Evidence suggests that anxiety arousal could enhance 
attention to health threat cues such as symptoms. This in turn could increase the 
amount of information available for the development of a representation. There is 
strong experimental evidence that sad and depressed moods (compared to induced 
happy moods) increase reports of physical symptoms (Croyle and Uretsky, 1987; 
Salovey and Birnbaum, 1989). Field studies have also reported that state anxiety is 
correlated with higher levels of reported symptoms (Watson and Pennebaker, 1989;
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Leventhal etal., 1996), but further research is needed to confirm if state anxiety 
promotes sensitively to symptoms and other illness clues.
Cameron (2003) suggests that, since anxiety about a health threat enhances 
monitoring for associated symptoms, it is likely that there will be beneficial 
consequences in terms of increased accuracy in reports of symptom characteristics. 
This is of particular interest because of the evidence that ill patients usually under­
report symptoms (Mayne, 1999). However, Cameron then goes on to add that there is 
a down side to this in which the anxiety arousal may undermine the accuracy of identity 
beliefs if the anxiety induced sensations add confusion to efforts to interpret symptoms.
Anxiety can induce heart rate awareness (Katkin, 1985) as well as gastrointestinal 
disturbances and other visceral changes. An increased level of anxiety can also 
exacerbate the painfulness of symptoms (Ahles etal., 1983; Ploghaus etal., 2001). 
This is a particular methodological challenge in the current study with many of the 
symptoms associated with anxiety also being relevant to the cardiac conditions under 
investigation.
The perceptual processing of threat cues can be further enhanced by anxiety through 
inhibiting the disengagement of attention. When people are induced to feel anxious 
they are less able to withdraw their attention from the threatening cues to attend to 
non-threatening cues (Fox etal., 2001). The amount of information integrated into 
illness representations can be enhanced through sustained attention when faced with a 
health threat. However, when an ability to disengage from threatening health 
information is reduced, anxiety can provoke rumination and intrusive thoughts that 
undermine functioning and well being (Lerman et a!., 1993).
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Anxiety may also elicit more subtle information processing effects, such as priming 
anxiety related memories and concepts and amplifying concrete-experiential 
processing.
4.6.2 Information processing strategies
Anxiety has many associations with illness representations through influences on 
information processing. First, anxiety can have an influence on illness representations 
through its automatic, subconscious effects on a variety of information processing 
strategies. This includes the systematic strategies of ‘directed processing’ and 
‘substantive processing’ (Clore etal., 1994; Forgas, 2000).
Directed processing is the biased evaluation of information to support a favoured 
position, often directed in a self-protective manner. Substantive processing is open and 
effortful reasoning aimed at developing accurate evaluations of information. Through 
this type of processing it is possible that anxiety arousal can increase the emotional, 
threatening contents incorporated into an illness representation. For example, anxiety 
may lead to more symptoms being associated with the illness identity and a belief in 
more negative consequences. These two processes, directed and substantive, usually 
operate simultaneously when confronting health threatening information. There is a 
need to balance the motivation to act and the motivation to reduce stress through 
understanding these processes.
Second, anxious avoidance-orientated states promote concrete spatial processing and 
inhibit the verbal processing of information, while approach-orientated states (positive 
affects) induce the opposite pattern (Gray, 2001). Although anxiety may facilitate the 
integration of concrete and imagery-laden information (like a doctor holding a bottle of 
red pills) into illness representations, anxiety may cause problems in incorporating the 
abstract-conceptual content (doctor saying why you should take them) of informational 
presentations. These problems can undermine adherence and well-being, which can
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be made worse by an anxiety-induced impairment of working memory (Oaksford etal., 
1996) and by memory impairments resulting from efforts to suppress displays of 
distress (Richards and Gross, 1999).
4.6.3 Anxiety and information about health threats
Anxiety may play a direct informational role in evaluating illness-related experiences.
For example, someone who feels anxious about a therapy regimen may interpret the 
anxiety as a gut-level indicator that they can’t do it. The information that anxiety 
provides can shape the development of illness representations (Martin, 2000; Schwartz 
and Clore, 1988). People observe their affective states and the contexts in which they 
occur and make inferences about their health status and illness attributes through this. 
Anxiety and relief experiences give concrete clues of danger and safety; these are 
used to evaluate one’s status in health threat situations.
The meaning given to an anxious affect is often used in the interpretation of symptoms. 
For example, one study showed that when community residents were undergoing 
stressful experiences, they were more likely to attribute ambiguous symptoms to stress 
than to illness, and were less likely to seek care for these symptoms when the stressor 
had started recently (Cameron, Leventhal, and Leventhal, 1995). People frequently 
identify stress as a primary cause of their illnesses including conditions such as heart 
disease and diabetes (French et at., 2001; Hampson, 1997).
4.7 Conclusions
In this chapter I have reviewed the relevance of the CSM to cardiac testing, and how 
anxiety can influence illness cognitions. Leventhal etal., (2003) argue that 
interventions are most likely to succeed when their contents are informed by the 
cognitive representations of specific illnesses and procedures for their control. The 
CSM may be valuable in developing campaigns for informing large segments of the 
population about illness threats. Illness perceptions are important because the way a
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condition is appraised is likely to affect anxiety levels, emotion representations of the 
condition and the way a person copes. Understanding the influence of anxiety on 
illness representations may provide better insight into the psychological impact of the 
cardiac screening programme being investigated.
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Chapter 5. Summary
The current review has identified the following important points:
1) The evidence shows there are typically few significant adverse effects of 
participation for people who have a negative diagnosis after the screening test. 
However, little research has been carried out with young people, and none with the 
cardiac conditions being considered here. It cannot be assumed that findings from 
other screening programmes and conditions will necessarily apply in this case.
2) Most research on the adverse impact of screening has focused on anxiety, and there 
is a need to consider broader outcomes such as general perceptions of health.
3) There is inconclusive evidence about the psychological impact of screening for those 
with false positives. This lack of conclusive evidence about false positives is partly due 
to the lack of comparability of studies which vary in terms of the conditions studied, the 
evaluation design, the populations and timescales. The present study cannot 
unfortunately add to this evidence, since although the sample was large, the number of 
false positives who provided data was small.
4) Psychological responses to screening are further affected by factors other than the 
condition under investigation, such as aspects of the screening process, type of 
screening, the role of the physician and the broader context of screening.
5) It is important to have a theoretical framework in which to understand why 
participants respond in the ways they do. The Common Sense Model (CSM) of illness 
representations provides a theoretical framework where both the cognitive and 
emotional representations can be quantitatively assessed through the revised Illness 
Perception Questionnaire (IPQ-R).
6) Emotions are an important component of illness representations, and anxiety both 
influences and is influenced by illness representations.
In evaluating the psychological impact of a screening programme it is imperative to use 
well-validated psychological measures, large samples (catering for individual as well as 
group differences such as gender and age), and carefully constructed repeated-
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measures design with evaluations at relevant time intervals. It is also important to 
ground this in a theoretical framework. The current study was designed to address 
some of the shortcomings in the available evidence on psychological impact on 
screening in the context of cardiac testing of young people. It will investigate the 
psychological impact of cardiac screening in young people by evaluating levels of 
anxiety and self-rated health throughout the testing procedure.
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Chapter 6. Hypotheses
The research described in this thesis was carried out in the context of a cardiac testing 
programme for young people carried out through the charity Cardiac Risk in the Young 
(CRY). Testing was carried out in two settings -  school-based programmes and 
community programmes -  allowing the following hypotheses to be tested in this thesis.
Anxiety
1. Participants’ anxiety levels will decrease from before to after screening in those 
with negative results.
2. Participants in the community group (recruited through public advertisement 
following a death in the community) will have higher levels of anxiety at baseline 
before testing than those recruited through school-based programmes.
3. Participants presenting with symptoms consistent with cardiac conditions will 
have significantly higher levels of anxiety than those without symptoms.
Self Rated Health
4. Participants’ self rated health will improve from before to after screening in 
those with negative results.
5. Participants in the community group will have poorer levels of self rated health 
at baseline before testing than those recruited through school based 
programmes.
6. Participants presenting with symptoms consistent with cardiac conditions will 
have significantly lower levels of self rated health than those without symptoms.
Illness Representations
7. Illness representations will predict levels of anxiety throughout the testing.
8. Illness representations will predict anxiety levels at later stages of the testing 
independently of other factors (gender, age, symptoms level, study type and 
anxiety).
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9. The more negative the representation of the cardiac conditions the more 
reassured the participant will be following the negative test result.
As noted in Chapter 5, the study was not powered to investigate the psychological 
response to people with positive test results, since the number of positives (both true 
and false) who provided data was low. The experience of participants with positive 
results is therefore presented descriptively in Chapter 12.
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Chapter 7. General Methods
7.1 Design
The cardiac screening environment directed the study design. The contact 
schedule for participants in the normal routine of the cardiac screening 
programme constrained the times at which research measures could be 
administered. The first contact was when the medical information and consent 
were sent out. The questionnaire administered at this time was completed after 
the person had filled in the medical questionnaire and consented to participate 
in the screening. Participants received the invitation and questionnaires 
approximately three weeks before the test.
The second questionnaire was completed on the day of the testing just prior to 
the screening. This was consistently 5-10 minutes before having the ECG after 
the person entered the waiting room to be tested. The final questionnaire was 
sent to the participant after the testing with the result letter. This was 3-4 weeks 
after having the ECG. It was therefore problematic controlling the time between 
receiving the questionnaires with the result letter, and when they were actually 
completed.
A better understanding of the exact pattern of data completion could have been 
aided by questions in which the person reported the date they received the 
informed consent and the date they completed the questionnaire. Similarly, a 
question about when the results letter was received and when they completed 
the anxiety measures should have been included. Nevertheless, it was in the 
vast majority of cases that the questionnaires were completed within 2 weeks.
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Despite this potential shortcoming, one of the strengths of this study is that it 
was conducted in a naturalistic setting, adding to its ecological validity. 
Furthermore, the time intervals that were used in this study were appropriate for 
the measures I was using to evaluate the psychological impact of the 
programme, as well as the times at which changes would be expected.
7.1.1 Anxiety and self rated health studies
The first part of this project is a prospective investigation of psychological responses to 
screening, involving assessments of anxiety and self rated health at the time of 
invitation, immediately before testing, and 2-3 weeks later, following receipt of results.
7.1.2 Illness representations study
The second part of this project is a cross-sectional investigation of participants’ illness 
representations, assessed at the time of invitation, and a prospective investigation of 
how these relate to the psychological responses throughout the screening.
7.2 Participants
7.2.1 Anxiety and Self rated health studies
Participants consisted of two separate screening groups, identified as school and 
community. The school group underwent electrocardiogram (ECG) screening, while the 
community sample were offered more comprehensive ECG and echocardiographic 
(Echo) scanning, and an opportunity to discuss issues with a cardiologist (see section 
7.4).
In the school group, two schools agreed to participate in the ECG screening; on two 
consecutive years at Millfield School and once in the Western Isles. “Millfield 1” and 
“Millfield 2” correspond with the two separate groups of participants tested at Millfield 
on the consecutive years. In both schools a standard letter was distributed through 
their school administration to invite students to the screening. Appointments were
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made with a designated local administrator. The vast majority of participants were aged 
14-19 years old. However a small number of participants in the Western Isles 
screening were between the ages of 19-31 years old, and were either family members 
of those invited or worked at the school. 522 participated in the screening, of whom 
443 completed (437 aged 14-19) at least one of the psychological questionnaires.
These two schools represent very different sectors of the population. Millfield School is 
an independent fee paying public school in Somerset, noted for its sporting excellence. 
The senior school has more than 1250 boys and girls. The Nicholson Institute is in 
Stornoway on the Isle of Lewis. This is the largest school in the Western Isles and is a 
state funded school. Pupils from other state schools in the Western Isles were also 
invited to the testing at the Nicholson Institute, with a total of approximately 880 boys 
and girls between the ages of 15-19.
Community screenings were advertised in local communities and publicized by local 
press. Public advertising of the events usually followed the death of a young person in 
the local community due to a cardiac or unknown condition. People requesting testing 
arranged an appointment with a local representative. The only requirement was that 
they were within the age range of 14 and 35 (sometimes exceptions were made) to 
participate. 303 individuals underwent community screening and completed some 
psychological assessments of whom 180 were aged 14-19. Data were collected during 
eight sets of community screenings between 2001 and 2003 in several parts of the 
country, including the North-East, Northern Wales, Manchester and Liverpool.
To best understand the results in this study I aimed to compare them with data 
collected from two further samples. Firstly, I had intended to compare the school 
samples with students from the same school that decided not to attend. All people who 
were sent the questionnaire were asked to return it even if they decided not to attend. 
However, none of the ‘non participants’ completed the questionnaires. It is unclear why
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this was or whether they received the forms in the first place. The most likely reason is 
that, having decided not to participate in the cardiac screening, they did not read all (if 
any) of the literature before deciding not to participate. Alternatively, some of the 
students may never have received the information or invitations at all.
Secondly, I aimed to compare this sample with that of a similarly matched school. This 
comparison group, did not undergo any type of cardiac testing. The 6th form tutor at 
City of London Freemen’s private school administered the questionnaires to students 
over 16 years of age. This school was selected as an appropriate match for age, 
gender and the socioeconomic status of Millfield School. A letter and questionnaire was 
given to each student who agreed to participate. No reference was made in the letter to 
cardiac conditions or sudden cardiac death. The information letter (Appendix IV) 
outlined that life is often said to be more stressful than ever before, that young people 
face more demands and decisions than in the past and that currently we do not know 
what young people in general feel or think about their health. It also specified that 
surveys had been carried out in University students but we wanted to measure anxiety 
and health perceptions in people aged 16-18. 128 completed the questionnaire.
7.2.2 Illness representations s tudy
The participants who completed the illness representation questionnaire in addition to 
the anxiety and self rated health measures are a subgroup of those reported in section 
7.2.1.
Initially I only collected data on anxiety levels and self-rated health. After the first stage 
of data collection it was clear that more information on the way participants perceived 
cardiac conditions would be important in explaining the patterns of psychological 
responses to the testing procedure. Data were collected from 440 of the 746 taking part 
in the anxiety and self-rated health studies. The comparison group did not complete the 
illness perception questionnaires.
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Within the introductory letters sent to the participants various points were included that 
may have had a direct impact on participants’ illness perceptions. All participants were 
sent standardized general information outlining what people should expect on the day 
in regard to the ECG test, including the fact that treatment would be offered at a 
supporting hospital if required. Consequences were also addressed in the general 
information in a number of places stating “In the rare event that a previously 
undetected cardiac condition is diagnosed.... There is a possibility it may affect a 
number of life issues. However, it must be stressed that undetected heart conditions 
are rare, and these are potentially life saving tests.”
The general information also presented background on the charity offering the tests. 
This included the statement, “experts believe that 4-8 young people die each week in 
the UK from undiagnosed cardiac conditions. It is important to stress that the majority 
of these deaths are preventable.” It is reasonable to suggest that this could have a 
direct impact not only on the development of emotional representations and perceived 
consequences of these conditions, but also increase anxiety levels and a desire to be 
tested to remove the risk of being affected. Furthermore, the media attention around 
some of the screenings, when offered to a community after a death, is likely to have 
endorsed these points and highlight the importance of being tested to reduce risk.
Not all of the information in the introduction letters was the same. This was largely due 
to the different methods of funding the screening. For instance in the Western Isles, 
funds had been raised for the charity in memory of a local school teacher who had died 
suddenly. In the students’ information letter there are two further points about the work 
of the charity. One of these states that the charity’s remit is “to highlight the symptoms 
of undetected heart conditions and emphasis how much can be done should a 
diagnosis be confirmed”. This puts particular emphasis on symptoms and possible 
treatment options after a diagnosis is made. Another point highlights the consequences
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for those who are not screened “to offer counseling and support to families affected by 
the loss of an apparently healthy child / young person due to an undetected heart 
condition.” In the Millfield testings this information was not included. The various 
introduction letters are included in appendix II.
7.3 Procedure
The procedure and time frame for the study is outlined in Table 7.1. The measures are
described in section 7.5.
Table 7.1 Time and measures
When questionnaires were 
completed
Measures (Appendix III)
Time 1
(2-3 weeks 
prior to time 2)
With the consent form at the initial 
invitation for the cardiac test
Invitation/Consent, 
Medical Questionnaire, 
HADS anxiety measure, 
Self-rated health, 
Modified IPQ-R
Time 2
(prior to 
screening)
While waiting immediately before 
having the cardiac test (approx 5-10 
minutes before the first test)
HADS anxiety measure, 
Self-rated health.
Time 3
(2-3 weeks 
after time 2)
When they had received their test 
result with a letter confirming either 
a negative result (clear) or that a 
cardiac abnormality was identified 
and further tests were required to 
confirm their cardiac status.
HADS anxiety measure, 
Self-rated health, 
Reassurance scale, 
open-ended questions.
Time 4
(4-8 weeks) 
(Western Isles 
only)
When those requiring follow up 
tests had received a final ‘all clear’ 
or a cardiac condition was 
diagnosed
HADS anxiety scale, 
Self-rated health, 
Reassurance scale, 
open-ended questions.
Comparison
Group
Questionnaires administered and 
collected by head of year tutor
HADS anxiety scale, 
Self-rated health,
Date of Birth and Gender.
Time 1 - A standard letter including the consent form, information about the testing 
procedure, and both medical and psychological questionnaires were sent out to all 
school students in the relevant year groups in the school screenings. In the community 
screenings participants had first to contact the screening administrator to confirm place 
availability, before being sent the information. The groups differed in the information
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about screening (ECG vs. ECG, ECHO and consultation), and in the consent forms. 
Copies of this material can be found in appendix II.
As part of the screening programme, all participants completed a short medical 
questionnaire concerning cardiovascular disease and symptoms relevant to cardiac 
conditions (see section 7.5.2). They were also asked if they would fill in a 
psychological questionnaire. It was clearly stated it was not mandatory for them to 
complete the psychological questionnaire if they decided to have the cardiac test. They 
were asked to send their consent forms, medical and psychological questionnaires to 
the screening administrator (person arranging their appointment) two weeks before the 
testing day. Participants aged 16 years and older gave written consent, while for those 
under the age of 16, parental consent was given.
Time 2 - On the day of the testing, clients were asked to fill in a questionnaire 
immediately prior to the cardiac testing.
Time 3 - Clients were sent the results of the cardiac testing as well as a third 
questionnaire 2-3 weeks after the test. At this point the vast majority of clients were 
cleared. I sent follow up “reminder” questionnaires to all participants in the community 
screenings 3 weeks after sending the third questionnaire, if I had not received a 
response. This increased the response rate in those samples by approximately 20%. It 
was not possible within the school sample to send out reminder letters at three weeks. 
In the community screenings and Millfield, those with abnormal results at time 3 were 
either referred to the consultant cardiologist Dr Sharma at Lewisham hospital, or to a 
local cardiologist for the further testing. This was on the instruction of the General 
Practitioner after the receiving a letter confirming that a referral to a cardiologist was 
required for the patient.
Time 4 - Some cases were told they had an abnormality and were asked to attend a 
second appointment at which further tests would be carried out to ascertain if they had 
a cardiac condition. After this the final psychological questionnaire was given to them, 
(at time 4). This was sent with a final result letter either referring them to a cardiologist
for further tests or a letter stating that the cardiac results were negative. In a small 
number of cases a cardiac (or cardiac related) diagnosis was made. However, the vast 
majority of cases were given an all clear. Details of the numbers falling into each group 
are given in sections 8.1 and 8.2. Depending on the follow up tests required, and 
expertise necessary in the diagnosis, they might have been carried out locally or at a 
specialist clinic in London. In screenings where more than 10 clients required follow up 
tests (such as the Western Isles), a specialist team, including a cardiologist, visited the 
screening venue to conduct the required tests. Although there were some positive 
screening outcomes from all the samples studied, in this study, it was only possible to 
carry out Time 4 evaluations in the Western Isles sample.
Comparison group - Students at the City of London Freemen’s School completed a 
brief questionnaire containing measures of anxiety and self-rated health, gender and 
date of birth. This is a private school with a similar demographic intake to Millfield 
School.
7.3.1 Ethical approval
The procedure for ethical approval for this psychological study varied across the 
different testing sites. In Scotland, the rationale for the psychology study and the 
questionnaires were submitted to the Western Isles Health Board after the initial ethical 
approval for ECG testing was granted. The documents were approved and were 
incorporated within the medical questionnaires. No formal approval documents have 
been recorded.
In the case of the private schools, no ethical approval was required for ECG testing.
The psychological questionnaires and cover letters were part of the initial paperwork 
provided to the school Doctor. The school approved all information that was to be sent 
to the students and their parents prior to dissemination. It was clearly stated that if they 
chose not to complete the psychology questionnaires it would not affect their offer of 
cardiac testing. Consent was implied from completion of the questionnaires.
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No ethical approvals were sought for the community screenings where the 
questionnaires were completed after the individual consented to the cardiac testing. It 
was clearly stated that if they chose not to complete the psychology questionnaires it 
would not affect their offer of cardiac testing.
In the control study, the psychological questionnaire was approved by the school 
Headmaster and delegated to the head of the 6th year to administrate the circulation 
and collection of questionnaires.
There are a number of key issues in regard to ethical aspects that I considered when 
conducting the study. First, what to do if highly anxious individuals were identified. This 
study was not designed as an anxiety screening study, and no contact was made with 
participants in regard to their anxiety levels. Future studies may consider including 
anxiety as part of a wider screening assessment. But it should also be noted that 
Snaith (2003) has emphasised that the HADS self-assessment scale is only valid for 
screening purposes, and a definitive diagnosis must rely on the process of a clinical 
examination.
Another important issue is the ethics of gathering anxiety data on participants. The 
reason for conducting the psychological study was in part to investigate ethical 
concerns (primarily in the potential causing of anxiety) around screening programmes, 
and to evaluate the way the programme was conducted.. It can therefore be seen that 
it is essential to carry out this type of psychological evaluation to answer the question 
of whether the cardiac screening programme itself is ethical, and how it can best be 
conducted to minimize any psychological impact.
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7.4 Diagnostic cardiac tests
The two study types (school and community) had different cardiac tests, the community 
being more comprehensive.
In both the school and community testing, the screening team were present for one 
day. The team consisted of a manager of the event, their assistant and a number of 
technicians. The manager and assistant were responsible for checking the height and 
weight of the participant and that all the information in the medical and psychological 
questionnaires as well as the informed consent was completed prior to ECG. The 
consultant cardiologist who supervised the screening programme approved all ECG 
and ECHO technicians.
7.4.1 School - Electrocardiogram  (ECG)
The diagnostic test was a resting 12 lead 
electrocardiogram (ECG) (pictured on the left). 
The ECGs were carried out in the school health 
centers. Depending on the number of clients 
there were either two or four ECG technicians 
present. Technicians were nurses who were 
employed in cardiac departments in NHS hospitals. Each of these technicians had a 
private space to conduct the testing. Each ECG took 5-10 minutes to conduct and up to 
50 ECGs were conducted by each technician per day.
The ECG was scrutinized for signs of cardiac conditions that might cause a young 
SCD, primarily the cardiomyopathies (including hypertrophic cardiomyopathy), ion 
channelopathies (including long QT), and Wolff Parkinson White. If an abnormality was 
identified in the ECG, the individual was invited for a follow up appointment in which 
they were given another ECG, an echocardiogram and a physical investigation with a
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cardiologist. Further tests, such as 24 hour ECG holter monitors and exercise tests, 
were sometimes required before a final confirmation of health status could be given.
7.4.2 Com m unity - ECG, ECHO, and cardiac consultation
Each person was given an ECG, an 
echocardiogram (pictured on the left) and a 
consultation with a cardiologist including 
measurement of blood pressure, and 
listening to the heart with a stethoscope.
The testings were held either in community 
health centers or county halls. The testing 
process lasted up to 40 minutes for each client. ECHO technicians worked as clinical 
physiologists in the cardiac departments of NHS hospitals. Each ECHO technician 
could conduct approximately 25 ECHOs per day, approx 20-25 minutes per test. 
Although the cardiologist’s role was not diagnostic but rather to maintain scientific 
medical rigour, he was available to discuss clinical concerns and offer reassurance to 
participants. Further tests were sometimes required before a diagnosis could be given.
7. 5 Psychosocial measures
Participants were asked to complete a number of psychological questionnaires, copies 
of which are included in appendix. These included:
7.5.1 Anxiety scale from  the H osp ita l A nxie ty  and Depression Scale (HADS)
The Hospital Anxiety and Depression scale is a 14 item self report screening scale that 
was developed to identify the presence of anxiety and depression in nonpsychiatric 
medical settings. Emotional distress was assessed with items that were 
uncontaminated by the somatic symptoms associated with medical disorders (Zigmond 
and Snaith, 1983). The scale consists of a 7-item anxiety scale and a 7-item 
depression scale. Each item is scored on a 4-point Likert scale (from 0-3). The
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respondent is asked about their experience over the past week. Each scale ranges 
from 0 (min) -  21 (max). According to Zigmond and Snaith (1983), a score of between 
8-10 identifies a possible or mild case and a score of 11 or more a probable presence 
of a clinically meaningful anxiety or depressed condition (see appendix III).
The HADS scale is one of the most frequently used scales to assess psychological 
distress in somatically ill patients. Only the anxiety subscale was applied to this study.
It was selected because heart conditions are often symptomatic, so a measure that 
excluded somatic symptoms was thought to be advantageous. The HADS scale has 
been evaluated in adolescents, and its psychometric properties and brevity made it 
appropriate for this study (White et al., 1999).
The HADS anxiety scale was administered at all four time points, and was also 
completed by the comparison group. The first HADS anxiety questionnaire requested 
the participant reported their level of anxiety as experienced over the previous week. 
Snaith has said that it is reasonable to administer the scale again but at no less than 
weekly intervals (Snaith, 2003). The second questionnaire was completed 2-3 weeks 
after the first questionnaire, at the time of the testing. This second HADS anxiety 
questionnaire was identical to the first, requesting the participant to report their 
experience of anxiety over the previous week.
At time 3, after receiving the results, the wording of the HADS scale changed, asking 
the participant to report on “how they had been feeling since receiving the test result”. 
This was with the aim of getting a more accurate measure of anxiety in relation to the 
test result, as some people may have completed the questionnaire at different time 
intervals after receiving the results.
The authors of the original scale comment that the time frame of the scale refers to 
mood during the past week so as to avoid the influence of possible immediate
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changes, such as those due to the stress of attending the clinic appointment (Zigmond 
and Snaith, 1983). It is therefore reasonable to expect for the measure to be sensitive 
to the changes at time 3, after the test result.
The Cronbach alpha coefficient for the HADS anxiety scale was 0.79 at time 1, 0.79 at 
time 2 and 0.81 at time 3.
7.5.2 Medical Questionnaire
The medical questionnaire assessed common symptoms of cardiac conditions in youth. 
Several studies indicate that young people who experience exercise-related 
cardiovascular events had prodromal symptoms which were often ignored (Thompson 
et al., 2007). For example, a study of 134 young victims of SCD showed that 18% had 
reported probably cardiac symptoms in the years before their deaths (Maron et al., 
1996). Other studies have shown that half joggers and 75% of squash players who 
died unexpectedly during physical exertion had probable cardiac symptoms in the 
months before death (Northcote, Flannigan, and Ballantyne, 1986; Thompson etal., 
1979). Participants in the present cardiac testing were therefore asked if they had ever 
fainted and if they experience four other cardiac symptoms: chest pain, breathlessness, 
palpitations, and dizziness. Participants were also asked their levels of sporting activity 
if there was a family history of heart disease and if there had been a sudden cardiac 
death in the family, and the age of the death. Full details of this questionnaire are in 
appendix I.
7.5.3 Self Rated Health
Self-rated health is a consistent predictor of mortality in longitudinal studies (Idler and 
Benyamini, 1997). It was assessed with a single item ‘In general how would you say 
your health is: ‘Excellent’, ‘Very good’, ‘Good’, ‘Fair’ or ‘Poor’, and was scored as 
‘Excellent’ = 1 and ‘Poor’ = 5. It was administered at all four time points, and was also 
completed by the comparison group. Often these responses are dichotomized into two
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categories, with individuals reporting "Fair" or "Poor" health classified as "poor health". 
However, for this study the scale was analysed as a continuous variable, to enable a 
repeated measures analysis to be carried out and to maximize the predictive power of 
self-rated health in the regression analysis.
7.5.4 The Revised Illness Perception Questionnaire (IPQ-R)
Illness representations were assessed using the Revised Illness Perception 
Questionnaire (IPQ-R, Moss-Morris et al., 2002). This is a 69 item questionnaire 
assessing 11 dimensions of the cognitive representation of illness, including identity, 
timeline acute/chronic, timeline cyclical, consequences, personal control, treatment 
control, illness coherence, emotional representations, psychological attributions, risk 
factor attributions, immune attributions and chance attributions. The IPQ-R was 
reworded to be applicable to participants undergoing testing for cardiac conditions in 
this study. The original wording of each IPQ-R item and the rewording used in this 
study are shown in appendix III. In some cases items were deleted if they were 
inapplicable. The items and subscales that were excluded are discussed below;
7.5.4.1 Emotional representations
Six items assessed emotional representations of cardiac conditions. These six items 
were previously found to be sensitive to differences in illness perceptions and to predict 
health care responses such as seeking medical care (Cameron, Leventhal, and 
Leventhal, 1993). An example of the way the items were reworded was the question 
from the IPQ-R ‘I get depressed when I think about my illness’ was changed to ‘I get 
depressed when I think about having a heart condition’ in this study. Each item was 
rated on a 5-point Likert-type scale: strongly disagree to strongly agree. Higher scores 
indicated higher levels of emotional responses to cardiac conditions.
7.5.4.2 Illness coherence
This five-item scale assessed understanding of cardiac conditions. Items included ’I 
have a clear picture or understanding of heart conditions’ and The symptoms of heart
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conditions are puzzling to me’. Scores on the 5-point scales were summed, with higher 
scores indicated greater levels of understanding of cardiac conditions.
7.5.4.3 Treatment control
This five-item scale assessed perceptions of what can be done for a person if 
diagnosed with a cardiac condition. Items included Treatment can control the 
symptoms of a heart condition’ and There is nothing which can help those with heart 
conditions’. Higher scores on the treatment scale indicated a stronger belief that things 
could be done to help people with cardiac conditions.
7.5.4.4 Timeline
Beliefs about whether cardiac conditions are acute or chronic were assessed with a 
six-item scale, as in the original IPQ-R scale. Items included ‘A heart condition will last 
a long time’ and ‘A heart condition is likely to be permanent rather than temporary’. 
Each was rated on a 5-point scale from strongly agree to strongly disagree. Higher 
scores on the timeline scale indicated a belief that cardiac conditions were chronic and 
would last a long time.
7.5.4.5 Consequences
This six-item scale assessed individuals’ perception of the consequences of having a 
cardiac condition. Items included ‘Having a heart condition would strongly affect the 
way others see me’ and ‘ Having a heart condition would have major consequences on 
my life’. Higher scores indicated a greater consequence of having a cardiac condition.
7.5.4.6 Personal Control
Three items from the IPQ-R personal control subscale were modified to address the 
different ways a person may control their health through their lifestyle. Three of the 
items of the IPQ-R were excluded on the basis of being inappropriate; ‘I have the 
power to influence my illness’, ‘My actions will have no affect on the outcome of my 
illness’ and There is a lot I can do to control my symptoms’. These items were 
deemed inappropriate as the participants had not been diagnosed with an illness, and 
therefore it would be confusing and misleading to ask if they felt they could have power 
over it or affect the outcome of it. Items that were included were ‘Having a heart
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condition would depend on the way I live my life’ and ‘Having a heart condition would 
depend on me’. Higher scores indicated greater control over having a cardiac 
condition.
7.5.4.7 Identity
The identity dimension of the IPQ-R was excluded from this study on the grounds that it 
would be misleading to ask people how they identified the symptoms of a condition 
they had not been diagnosed with. Additionally, relevant symptoms were assessed on 
the medical questionnaire.
7.5.4.8 Time-cycle
The time-cycle dimension of the IPQ-R was excluded on the basis of it being 
dependent on a previous illness diagnosis.
7.5.4.9 Causal attributions
Participants’ beliefs about the causes of cardiac conditions in young people were 
assessed with 11 causal items from the original IPQ-R. Apart from slight rewording of 
some items, the only changes from the original were the exclusion of ‘altered immunity’ 
and the inclusion of ‘exercise’. Causal items included ‘Stress or worry’, ‘Emotional 
state’, ‘Mental attitude’, ‘Smoking’, ‘Diet or eating habits’, ‘Poor medical care in the 
past’.
7.6 Other measures
7.6.1 Worry about genetics
Due to the inherited nature of many of the conditions being investigated in the 
screening, I felt that a specific item addressing genetic concerns should be included. 
This was worded as The genetic (inherited) aspects of some heart conditions worry 
me’ and was rated on a 5 point scale from strongly agree to strongly disagree.
7.6.2 Reassurance and screening approval scale
A scale was constructed to measure participant reassurance after the cardiac test and 
their approval of the testing procedure, through recommending this to a friend or having
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the test done again in the future. It consisted of three items (such as “/ feel reassured 
now I have had this cardiac test”) which participants were asked to record how strongly 
the agreed/disagreed with. The scores were converted into a 15 point scale with a high 
score being a very positive response and a low score being a very negative response. 
The three item scale has a good internal reliability of (a =0.70).
7.7 Analysis
All data were analysed using SPSS v10. Data were collected in this study from 
adolescent boys and girls aged 14-19 years, and from adults. The data was made up of 
both continuous (anxiety, self rated health, illness representations) and categorical 
variables (age, gender, study type and symptom groups). Parametric statistics were 
used to explore and predict the strength or relationships between these variables and 
the differences between the groups. Separate analyses of anxiety and self-rated health 
responses were carried out with the two age categories. The analyses of adolescents 
are described in Chapters 8 and 9, and adults in Chapter 10.
7.7.1 Anxiety and self rated health
Participants who were diagnosed with an ECG abnormality or who required further 
tests to confirm their cardiac status, were excluded from the main analyses, and were 
analysed separately. Repeated measures analysis of variance, independent and paired 
t tests were conducted in the analysis of the anxiety and self rated health data.
Between group analysis for each of the key factors, gender, age, symptoms and study 
type were performed, as well as for direction of change of anxiety and self rated health 
throughout the testing. Post Hoc tests using pairwise comparisions were carried out on 
the sample with completed repeated measures data. To ensure that the cumulative 
Type I error was below .05, the Bonferroni correction was used whereby the a was 
divided by the number of pairwise comparisons. This was only commented on if the
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criteria set by the Bonferroni correction was not met. Comparisons were made with a 
control group and previously published reports.
7.7.2 Illness representations
Principal components factor analysis and reliability (alpha coefficients) analysis were 
used to evaluate the IPQ-R scales (timeline, serious consequences, personal control, 
treatment control, illness coherence and emotional representation constructs). Varimax 
rotation was chosen to reflect the methods used by Moss-Morris et al., when 
developing the IPQ-R. Independent sample t tests with unequal variance were 
conducted to compare means and stand deviations with previously published reports. 
Regression analysis was conducted to identify the factors that account for variability in 
anxiety and self rated health levels throughout the testing procedure. Means and 
standard deviations were calculated and interrelationships between the IPQ-R factors 
were evaluated with simple product moment correlations and compared to previously 
published reports. Partial correlations were also performed on those adolescents with 
abnormal results.
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Chapter 8. Anxiety in adolescents
8.1 Baseline characteristics and questionnaire completion rates
Table 8.1. Socio-demographic characteristics of groups
N M aae (SD) Age range Gender 
Male Female
Negative test results 
at time 3 
N(%)
School 443 16.46(1.53) 14-31 236 (53.3%) 207 (46.7%) 418 (94.4%)
437 16.34(1.02) 14-19 234 (53.5%) 203 (46.5%) 412 (94.3%)
Community 303 19.67 (6.06) 9-38 199 (65.7%) 104 (34.3%) 276 (91.1%)
180 16.19 (1.47) 14-19 120 (66.7%) 60 (33.3%) 167 (92.8%)
Comparison 128 17.07 (0.78) 16-19 73 (57%) 55 (43%) N/A
The characteristics of the sample are summarized in Table 8.1. This shows the 
numbers of participants who completed the psychological questionnaires in the school, 
community and comparison groups. The majority of participants were male in each 
study group. The community study was significantly older with a higher proportion of 
boys and men. Although the age range in the different samples is up to 38, the vast 
majority of participants were adolescents. In the school sample 98.6% were aged 14- 
19, compared with 59.4% in the community sample. 52 participants (25 (5.6%) in the 
school sample and 27 (8.9%) of the community sample) received a positive screening 
result and required further tests to confirm a diagnosis and were therefore not included 
in the main analyses. Analyses were carried out on all participants who received a 
negative diagnosis at time 3.
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Figures 8.1 Histograms of the age distribution of participants in each sample. 
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Table 8.2 - Completion rates for psychology questionnaires throughout the testing
Tests Location
Time pN N Time 3 results N (%)
2 3 4 Negative Positive
SCHOOL SCREENINGS - ECG ONLY
Millfield -  private school 112 112 51 119 119
Western Isles-state school 203 101 89 12/22 210 289
Millfield2 -  private school 99 104 51 114 114
Total fo r school ECG screenings 414 317 191 443 522
114(95.8%) 5(4.2%)
193(91.9%) 17(8.1%)
111 (97.4%) 3 (2.6%)
418(94.4%) 25(5.6%)
COMMUNITY SCREENINGS - ECG, ECHO, + CONSULTATION WITH CARDIOLOGIST
Darwen 33 34 21 39 39 35 (89.7% 4(10.3%)
Newcastle 30 30 18 37 37 35 (94.6%) 2 (5.4%)
Liverpool Manchester 37 37 11 38 38 35 (92.1%) 3 (7.9%)
Newcastle 36 35 12 37 37 34(91.9%) 3(8.1%)
Redcar 35 33 27 36 36 30 (83.3%) 6(16.7%)
Darwen 35 40 30 40 40 38 (95%) 2 (5%)
North Wales 37 37 10 37 37 32 (86.5%) 5(13.5%)
Newcastle 39 37 25 39 39 37 (94.9) 2(5.1%)
Total fo r community screenings 282 283 154 303 303 276 (91.1%) 27 (8.9%)
Totals fo r both study types 696 600 345 746 825 694 (93%) 52 (7%)
Table 8.2 shows the numbers of participants who completed the psychological 
questionnaires (pN) out of the total number (N) in either the sample within schools or 
community. pN refers to the total number that participated in the psychology study,
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participants were included if they completed one or more of the psychological 
questionnaires at either time 1, 2, or 3. N refers to the number of people who 
participated in the cardiac study. All of those who participated in the cardiac testing 
completed a psychological questionnaire on at least one occasion, the one exception 
being in the Western Isles where only 73% (210/289) of the sample completed at least 
one of the psychological questionnaires. Many of the participants in the Western Isles 
chose not to complete the first questionnaire, and because of time restraints on the day 
of the testing the screening team only administered the second questionnaire to 
approximately 35% of the sample prior to testing.
Of the individuals who completed any questionnaires (pN), 93% completed at time 1, 
80% at time 2, and 46% at time 3. In table 3, the final two columns Time 3 results’ 
identify the number of participants who completed at least one psychological 
questionnaire (pN) and had either abnormal (positive) or normal (negative) results at 
time 3.
One of the assumptions of the parametric statistics that have been used in this study is 
that the underlying distribution of scores in the population is normal. Although the 
anxiety and self rated health data were significantly skewed, it can be assumed that the 
assumption of normality is met when there is a large sample size, which is greater than 
100 (Katz, 1999). In each of the repeated measures analyses the assumption of 
sphericity was not met. Therefore the Greenhouse-Geisser Epsilon was used to correct 
the F test.
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Figure 8.2 Flow of participants through the screening procedure
Total number of participants in the Cardiac testing N=825 
Total number of participants completing one or more Psychological questionnaire N=746
School N=443 Community N=303
Health questionnaire, consent form, psychological 
questionnaire at time 1 (2-3 weeks prior to appointment) 
School N=414 Community N=282
Psychological questionnaire at time 2 
(5-10 minutes prior to the 12-lead ECG)
School N=317 Community N=283
Result letters with Psychological questionnaire at time 3 
(2-3 weeks after ECG test)
School N=191 Community N=154
Negative (normal) result letter 
School Community
94.4% 91.1%
No further action required
Positive (abnormal) result letter 
School Community
5.6% 8.9%
Further action required
Western Isles only 
Negative (normal) result letter after 
repeat ECG and ECHO 
Psychological questionnaire time 4 
(N=12)
Positive (abnormal) results 
Referred into the NHS fo r further tests. 
(Western Isles and all other participants) 
Further investigation may include; 
Echocardiography;
Exercise tests;
Holter m onitoring;
T ilt tests;
E lectrophysiological studies;
Cardiac MRI.
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8.2 Anxiety responses in adolescents
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Figure 8.3 Anxiety responses in adolescents 
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209 of the total sample of 617 participants aged 14-19 years completed anxiety
measures at all three time points. A repeated analysis of variance was conducted to
compare scores on the anxiety scale at the three times. There was a significant effect
of time on levels of anxiety (F(1.9,398) = 8.99, p < 0.001). Post hoc tests indicated that
anxiety did not differ at times 1 and 2, but that both were higher than time 3 (time 1-3 p
= 0.002, time 2-3 p < 0.001).
Table 8.3 Mean (SD) scores for paired sample t tests for Anxiety at Time 1, 2, & 3 
(adolescents)
T1 T2 T3 N
Pair 1 
Pair 2 
Pair 3
5.36(3.43)
5.27(3.31)
5.25(3.07)
5.16(2.98)
4.57(3.18)
4.53(3.19)
424
254
216
0.345
0.000
0.000
The same pattern emerged when pairwise comparisons between each sample were 
made using t-tests. These comparisons included all adolescents available, rather than 
only those with complete data. As can be seen from table 8.3, there was a significant
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decrease in anxiety from time 1 to time 3, and time 2 to time 3, but no difference in 
anxiety between time 1 and time 2. It appears, therefore, that levels of anxiety were not 
raised in anticipation of testing (time 2) in comparison with normal levels (timel), but 
that a negative test outcome stimulated some reduction in anxiety (time 3). Thus 
hypothesis 1 was supported.
Although anxiety fell on average, it is possible that some individuals reacted negatively 
to the screening procedure. This was tested by calculating the direction of change 
between Time 1 and Time 3; I reasoned that if an individual was more anxious after 
receiving a negative screening result than when invited for the test, this might represent 
a genuine adverse response. 140 of the adolescents (55%) showed a decrease in 
anxiety between times 1 and 3, with 29% reporting an increase and 16% no change. 
Repeated measures analysis with direction of change as the between-subject factor 
revealed a significant group by time interaction (F(3.5, 364) = 70.4, p <0.001) illustrated 
in Figure 8.4.
Figure 8.4 Patterns of anxiety response
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This analysis revealed a number of interesting effects. First, the adolescents who 
showed an increase in anxiety after testing started at a low level in comparison with 
those whose anxiety fell. Second, in the anxiety decrease group, levels did not fall to 
very low levels, but only to the same values as the no change group. Third, even at the 
post-screening assessment, anxiety levels in the increase group were not as high as 
the values at timel in the anxiety reduction group. This study therefore found no 
evidence that the screening experience led to very high levels of anxiety, even in a 
subgroup.
8.3 Anxiety by study type and gender - comparing school and community 
studies in adolescents
The second hypothesis (page 84) was that participants in the community screening 
would have higher initial anxiety than those in the school programmes, because they 
had volunteered for screening following a SCD in the local community. A repeated 
measures analysis of anxiety over the study period was therefore conducted with study 
type (school, community) and gender as between-subject factors. The data are shown 
in figure 8.5.
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Figure 8.5 Anxiety time 1,2 & 3 by study type and 
gender - adolescents
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There was a significant interaction between study group and gender (F(1,205) = 4.71, p 
= 0.031). Girls had higher levels of anxiety in both the school and community testings. 
But while the girls in the community group were more anxious than those in school 
testing, the reverse was the case for boys. These effects did not interact with time, so 
the changes over time were similar in the different subgroups. Thus hypothesis 2 was 
partly confirmed for girls and not for boys. The explanation is not clear, but one 
possibility is that selection factors influenced the participation of boys in the community 
testings, with more anxious boys choosing not to take part. This issue will be 
discussed later in section 8.7.3.
It is important to note that there were no significant differences in the school screenings 
between the Western Isles (a state school in Scotland) and Millfield (a private school in 
England). Furthermore, there were no significant differences between locations of 
community screenings (such as Redcar, Liverpool, North Wales). The results of these 
analyses are not presented.
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8.4 Anxiety levels by Symptoms
Table 8.4 Frequencies for responses on the medical questionnaire
N
No
% N
Yes
%
Fainting 600 (82.9%) 124 (17.1%)
Dizziness 512 (70.8%) 211 (29.2%)
Palpitations 610 (85.3%) 105 (14.7%)
Chest pain 509 (70.6%) 212 (29.4%)
Breathlessness 561 (78.2%) 156 (21.8%)
Family history 400 (56.6%) 307 (43.4%)
Sudden Cardiac Death in the family 433 (82.0%) 95 (18.0%)
Table 8.4 shows the numbers of participants reporting each of the symptoms in the 
medical questionnaire. 43.4% reported having a family history of heart disease and 
18% reported having a sudden cardiac death in their family. Chest pain was the most 
commonly reported symptom (29.4%), followed by dizziness (29.2%), breathlessness 
(21.8%) fainting (17.1%) and palpitations (14.7%).
I calculated the proportion of adolescents and adults who reported at least one of the 
five symptoms (fainting, dizziness, palpitations, chest pain, and breathlessness). The 
results are shown in Table 8.5.
Table 8.5 Symptoms grouped into symptomatic and asymptomatic by age group
Age 14-19 age 20-35
N % N % N %
Symptoms None 277 39% 249 42% 28 26%
One or more 429 61% 350 58% 79 74%
Overall, almost two-thirds of participants had either fainted or were experiencing 
breathlessness, chest pain, palpitations or dizziness. Adults were more likely than 
adolescents to report at least one symptom (x2 = 9.03, p = 0.005). Additionally, the 
mean number of reported symptoms was also less for those aged 14-19 than those 
aged 20-35 (F (1,705) = 9.12, p = 0.003).
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91 (44%) of the 209 adolescents who completed all assessments reported no 
symptoms compared to 118 (56%) reporting 1 or more symptoms. A repeated analysis 
of variance was conducted with symptom group as the between-subject factor to 
compare scores on the anxiety scale. This revealed a significant difference between 
the groups (F(1,207) = 17.434, p < 0.001), but no significant symptom group by time 
interaction (F(1.9, 395) = 1.402, p = 0.247) shown in figure 8.6.
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As can be seen in Figure 8.5, adolescents who were symptomatic had higher anxiety 
levels throughout the study, confirming hypothesis 3, but did not react differently to the 
testing procedure. Pairwise comparisons between each symptom group were made 
using t-tests. In the asymptomatic group there were no changes in levels of anxiety 
between time 1 and 2, but significant decreases in levels of anxiety between time 1 and 
3 and time 2 and 3 (p < 0.001). In the symptomatic group there were no changes 
between times 1 and 2 or between times 2 and 3. However, there was a significant 
decrease in anxiety between time 1 (invitation) and time 3 (post-screening (p < 0.05).
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Post hoc results indicated that throughout the testing those who were asymptomatic 
had significantly lower levels of anxiety than the symptomatic group (p < 0.001).
There were five somatic symptoms assessed in the medical questionnaire. In order to 
find out which of these symptoms predicted anxiety, I carried out a series of multiple 
regressions on anxiety, including the symptoms along with gender, age at the time of 
testing, and study group as predictors.
Table 8.6 Regression for symptoms on anxiety at time 1, 2 and 3 in adolescents
Anxiety time 1 Anxiety time 2 Anxiety time 3
6 Sig 6 6 Sig
Fainting ns ns ns
Dizziness 0.157 *** ns 0.106 **
Palpitations 0.084 ** ns ns
Chest pain 0.112 ** ns ns
Breathlessness 0.157 *** ns ns
Anxiety time 1 0.680 *** 0.593 ***
***p< 0.001 ** P  < 0.05 ns = not significant
Table 8.6 shows that dizziness, palpitations, chest pain and breathlessness were all 
independent predictors of anxiety levels at time 1 (p < 0.05). The strongest predictors 
were dizziness and breathlessness. Fainting was the only symptom not to be a 
predictor of anxiety levels. In addition gender was an independent predictor.
In the regression analysis on anxiety time 2 , 1 included anxiety time 1 along with the 
other variables. In this analysis, the predictors of anxiety at time 2 were anxiety at 
timel (p < 0.001) and study group (p < 0.05). It would therefore appear that prior 
anxiety levels mediate the predictive role of the specific symptoms. In the third 
regression on time 3 anxiety, “dizziness” was an independent predictor (p < 0.05) as 
well as gender and anxiety at tim el.
These regression analyses indicate that all of the symptoms apart from fainting were 
associated with elevated anxiety.
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8.5 Comparison of anxiety levels with control samples
The interpretation of these anxiety results would be greatly facilitated by knowledge of 
how levels compare with those in adolescents who are not involved in cardiac testing at 
all. In table 8.7 I present the data from the comparison group, and results from two 
published studies: data from 260 school children aged 12-16 (White et a/., 1999), and a 
sample of 351 university students (Andrews and Wilding, 2004).
Table 8.7 Comparison of anxiety levels for adolescents at each time interval compared 
with the control group and published norms
Comparison
group
Screening group (14-19 years old) 
(Negative Diagnosis at time 3)
White et 
al. ,1999
Andrews 
and Wilding 
2004
Anxiety City of Time 1 Time 2 Time 3 School University
London
Freemen’s
Prior to test Immediately 
before test
(after results
normal vs.
abnormal
ECGs)
Children 
(age 12- 
16)
Students
(Before
entry)
Mean(SD) 7.77(3.29) 5.53(3.43) *= 5.24(3.04) *= 4.57(3.17) *= 7.2 8.76(3.89)*+*
N=139
* *
N=545
* *
N=446
* *
N=261
N=249 N=351
Mean(SD) 8.49(3.19) 6.59(3.42) 6.19(3.07) 5.65(3.06) 8.4
Girls
Mean (SD) 6.93(3.11) 4.71(3.2) 4.6 (2.87) 3.68(2.99) 6.3
Boys
Normal <8 44.6% 
(<9=61.8%)
75.3.5% 75.7% 80.8%
<9=67%
39%(137)
Possible 8-10 38.1%
(9-11
=23.7%)
14.5% 18.9% 13.4%
9-11=19%
29%(103)
Probable 11 + 17.3%
(>11=14.5%)
10.1% 5.4% 5.7% >11=14% 32%(111)
*Significant difference from comparison group (p < 0.001). =  Significant difference from White et al. (p < 0.001) 
**Significant difference from Andrews et al. (p <  0.001), ***Significant difference from White et al. (p < 0.05)
Comparisons using t-tests revealed that there were significant differences in anxiety 
levels between the screening group and both the averages previously published by 
White et al., (p < 0.001) and Andrews and Wilding (p < 0.001), and the comparison 
group I collected (p < 0.001). Anxiety levels in the screening group were lower at each 
of the time intervals. Interestingly, the comparison sample I collected also reported 
lower anxiety levels than the published values (t(138) = 2.03, p < 0.05), although the 
difference was small.
114
In a second analysis, respondents were divided into those with normal (<8), borderline 
(8-10) and high anxiety levels (11+). This confirmed the low anxiety levels in 
adolescents taking part in screening; 75 -  81% had anxiety scores in the normal range, 
compared with 44% in the comparison school, and 67% in White's study.
8.6 Comparison of anxiety levels between completed data and all other 
participants
Independent sample comparisons using t -tests were conducted to evaluate the 
differences in levels of anxiety throughout the testing procedure for participants who 
completed each time interval, and those who only completed one or two time intervals.
It included participants of all ages with a negative test result at time 3. There were no 
significant differences between these groups at any of the time intervals (table 8.8).
Table 8.8 Anxiety levels comparing repeated measures sample with the rest of the sample
Anxiety time 1 
M(SD) N
Anxiety time 2 
M(SD) N
Anxiety time 3 
M(SD) N
Completed 
Not completed
5.4(3.6) 253 
5.9(3.56) 399
536(3.16) 253 
5.54(3.26) 292
4.75(3.21) 253 
4.8(2.94) 64
P value 0.077 0.512 0.913
8.7 Discussion
The current study explored anxiety levels throughout the testing procedure, as well as 
other factors affecting participants’ experience of the screening process. Statistical 
analysis was conducted on anxiety levels measured throughout the testing procedure.
8.7.1 Comparison between participants and non participants
The mean levels of anxiety were low in this study and significantly lower than those 
reported by White etal., (1999) and Andrews and Wilding (2004). It may be argued that 
this discrepancy with White et a/’s., sample is due to the differences in age groups, the 
current study being slightly older. However, White etal., reported no significant
115
differences between ages. Furthermore, the differences in this study between the 15- 
16 year old and 17-18 year old age groups were not significant (data not shown).
Those who participated in the screening programme also had significantly lower levels 
of anxiety than the comparison group (not offered screening). It should be noted that 
there were no differences throughout the testing in anxiety levels between participants 
with completed data and all other participants. Before I discuss the changes in anxiety 
levels throughout the testing procedure, it is important to acknowledge that the 
participants in this study appear to be an unusually low anxiety group. Although this is 
the most probable explanation of the results, there is another explanation that is 
possible in principle but highly unlikely. It is theoretically conceivable that something in 
the study may have reduced levels of anxiety to below normal values. This would have 
to have occurred at time 1, with the invitation letter, and continued throughout the 
testing to a further reduction at time 3. It is difficult to imagine what this stimulus could 
have been, so the conclusion that screening attracted less anxious adolescents seems 
more plausible.
The decision making process in screening has been the focus of a great deal of 
research. Some research has looked at the direct relationship between anxiety and 
participation. For instance, it has been shown in adult populations that non-attenders 
are more anxious (French etal., 1982). In adolescents, anxiety was identified as one of 
the main reasons against genetic testing for breast cancer, albeit in a group who were 
just asked their opinions and not actually offered testing (Harel et al., 2003). This 
relationship of anxiety and attendance is not unequivocal and some studies have found 
that anxiety does not predict attendance with no differences in anxiety levels between 
attendees and non-attendees being identified (Sutton etal., 1995). However, the 
majority of the research on attendance has been conducted in the area of breast 
cancer screening so may not apply to adolescents.
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In the case of screening adolescents, the decision making process may be influenced 
by many factors other than anxiety. These could include parental influence, peer 
pressure, or advice from athletic trainers. With many potential influences in the decision 
making process in adolescents, it is important not to oversimplify the debate about 
attendance and anxiety levels. Although the screened group in this study had a lower 
level of anxiety in comparison with the other samples, there was still great variability 
between individuals, with changes in levels of anxiety reported throughout the testing 
procedure.
8.7.2 Anxiety changes during the testing procedure in adolescents
Hypothesis 1 predicted that participants’ anxiety levels would decrease from before to 
after screening in those with negative results. There were no significant differences 
between the levels of anxiety at time 1 (when the participants filled in their consent 
form) and time 2 (prior to their testing during the clinic). However at time 3 (after 
receiving a negative result) anxiety levels declined, showing a significant decrease 
after the testing both in comparison to time 1 and time 2. It is important to note that 
there was a somewhat different pattern of response in the adult age group, which will 
be discussed in chapter 10.
There are a number of possible explanations for this. Anxiety levels may have dropped 
(at time 3) below the normal levels of anxiety (as measured at timel). Such reduced 
level of anxiety would either remain stable or return to normal baseline levels at a later 
date, as shown hypothetically in Figure 8.7.
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Figure 8.7 Anxiety time 1,2 & 3
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Alternatively, it is possible that the base-line measure taken at timel failed to capture 
normal anxiety levels, with anxiety increasing immediately after receiving the invitation 
letter (as shown hypothetically in figure 8.8) with a return to normal levels at time 3.
Figure 8.8 A nxiety tim e 1,2 & 3
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The conclusion that a negative test outcome stimulated some reduction in anxiety (time 
3) is consistent with the previous work by Michie et al., (2001) who examined the way 
in which young people reacted to a negative FAP diagnosis in predictive genetic 
testing. In the current study, however, the base-line measure was administered 
contemporaneously with the letter of invitation, and this may have had an immediate 
impact upon the individual. Indeed, previous evidence has shown that the invitation 
letter can have both a positive and negative effect on the screened group, or at least
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some of the participants. Raised anxiety levels can act to motivate people to engage in 
health preventative behaviour, with anxiety predicting reasons for contemplating testing 
(Wroe et al., 1998). Thus, it could be argued that the base-line measure failed to 
capture the typical levels of anxiety, instead, measuring an already elevated anxiety 
level due to the letter of invitation. It may well be that an anxiety measure that was 
administered prior to the invitation to cardiac testing would have gleaned different 
results.
However, the scale used in this study (the HADS anxiety scale) is validated, widely 
used and chosen precisely because it measures anxiety as is experienced over the 
previous period of one week, and should therefore reflect a more stable or normal 
anxiety level. Furthermore, at the time of designing the study I felt it to be problematic 
to administer a questionnaire prior to the invitation, with no reference to the impending 
offer of screening. This would have been difficult enough in the schools, but virtually 
impossible in the community groups, since I would have to have taken measures 
before they made their first contact with the screening administrator.
Determining an accurate baseline measure may also have to allow for the possibility 
that some of the participants waited for a period of time before replying to the invitation 
and completing the questionnaire. Specifying the date that the invitation was received 
and completed would have helped to determine whether this was the case.
Another possible confounding factor may be that the psychological impact of the 
programme was not on the participants, but instead on their parents. The parents may 
have become more anxious after becoming aware of the screening programme and 
encouraged their children to attend. The debate about assessing the psychological 
impact of screening adolescents should be broadened to evaluate the impact on the 
whole family, especially within the context that many of the conditions are genetic and 
will have implications for other family members if diagnosed. Anecdotal evidence from
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the screening programme did support the possibility that on some occasions the 
parents appeared more concerned about the testing than their children.
If anxiety increased after the invitation, this did not appear to be by a detrimental 
amount. This can been seen in the low frequency of ‘possible’ and ‘probable’ cases of 
clinical anxiety levels throughout the testing procedure (Table 8.7).
Interestingly, anxiety did not rise in anticipation of the actual testing itself at time 2, in 
comparison with time 1. Thus even though these participants were confronted with 
medical tests with which they were unfamiliar, and were being examined for a 
potentially dangerous medical condition, they did not respond with increased distress. 
This might have been due to the effective way in which the medical staff involved with 
the testing interacted with participants, and reassured them about the procedures 
involved, or possibly because the information presented to participants with the 
invitation adequately addressed their expectations so that the tests themselves were 
not worrying.
Overall, it seems that those who participated in the study had lower levels of anxiety 
than those who did not participate and their level of anxiety decreased after receiving a 
negative result. Future studies should also try to evaluate if there was a return to 
baseline anxiety levels at a later follow up, or whether the positive impact of screening 
resulted in an enduring reduction in anxiety in comparison with time 1. This would help 
tease out which of the hypothetical sequences outlined in Figures 8.6 and 8.7 is 
correct.
8.7.3 Influence of study type (school vs. community) and gender on anxiety in 
adolescents
Hypothesis 2 predicted that participants in the community group would have higher 
levels of anxiety at baseline before testing than those recruited through the school
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based programme. This difference would primarily be due to the heightened publicity of 
the potential consequences of cardiac conditions, used to advertise the community 
screenings. Although differences did occur, the results did not confirm this initial 
prediction. Unsurprisingly, girls reported higher levels of anxiety than boys in both study 
types and the girls in the community group were more anxious than both the boys and 
girls in the school screening. However, boys in the community group were the least 
anxious group, thus undermining the earlier prediction of differences due to study type.
It could be argued that girls react negatively to a threat message and boys react 
positively, with corresponding anxiety levels. However, the pattern of anxiety responses 
was the same for each of the groups, staying the same between time 1 and 2 and 
reducing at time 3. Therefore, it would appear that any differences that did occur 
between the two study types were due to the people who decided to participate in the 
screenings. The boys who decided to take part in the community screening were less 
anxious than those who took part in the school screening, conversely with the girls 
being more anxious in the community screening compared to the school screening.
Unlike the community screening, the school screening was more formal, less time was 
taken with each client to discuss any concerns, and no appointment was made with a 
cardiologist to discuss any aspects of the screening process or their health. The lack of 
effect of study type on anxiety may partly be because the majority of the general public 
would be unaware of different diagnostic sensitivities of tests when echocardiography 
is included in the procedure. Quite possibly the presence of the cardiologist was 
unnecessary, as participants felt the tests were diagnostically sensitive enough to 
determine if they were at risk.
The question of differences between community and school screenings has important 
financial implications for implementing a screening programme. It is important to 
recognize that participants do not appear to have been more reassured by the more
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elaborate Echo screening compared with the simpler ECG screening. This analysis of 
study type suggests that there is limited/no psychological benefit to the participant 
having the more comprehensive testing and consultation with the cardiologist. Both of 
these significantly increase the financial costs of the screening. Of course there will be 
fewer ECG abnormalities requiring further cardiac tests -  false positives - in the more 
comprehensive testing and greater diagnostic sensitivity.
This is not to say that the role of the expert consultant is not important in particular 
contexts. Indeed once a person is diagnosed or considered at greater risk of one of 
these conditions this will be of great importance, as exemplified in the new NSF 
chapter. However, this type of patient/participant (i.e. a person with a young SCD in 
their family) should not be participating in a screening programme and should be 
referred directly to a specialist consultant.
8.7.4 Influence of symptoms on anxiety in adolescents
Hypothesis 3 predicted that participants presenting with symptoms consistent with 
cardiac conditions would have significantly higher levels of anxiety than those without 
symptoms. The results show differential levels of anxiety by symptom groups.
Symptom groups were defined on the basis of whether people were asymptomatic (not 
reporting any symptoms) or symptomatic (reporting one or more symptoms). Those 
with no symptoms were less anxious than those with symptoms, thus confirming 
hypothesis 3.
The data show the different patterns in responding to the screening process: those who 
were asymptomatic had stable anxiety levels between times 1 and 2, which decreased 
significantly at time 3. The symptomatic group had a higher anxiety level at timel, 
which decreased throughout the testing but did not change significantly either between 
times 1 and 2 or times 2 and 3.
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All of the symptoms with the exception of fainting were significant independent 
predictors of anxiety at time 1. The only symptom to have an independent predictive 
role in anxiety, once prior levels of anxiety were included in the regression, was 
dizziness. It is interesting that fainting is not a symptom that predicts anxiety, as it is an 
experience that may be expected to be associated with anxiety. This is due to the 
death like experience one has when fainting. The influence of symptoms on anxiety will 
be explored further in the full regression analysis including illness perceptions within 
chapter 11.
It is well acknowledged that the cardiac conditions and anxiety are symptomatically 
similar. Therefore, it is difficult to conclude the causal effect between the symptoms 
and anxiety, and determine the true nature of this relationship. However, it would seem 
intuitive that a person who has a number of symptoms (whether due to anxiety or an 
underlying condition) may become more anxious. Further research and analysis is 
required to clarify the causal relationship between anxiety and physical symptoms. It 
would also be interesting to know the population norms of reported symptoms, to see if 
those who attend the screening are representative of the population, or whether those 
people with one or more symptoms are more likely to attend. With the low levels of 
anxiety reported in the screened group, and strong correlations between symptom 
groups and anxiety, it would be surprising if the screened group were more 
symptomatic than the general population.
8.8 Conclusion for anxiety results
Cardiac screening does not appear to have a negative psychological impact on those 
who participate. The findings in this study were similar to those reported by Little et al., 
(1990) of ECG testing in a dental clinic in which, although some cases of increased 
anxiety were identified, the significant majority found the testing acceptable. The results 
also support the previous findings of genetic screening in adolescents (Michie et al., 
2001) in which participants with negative results showed a significant reduction in
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anxiety after receiving their result. The prospective nature of the present study and its 
large and diverse sample allows this conclusion to be drawn with greater confidence. 
The type of study did not appear to affect the way participants responded to the 
screening. Those with one or more symptom were more anxious before, during and 
after the screening compared to those not reporting symptoms. It should be noted that 
those who participated probably had lower levels of anxiety than those who did not 
participate and that non-participants may have responded to the screening differently.
Considering the variability in anxiety levels throughout the screening it is essential to 
take into account the relationship between anxiety and illness representations to 
understand the way people respond. This will be discussed in chapter 11.
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Chapter 9. Self rated health in adolescents
9.1 Baseline characteristics and completion rates of the participants
The characteristics of the sample that completed the self rated health measure were 
presented in chapter 8. Table 8.1 shows the number of participants who completed the 
psychological questionnaires in the school community and comparison groups, and 
table 8.2 shows the completion rates at each time interval throughout the testing.
9.2 Self rated heath across the three time points
Figure 9.1 Self rated health response - 
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204 of the adolescents completed self rated health measures at all three time intervals. 
The repeated analysis of variance revealed a significant effect of time (F(1.96,396) = 
5.04, p = 0.007). Post hoc tests indicates that self rated health did not change between 
times 1 and 2, but increased between time 2 and time 3 (p < 0.001). Self rated health 
at times 1 and 3 did not differ.
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Table 9.1 Mean (SD) scores for pairwise comparisons of self rated health at Time 1, 2, & 3
T1 T2 T3 N P
Pair 1 2.84(0.84) 2.76(0.81) 410 0.034
Pair 2 2.88(0.82) 2.96(0.78) 251 0.057
Pair 3 2.86(0.75) 3.01(0.76) 213 0.000
A slightly different pattern emerged when pairwise comparisons between each sample 
were made using t-tests. These comparisons included all participants available, rather 
than only those with complete data. As can be seen in table 9.1, there was a 
significant decrease in self rated health from time 1 to time 2 (p < 0.05), an increase in 
self rated health from time 2 to time 3 (p < 0.001), and near significant increase from 
time 1 to time 3 (p = 0.057). It appears, therefore, that self rated health decreased in 
anticipation of testing (time 2) in comparison with normal levels (timel), but that a 
negative test outcome stimulated some improvement in self rated health (time 3). 
Although these changes occurred it can be seen that the improvement in self rated 
health between time 2 and 3 is more of a return to baseline levels than an actual 
improvement in self rated health as there were no differences between time 1 and 3.
These overall results indicate that self rated health was better post-screening, as 
predicted by hypothesis 4. However, it is possible that some participants experienced 
deterioration in self rated health. Changes between invitation and post-screening were 
therefore calculated. Self rated health worsened in 38 (15%) of cases, improved in 63 
(25%) and remained the same in 150 (60%). Repeated measures comparison between 
these groups showed a significant group by time interaction (F(2.2, 222.7) = 110.7, p 
<0.001), detailed in Figure 9.2. It can be seen that the participants whose self rated 
health deteriorated after screening started with high levels and fell to a value similar to 
that recorded by the improvement group at invitation. So even in this subgroup, self 
rated health did not fall to dramatically low levels.
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9.3 Self rated health by study type and gender
Figure 9.3 Self rated health response by study type and gender •
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As with the anxiety data (section 8.3), I conducted a repeated measures analysis of 
variance with study type and gender as between-subject factors, to compare self rated 
health responses to the different testing programmes. There was, however, no 
significant study type effect or interaction between either study type or gender and 
time. There was a significant main effect of gender (F(1,200) = 5.685, p < 0.05) as 
shown in figure 9.3 Women had lower levels of self rated health in both the school and 
community testings. Thus type of testing had no influence on self rated health. 
Hypothesis 5 was therefore not confirmed.
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9.4 Self rated health and symptoms
The relationship between self rated health and the presence of symptoms consistent 
with cardiac conditions was tested using repeated measures analysis of variance 
comparing adolescents with no symptoms and at least one symptom. There was a 
significant between group effect (F(1,202) = 4.603, p < 0.05) (p = 0.033), but no 
interaction with time. As can be seen from figure 9.4, the symptomatic group reported 
poorer self rated health throughout the study.
Figure 9.4 Self rated health response by 
number of symptoms - adolescents
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A similar pattern emerged with pairwise comparisons between each symptom group 
involving all available participants with negative test results. As can be seen from table 
9.3 self rated health did not differ at times 1 and 2, but there was an improvement 
between time 2 and time 3 in both the asymptomatic group (p < 0.001) and the 
symptomatic group (p < 0.05).
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Table 9.2 Mean (SD) scores for self rated health at Time 1, 2, & 3 by symptom group
Symptom group Srh time 1 Srh time 2 Srh time 3 N P
Asymptomatic 2.99(0.78) 2.92(0.74) 180 0.314
3.06(0.72) 3.13(0.64) 109 0.207
2.94(0.7) 3.13(0.64) 95 0.001
Symptomatic 2.72(0.87) 2.63(0.83) 230 0.053
2.74(0.87) 2.84(0.86) 142 0.149
2.8(0.78) 2.92(0.84) 118 0.038
The t-test analysis also confirmed that in all available participants, there was a 
significant difference between symptom groups at all three time points (shown in table
9.3).
Table 9.3 Mean (SD) scores for self rated health at Time 1, 2, & 3 between symptom groups
Symptom Srh Time 1 Srh Time 2 Srh Time 3
Group M(SD) N P M(SD) N P M(SD) N P
Asymptomatic 2.98(0.79) 220 2.92(0.75) 193 3.12(0.64) 112
0.000 0.000 0.005
Symptomatic 2.67(0.87) 294 2.63(0.83) 248 2.84(0.85) 148
The results indicate the reporting of symptoms was associated with lower levels of self 
rated health throughout the testing procedure, confirming hypothesis 6.
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9.4.1 Which symptoms predict self rated health in adolescents?
I investigated which symptoms are associated with self rated health using the same 
regression strategy as described for anxiety in section 8.3.
Table 9.4 Regression of symptoms on self rated health at time 1, 2 and 3
SRH time 1 SRH time 2 SRH time 3
3 sig B B Sig
Fainting ns ns ns
Dizziness ns ns ns
Palpitations ns ns ns
Chest pain ns ns ns
Breathlessness -0.283 *** -0.146 *** -0.162 **
SRH time 1 0.556 *** 0.500 ***
** p < 0.005, *** p < 0.001, ns = not significant
The regression analysis identified breathlessness (li = -0.283, p < 0.001) gender (fc = - 
0.122), p < 0.005) and study group (fc = 0.095, p < 0.05) to be significant predictors of 
self rated health at time 1. Fainting, dizziness, palpitations, chest pain and age at time 
of testing were not predictors. This is a very different result from anxiety, where four of 
the five symptoms were predictors.
Interestingly, breathlessness remained a significant predictor (ft=-0.146 p < 0.001) of 
self rated health at time 2 after the inclusion of self rated health at time 1, even though 
this was a strong predictor (li=0.556, p < 0.001). The same pattern emerged at time 3, 
this time with age also as a predictor (ft=-0.114, p = 0.031), with breathlessness 
remaining an independent predictor (G»=-0.162, p < 0.005). Therefore, although prior 
levels of self rated health is the strongest predictor of future levels of self rated health, 
breathlessness plays an important role in this perception.
9.5 Self rated health levels - Comparison with control samples
In order to ascertain whether the levels of self rated health were representative of this 
age group, results from two groups that were not offered cardiac testing are reported. 
The first of these is the comparison school in which self rated health was measured
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along with anxiety. The second comparison is which a US adolescent population 
published by Boardman (2006). Boardman’s results were split into two separate waves, 
recorded by the same participants at two different time intervals. Their analysis was 
used in reporting the test retest reliability of self rated health in adolescents. In the 
analysis Boardman identified the frequencies for each level of response, so that it was 
possible to compare means (table 9.5).
Table 9.5 Comparison of self rated health for the 14-19 age group with other groups
Comparison
group
Screening group (14-19 years old) 
(Negative Diagnosis at time 3)
Population
norms
Population
norms
City of London 
Freemen’s
Time 1 
Prior to test
Time 2 
Immediately 
before test
Time 3
(after
results)
Boardman
(2006)
US
adolescents 
Wave 1
Boardman
(2006)
US
adolescents 
Wave 2
Mean(SD) 2.68(0.84)
N=129
**
2.79(0.85)
N=532
**
2.76(0.81)
N=441
**
2.96(0.78)
N=260+
2.87(0.91) 
N=13,511
2.9(0.9) 
N=13,511
+Significant difference from comparison group (p <0 .001). -  I have not included the significant differences between
time 1, 2 and 3 analysis - they were presented earlier
**Significant difference from Boardman Wave 1 and Wave 2 (p < 0.005)
There were no significant differences in self rated health between the screening group 
at time 1 and time 2 and the comparison group. But there was a significant difference 
between the time 3 responses and the comparison group (p < 0.001), with cardiac 
testing participants reporting higher levels of self rated health than the comparison 
group.
The comparison with population norms is interesting in that the US adolescents report 
significantly higher levels of self rated health as compared to the time 1 and 2 reports in 
this study and the comparison group (p < 0.005). At time 3 the reports in this study are 
similar to those of the US adolescents.
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The lack of difference between ratings at time 1 and the comparison group suggests 
that the cardiac testing population was reporting typical levels of self rated health for 
UK adolescents. The higher levels at time 3 may therefore reflect genuine 
improvements in self rated health. This pattern is confirmed in the analysis of the 
distribution of self rated health responses (results not shown). For example, the 
proportion who reported excellent self rated health increased from 21.1% at time 1 to 
25% at time 3, compared with 28.1% and 29.5% in the two waves of Boardman’s 
study. At the other end of the spectrum, only 2% reported fair or poor self rated health 
at time 3, compared with 7.1% and 6.5% in Boardman’s study.
9.6 Comparison of self rated health levels between completed data and all 
other participants
Independent sample comparisons using t -tests (table 9.6) evaluated the differences in 
self-rated health throughout the testing procedure for participants who completed each 
time interval, and those who only completed one or two time intervals. This included all 
participants testing negative at time 3.
Table 9.6 Self-rated health comparing repeated measures sample with the rest of the sample 
with normal cardiac findings at time 3
Self-rated health time 1 
Repeated self-rated health at time 1,2 m 
and 3 M(SD) N
Self-rated health time 2 
M(SD) N
Self-rated health time 3 
M(SD) N
Completed 2.85(0.83) 251 
Not completed 2.72(0.86) 385
2.78(0.79)
2.61(0.81)
251
295
2.94(0.78)
2.73(0.81)
251
63
P value 0.002 0.013 0.059
Table 9.6 shows that there were significant differences between these groups at time 1 
and 2, but not at time 3. At both time 1 and 2 participant’s self-rated health was more 
positive in the group that completed the self-rated health at all 3 time intervals. At time 
3 there were no significant differences, although the repeated measures ‘completed’ 
group was still more positive. The lack of significant difference at time 3 was probably 
due to the small sample size of the ‘not completed’ group.
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9.7 Discussion
The current study explored self rated health scores throughout the testing procedure, 
as well as other factors affecting participants’ experience of the screening process.
9.7.1 Were self rated health levels representative?
Self rated health scores at time 1 and 2 were similar to the comparison group so were 
probably accurate reflections of baseline measures. This would imply that the 
improvement shown at time 3 represents a genuine positive change in perception of 
health. However, the comparison with the US population norms confuses the issue 
since the time 1 and 2 scores and those of the comparison group were all significantly 
lower than these population norms.
There are a number of possible explanations for this. Firstly, it may be that US 
adolescents are healthier than UK adolescents. There is little evidence for this, and 
indeed a recent comparison of older adults showed that health was better in England 
than the US even after controlling for socioeconomic factors (Banks et a/., 2006). 
Secondly, it is possible that US adolescents report greater self rated health because of 
the optimistic bias and positive self-evaluation that is characteristic of US populations 
(Kitayama etal., 1997).
Conversely it may be argued that the self rated health measures at time 1 and 2 were 
lower than true baseline levels and the time 3 measure was a return to normality. This 
would mean that the comparison group had a below average perception of their health. 
This explanation is unlikely considering that the participants in the cardiac testing had 
lower levels of anxiety than the UK population comparison groups. However, it should 
be noted that significant differences were identified between the repeated measures 
group compared to the rest of the study sample. Participants in the repeated measures 
group had a more positive perception of their health, than the rest of the participants.
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On the basis of the comparison group data analysis, and the previous anxiety 
responses, which identified this sample to be significantly less anxious than population 
norms, it would be reasonable to suggest that the time 1 and 2 results are accurate 
reflections of baseline measures.
9.7.2 Self rated health changes during the testing procedure
Hypothesis 4 predicted that participants’ self rated health would improve from before to 
after screening in those with negative test results. There was a decrease in self rated 
health between time 1 and 2 which was significant in the pairwise analysis (table 9.1), 
but not in the repeated measures analysis (figure 9.1). It is likely that the discrepancy 
between the two was due to sample size differences, since there were only half the 
participants in the repeated measures than pairwise analysis. The pattern of response 
was similar in the two analyses.
The more interesting result is in accordance with hypothesis 4, in that self rated health 
improved following a negative result. This can be seen in the relationship between time 
2 and time 3 where there is a significant increase in self rated health. This conclusion 
can be made only cautiously, since the difference between time 1 and 3 was only 
marginal. It seems probably that the levels of self rated health at time 3 represent a 
genuine positive response to the good news of having a negative test result. After 
receiving the information that they did not have a cardiac condition, participants may 
have experienced a transient boost to their perceptions of their health. We do not 
know how long this lasted. Future studies could benefit from measuring self rated 
health at a later time interval to see if this increase is enduring or just a temporary 
response to “good news”. There was also considerable variation in responses, with 
15% showing a worsening of self rated health at time 3 (figure 9.2). So while the results 
generally support hypothesis 4, there are significant variations in response that deserve 
further investigation.
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9.7.3 Influence of study type and gender
Hypothesis 5 predicted that participants in the community group would have lower 
levels of self rated health at baseline before testing than those recruited through school 
based programmes. This difference would primarily be due to the heightened publicity 
of the potential consequences of cardiac conditions, used to advertise the community 
screenings.
In the anxiety analysis, differences between the two study types were complicated by 
gender. The present analysis was more clear, with no significant differences between 
study type. This disconfirms hypothesis 5. Gender was, once again, identified as a 
significant predictor, with girls having significantly lower levels of self rated health than 
boys.
The lack of differences by study type could be because self rated health is an 
insensitive marker, but this seems improbable since it did change over time and was 
related to symptoms. Alternatively, selection factors might have been operating, with 
participants with poor health selecting themselves out of the community testing, 
resulting in a lack of difference. This seems a somewhat tortuous explanation in the 
absence of corroborating data. The most reasonable conclusion is probably that there 
were simply no differences.
9.7.4 Influence of symptoms on self rated health in adolescents
Hypothesis 6 predicted that participants presenting with symptoms consistent with 
cardiac conditions would have significantly poorer self rated health than those without 
symptoms. Prior to the testing those with symptoms had significantly lower levels of 
self rated health than those who were asymptomatic; this continued throughout the 
testing and confirms hypothesis 6.
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Interestingly when I carried out the regression of specific symptoms on self rated health 
the only symptom to have a predictive role was “breathlessness”. This relationship 
carried through after the inclusion of prior levels of self rated health. Boardman (2006) 
carried out a regression on self rated health at wave 2 with wave 1 self rated health 
emerging as the strongest predictor. Some physical symptoms in his analysis did not 
predict self rated health, including sore throat or cough, feeling really sick, or aches, 
pains, or soreness in your muscles or joints. However, stomach ache or upset stomach 
was a predictor (p < 0.05), as was headache (p < 0.001). The strongest predictor after 
self rated health was feeling physically weak for no reason (p < 0.001). This final 
predictor could perhaps be seen in a similar light to “breathlessness” as measured in 
this study. The experience of physical symptoms has also been closely associated with 
self rated health in other studies (Bailis etal., 2001; Garrity, Somes, and Marx, 1978).
The premise for conducting the comparison of symptom groups was to mirror the 
anxiety analyses. The important conclusion is that even though individuals with 
symptoms had poorer self rated health, they did not react more negatively than the 
asymptomatic group to the cardiac testing procedure.
9.8 Conclusion for self rated health results
There is an improvement in self rated health after receiving a negative test result as 
compared to both time 1 (at the time of consent) and time 2 measures (immediately 
prior to testing). The degree of improvement is quite small, but runs counter to the 
notion that participation in cardiac testing has adverse effects on health perceptions. 
There may also be a small deterioration in self rated health immediately before testing, 
but this is resolved within a relatively short time. Levels of self rated health were similar 
in the participants in the two types of testing. There are significant differences between 
those who are symptomatic and those asymptomatic, with participants reporting one or 
more symptom having worse self rated health.
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Chapter 10. Anxiety and self rated health in adults
There were 110 adults aged 19-35 who participated in the cardiac testing. Only 5 of 
these were involved in school testing, and the remainder in the community cardiac 
testing. The 110 adults included 72 men and 38 women, with a mean age of 26.2 ± 
4.61 years. 12 (10.9%) of the adults had positive screening test results, and the 
remainder had negative results.
10.1 Anxiety
Satisfactory anxiety data were obtained from 91 adults on at least one occasion, but 
only 36 completed all three assessments. Figure 10.1 shows the results for these 
individuals.
Figure 10.1 Anxiety response in adults
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The repeated analysis of variance showed a significant effect of time (F(1.96,68.46) = 
5.76, p < 0.005). Post hoc tests indicated that anxiety did not differ between times 2 
and 3, but that anxiety at time 1 was higher than at time 2 (p < 0.05) and was higher 
than at time 3 (p < 0.001). It should be noted that the p value for difference between 
times 2 and 3 was not significant after the Bonferroni correction.
Table 10.1 Mean (SD) scores for pairwise comparisons of anxiety scores at Time 1, 2, & 3
T1 T2 T3 N P
Pair 1 7.02(4.25) 6.66(3.75) 79 0.033
Pair 2 7.08(4.21) 5.89(3.12) 42 0.001
Pair 3 6.55(3.56) 5.91(3.04) 40 0.084
The same pattern emerged when pairwise comparisons between each sample were 
made using t-tests. These comparisons included all participants available, rather than 
only those with complete data. As can be seen from table 10.1, there was a significant 
decrease in anxiety from time 1 to time 2 (p < 0.05), and time 1 to time 3 (p < 0.001), 
but no difference in anxiety between time 2 and time 3. Thus unlike the pattern in 
adolescents (Figure 8.1), the anxiety reduction was greatest between times 1 and 2, 
and not between times 2 and 3.
10.1.1. Gender differences in anxiety
Since there were so few adults in the school testing programme, a comparison 
between the two testing programmes was not carried out. However, I did compare 
anxiety responses in men and women. There were no significant gender differences 
either in the repeated measures analysis or in comparisons of men and women at each 
time point. Thus unlike the situation for adolescents, young women were not more 
likely to be more anxious than young men.
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10.1.2. Anxiety levels by cardiac symptom in adults
Table 10.2 Frequencies for responses on the medical questionnaire
N
No
% N
Yes
%
Fainting 84 (78.5%) 23 (21.5%)
Dizziness 69 (64.5%) 38 (35.5%)
Palpitations 77 (73.3%) 28 (26.7%)
Chest pain 69 (64.5%) 38 (35.5%)
Breathlessness 69 (65.7%) 36 (34.3%)
Family history 51 (48.1%) 55 (51.9%)
Sudden Cardiac Death in the family 73 (85.9%) 12 (14.1%)
Table 10.2 shows the numbers of participants reporting each of the symptoms in the 
medical questionnaire. 58.1% reported having a family history of heart disease and 
14.1% reported having a SCD in their family. Chest pain and dizziness were the most 
commonly reported symptoms (35.5%), followed by breathlessness (34.3%), 
palpitations (26.7%) and fainting (21.5%).
The same classification was used to define symptomatic and asymptomatic groups as 
in the adolescents. The sample in the repeated measures analysis was very small, 
with only 11 (31%) in the asymptomatic group compared to 25 (69%) reporting 1 or 
more symptoms. The repeated measures analysis showed a main effect of symptom 
group (F(1,34) = 13.689, p < 0.001), but no symptom group by time interaction.
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Figure 10.2 Anxiety response by symptom 
group - adults
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The results are shown in Figure 10.2. It would appear that anxiety remained low and 
stable in the asymptomatic group, and only fell in the symptomatic group. This was 
confirmed in separate analyses of the two groups, since the main effect of time was 
significant in the symptomatic group (F(2,50.9) = 6.90 p = 0.004) but not in the 
asymptomatic group.
The pattern was further confirmed in pairwise comparisons including all participants 
available with a negative result at time 3, rather than only those with complete data. In 
the asymptomatic group there were no changes in levels of anxiety over time.
However, in the symptomatic group there was a significant decrease between invitation 
(time 1) and pre-screening (time 2), with no further reduction after screening (Table
10.3)
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Table 10.3 Mean (SD) scores for pairwise comparisons of anxiety at Time 1, 
two symptom groups
2, & 3 in the
Symptom group Anxiety time 1 Anxiety time 2 Anxiety time 3 N P
Asymptomatic 5.24(3.56) 5.24(3.14) 21 1.000
3.85(3.31) 3.33(2.57) 12 0.298
4.08(2.81) 3.75(2.38) 12 0.489
Symptomatic 7.93(4.32) 7.14(3.87) 57 0.005
8.37(3.86) 6.91(2.73) 30 0.003
7.61(3.35) 6.83(2.84) 28 0.118
10.1.3 Discussion of anxiety results
The pattern of these results in adults is different to that for the adolescents. Whereas in 
adolescents anxiety levels dropped between time 2 (pre-screening) and 3 (after 
receiving a result), in adults this decrease occurred between time 1 (invitation) and time 
2 and time 1 and time 3. It should be noted that the difference between time 1 and 2 
should be treated with caution as it did not meet the criteria required for the Bonferroni 
correction. Similarly to the adolescents, those with cardiac symptoms were more 
anxious, either because of the overlap of cardiac symptoms and anxiety symptoms, or 
because having symptoms that might be indicators of cardiac disease made people 
anxious.
Anxiety levels on invitation were relatively high (mean > 7) in this population, 
particularly in those who experienced at least one symptom. Crawford et a/., (2001) 
recently published HADS data from a general population sample of 1792 adults. The 
mean anxiety score was 6.14 (SD 3.76), confirming somewhat elevated levels in this 
study, particularly since the present sample was predominantly male. It is unlikely that 
the screening programme selectively attracted more anxious adults, since this is 
inconsistent both with the adolescent findings and with the bulk of the literature. There 
are two other possibilities. One is that the invitation to screening provoked an increase 
in anxiety that was reduced by the time of testing. The alternative is that anxiety levels
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were already elevated in adults, perhaps because of the context of cardiac testing. 
Almost all the adults were recruited through the community screening programmes, 
and these were typically initiated when a young person in the community had died 
suddenly. These young adults may have been made nervous by this situation, leading 
to elevated anxiety. It is not possible with the data available to distinguish these 
explanations. However, what is clear is that anxiety levels generally fell over the 
screening period, and there is no evidence that participation had a negative effect on 
psychological well-being.
10.2 Self rated health in adults
40 of the total sample of adults completed the self rated health measures at all three 
time points. The repeated analysis of variance showed no significant effect of time 
(F(1.7,68) = 2.1, p = 0.139), suggesting that self rated health levels were stable (Figure
10.3).
Figure 10.3 Self rated health in adults
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Table 10.4 Mean (SD) scores for pairwise comparisons of self rated health over time
T1 T2 T3 N P
Pair 1 2.35(0.85) 2.37(0.73) 81 0.748
Pair 2 2.37(0.9) 2.6(0.79) 43 0.040
Pair 3 2.4(0.82) 2.6(0.76) 43 0.141
However, the pairwise comparisons between each sample showed a significant 
improvement in self rated health between times 1 and 3 (Table 10.4). It should be 
noted, however, that only three more cases contributed to the pairwise comparison of 
these time points than were in the repeated measures analysis. So although this 
analysis suggests an improvement in self rated health, it should be interpreted with 
caution.
10.2.1 Self rated health in men and women
There was no significant difference between self rated health scores in men and 
women, either in the repeated measures analysis or the separate comparisons of each 
time point.
10.2.2 Self rated health and cardiac symptoms
The analysis of the 40 adults who completed the self rated health measure at all three 
time points showed a near significant main effect of symptom group, (F(1,38) = 2.769, 
p = 0.104) but no interaction with time (Figure 10.4).
144
Figure 10.4 Self rated health responses by 
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Pairwise comparisons between the symptom groups were made using t-tests, 
including all participants available with a negative result at time 3. The only difference 
to emerge was poorer self rated health in the symptomatic group (2.19 (SD 0.87) than 
the asymptomatic group (2.83 (SD 0.72), p = 0.002) at time 1. The differences at later 
time points were not significant.
10.2.3 Discussion o f se lf rated health results
There appears to be a significant improvement in self rated health between time 1 and 
3 in the adults, paralleling the reduction in anxiety over this period. It is debatable how 
significant this effect is, since it appears to be dependent on a small number of 
participants. There was no sign of a deterioration in self rated health between invitation 
and testing, as was noted in the adolescent sample.
The absence of consistent differences in self rated health between the two symptom 
groups is striking. The only effect was at time 1, when participants first agreed to the 
testing. It has been shown that symptoms play an important role in predicting self rated
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health (Bailis, et a/., 2001), and therefore I would have expected the differences to be 
more pronounced. It may be that in comparison with adolescents, adults have a more 
enduring sense of self rated health that is less influenced by situational factors. 
However, as with the adolescents, the adults may have experienced a brief 
enhancement in feelings about their health when they received a clean bill of health as 
their negative results came through. Taken together, these results provide further 
support for the position that the cardiac testing did not have a negative impact on 
participants.
146
Chapter 11. Illness Perceptions results
11.1 Completion rates for the illness perception questionnaire
The modified revised Illness Perception Questionnaire (IPQ-R) was completed by 414 
participants in cardiac testing, with complete data in 374. Of these, 359 were 
adolescents aged 14-19 years, 327 of whom had complete data. The primary analyses 
described in this chapter were carried out on the 414 participants including both adults 
and adolescents; further analyses were carried out on the 327 adolescents with 
complete data.
11.2 Factor structure and reliability of the modified IPQ-R and causal scales
It was not the purpose of this study to question the structure of the scales as they are 
well established, and used repeatedly in a chronic illness setting (Hagger and Orbell, 
2003). Recently the IPQ-R has been adapted and used in a screening context by 
Hagger etal., (2005). In their study, the IPQ-R performed satisfactorily, although some 
items appeared not to fit well into the consequences scale. I also carried out a factor 
analysis to test whether the structure was equally appropriate for this sample.
The 31 items representing the timeline, personal control, treatment control, 
consequences, illness coherence and emotional representation dimensions were 
entered into principal components analysis (PCA) with Varimax rotation. Table 11.1 
shows the result of the factor loadings. The item numbers refer to the position of the 
item in the complete questionnaire given out at time 1. The IPQ-R was interspersed 
with other questions that were not part of the original questionnaire, but were included 
to evaluate various aspects of the screening process and participants perceptions of 
their general health. The adjustment to cardiac conditions questionnaire, which had 
been devised in 1997 to evaluate the Quality of life in patients with hypertrophic 
cardiomyopathy was included. This was adapted with the intention of gaining baseline 
data, prior to diagnosis, for those people who would be subsequently diagnosed with a 
condition. Further questions evaluating attitude to screening were also included, as
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were specific questions assessing the reasons why participants decided to be tested. A 
dietary questionnaire was incorporated as part of a broader study evaluating 
participants’ attitudes to their diet and how this related to general health perceptions. 
Further open-ended questions were incorporated to provide information on how the 
programme could be improved in the future, specifically with the intention of identifying 
areas that may not have been addressed within the specific quantative measures. A 
satisfaction with information scale appraised the quality of information and the way in 
which it was provided to participants. In the interests of keeping the focus of this thesis 
on the psychological impact of cardiac testing, I decided not to include these variables 
in the results.
Items loaded as expected on the emotional representations, illness coherence and 
timeline as expected. Consequences loaded on two factors. This may be explained by 
one factor representing more external consequences “Having a heart condition would 
cause difficulties for those who are close to me” and the other factor being more 
personal “a heart condition would not have much effect upon my life”. Treatment 
control loaded onto two factors. One factor specifically identified the role of treatment in 
positive outcomes. The other factor consists of 2 of the treatment items reflecting the 
lack of what can be done (either nothing or very little) for those with heart conditions. A 
third item in this factor is a personal control item and reflects a lack of personal control 
over being affected by a heart condition. The final factor is comprised of the other two 
personal control items “Having a heart condition would depend on me” or “the way I live 
my life” The poor factor loadings of personal control may partly be explained by only 3 
items being included in this scale, the original scale was comprised of 6 items. It is 
also debatable whether a screening context is the correct place to evaluate perceptions 
of personal control over a condition in which there is small potential risk of diagnosis 
and is potentially genetic. It is also reasonable to expect some overlap between 
treatment control and personal control, in view of the fact that the original IPQ scale
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Table 11.1. Principal components analysis of the modified IPQ-R; Varimax rotation)
46 When I think about having a heart condition I get upset
50 The thought of having a heart condition makes me feel afraid
48 When I think about having a heart conditions I get worried
49 The thought of having a heart condition makes me feel anxious 
45 I get depressed when thinking about having a heart condition
47 The thought of having a heart condition makes me feel angry
42 I don't understand heart conditions 
41 Heart conditions are a mystery to me
43 Having a heart condition doesn't make any sense to me 
40 The symptoms of heart conditions are puzzling to me
44 I have a clear picture or understanding of heart conditions 
16 A heart condition will last a long time
15 A heart condition is likely to be permanent rather than temporary
18 A heart condition will pass quickly
19 A heart condition would last a lifetime 
14 A heart condition will last a short time
34 A heart condition will improve in time
37 The negative effects of a heart condition can be prevented by treatment (TC) 
36 Treatment will be effective in curing a heart condition (TC)
38 Treatment can control the symptoms of a heart condition (TC)
23 Having a heart condition would strongly affect the way others see me
25 Having a heart condition would cause difficulties for those who are close to me
24 Having a heart condition would have serious financial consequences
39 There is nothing which can help those with heart conditions (TC)
32 Nothing I do will affect if I have a heart condition (PC)
35 There is very little that can be done if I have a heart condition (TC)
26 Having a heart condition would depend on the way I live my life (PC)
27 Having a heart condition would depend on me (PC)
22 A heart condition would not have much effect upon my life 
21 Having a heart condition would have major consequences on my life
20 Heart conditions are serious
Component
1 2 3 4 5 6 7 8
.844 
.827 
.825 
.809 
.746 
.740
.851
.850
.767
.730
-.729
.847
.737
-.712
.699
-.658
-.479
.733
.654
.614
.707
.705
.682
- .685
.634
- .525
.827
.823
-.726
.683
treated them as one factor, only to be separated into two separate factors in the 
revised IPQ-R scale.
This factor analysis suggests that the majority of items from the modified IPQ-R load on 
scales as expected. However, there may be limitations in the consequences, treatment 
control and personal control scales. Scores for scales were then calculated by 
averaging item ratings to give a mean value between 1 and 5. Items that did not factor 
or significantly decreased the internal reliability of the scales were excluded from this 
calculation. The Cronbach alpha for each of the IPQ-R scales and items included in 
each of the scales are presented in table 11.2. It can be seen that the internal 
consistency was high for emotional representations, illness coherence and timeline and 
moderate for treatment control. Further analysis of the consequences showed that 
removing one item (‘a heart condition would not have much affect upon my life’) 
increased the internal reliability of this scale to a=.59. This item had the lowest factor 
loading in the original consequences IPQ-R scale (Moss-Morris et al., 2002,). The poor 
internal consistency of the personal control scale was improved by removing one item 
(‘Nothing I do will affect if I have a heart condition’), with a Cronbach a of 0.63.
11.2.1 Factor analysis of the modified IPQ-R Causal Scales
The 15 items representing the causal dimensions were entered into principal 
components analysis with Varimax rotation. The “exercise” item was excluded from the 
analysis as it was ambiguous; it could mean that exercise actually causes the death or 
cardiac abnormality (i.e. the cases of high profile sports dying suddenly), alternatively it 
could be interpreted as “exercise”, or lack of it, causes the problem (lifestyle).
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Table 11.2 Modified IPQ-R Scales, alpha coefficients and normal distribution graphs.
Emotional Representations
Emotional representations (alpha .89)
48 When I think about having a heart conditions I get worried (r)
50 The thought of having a heart condition makes me feel afraid (r)
46 When I think about having a heart condition I get upset (r)
49 The thought of having a heart condition makes me feel anxious (r) 
45 I get depressed when thinking about having a heart condition (r)
47 The thought of having a heart condition makes me feel angry (r)
Illness coherence
Illness coherence (alpha .86)
42 I don't understand heart conditions 
41 Heart conditions are a mystery to me
43 Having a heart condition doesn't make any sense to me
44 I have a clear picture or understanding of heart conditions (r) 
40 The symptoms of heart conditions are puzzling to me
Timeline (alpha .80)
16 A heart condition will last a long time (r)
15 A heart condition is likely to be permanent rather than temporary (r)
18 A heart condition will pass quickly
14 A heart condition will last a short time
19 A heart condition would last a lifetime (r)
34 A heart condition will improve in time 126 176 418 476
Treatment control
Treatment control (alpha .62)
38 Treatment can control the symptoms of a heart condition (r)
39 There is nothing which can help those with heart conditions
37 The negative effects of a heart condition can be prevented by treatment (r)
35 There is very little that can be done if I have a heart condition
36 Treatment will be effective in curing a heart condition (r)
Consequences (alpha .59) (alpha .4467 -  if item 22 is included)_______________________
23 Having a heart condition would strongly affect the way others see me (r)
24 Having a heart condition would have serious financial consequences (r)
25 Having a heart condition would cause difficulties for those who are close to 
me (r)
21 Having a heart condition would have major consequences on my life (r)
20 Heart conditions are serious (r)
22 A heart Gondition would not have much effect upon my life
Consequences
Personal Control (alpha .63) If item 32 is included alpha decreases to .44
26 Having a heart condition would depend on the way I live my life (r)
27 Having a heart condition would depend on me (r)
32-Nothing I do will affect if I have a heart condition
Personal control
Personal control
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Table 11.3 shows the results of the factor analysis. This produced 3 factors with 
eigenvalues greater than one, accounting for 41.8% of the variance. The causal items 
Hereditary and Chance or bad luck did not load on any factors, so were deleted from a 
second factor analysis. This also produced 3 factors with eigenvalues greater than 
one, accounting for 46.3% of the variance.
Table 11.3 -  Factor analysis of causal items
Component 
1 2 3
Lifestyle causes (alpha .64)
55 Diet or eating habits 
64 Smoking 
63 Alcohol
59 Behaviour and lifestyle
.729
.707
.646
.591
Cause behavioural
Psychological causes (alpha .68)
62 Emotional state
60 Mental attitude e.g. thinking about life 
66 Personality
52 Stress or worry
61 Overwork
.746
.741
.612
.555
.529
Cause psychological
CauM p*ycfrotoflic«i
External causes (alpha .50)
57 Poor medical care in my past 
54 A germ or virus
58 Pollution in the environment 
65 Accident or injury
.695
.635
.602
.521
Cause external
Factor 1 consists of four items related to lifestyle, so has been lifestyle causes. It had 
reasonable internal consistency (a = 0.64). Factor 2 contained five items related to 
mental state. I have labeled this psychological causes (a = 0.68). The third factor 
included a series of mixed external causes (a = 0.50).
It can also be seen from Table 11.3 that beliefs in lifestyle causes of cardiac conditions 
were the strongest on average, with somewhat weaker beliefs in psychological and 
external causes. However, there was substantial variation in the strength of beliefs in 
all three sets of causes.
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11.3 IPQ-R factors - comparisons and interrelationships
11.3.1 Between s tudy com parisons fo r IPQ-R factors
Table 11.4 M (SD) comparison across studies with adolescents
Cervical Colorectal
chronic pain acute pain screening screening cardiac screening
Adolescents adults
N=63 N=35 N=660 N=701 N=359 N=51
M (sd) M (sd) M (sd) M (sd) M(sd) M (sd)
Timeline 3.85(0.74) 2.23(0.90)**** 2.63(0.96)**** 2.97(0.86)**** 3.55(0.52)
3.82(0.55)***
Consequences 3.91 (0.65) **** 2.37 (0.74) **** 2.71 (0.96) **** 2.66(0.86)**** 3.19(0.52)N=357
3.45(0.65)**
Personal control 3.07(0.67)*★ 3.82(0.59)**** 2.82 (0.9)ns 3.30(0.68)**** 2.81 (0.78) N=356
2.92(1) 
ns N=48
Treatment control 2.84(0.67) 3.89(0.66)* 3.97(0.78)**** 3.57(0.67)ns 3.63(0.43) 3.64(0.4)ns
Emotional reps 3.29(0.69) * ★★★ 2.69(0.67)ns 3.06(1.14) 2.84(0.83)** 2.70(0.83)N=358
3.09(0.82)***
Illness coherence 2.67(0.96)** 1.86(0.60)**** 3.13(1.24)ns 2.77(0.81)hititit 3.03(0.78)N=358
2.82 (0.76)ns
P < 0.001****, p < 0.005***, p < 0.01**, p < 0.05*,ns = not significant.
I compared the means and standard deviations of the IPQ-R scales to two sets of 
published findings. The first is Moss-Morris e ta l.f (2002) who published descriptive 
data for each of the dimensions for 63 chronic and 35 acute pain patients. The second 
study evaluated illness representations and emotion in people with abnormal screening 
results (Hagger and Orbell, 2006). This included a sample of 660 women who had had 
abnormal PAP smear results and were referred for colposcopy, and 701 men and 
women who had undergone faecal occult blood testing (FOBT) for bowel cancer, and 
had been referred for colonoscopy because of traces of blood being found in their 
faeces. The women in the colposcopy clinic were asked to complete the IPQ-R in 
relation to The problem with my cervix...’, while the patients awaiting colonoscopy 
completed the IPQ-R in relation to The problem with my bowel motions (small amounts 
of blood being found)...’ In these two studies, the IPQ-R items were rated on 6 rather 
than 5-point scales, so scores were recomputed for comparison with the present data.
Participants in the cardic screening believed that the cardiac conditions were more 
chronic than were the conditions rated in the cervical or colorectal screenings (p <
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0.001), and timelines were also greater than those of patients with acute pain (p < 
0.001). Patients with chronic pain felt their condition was more chronic than 
adolescents’ perceptions of cardiac conditions (p < 0.005). Beliefs about consequences 
were greater for cardiac conditions in adolescents as compared to people being 
screened for colorectal and cervical cancer (p < 0.001) and significantly higher than 
acute pain patients ( p < 0.001). Again, however, consequences were significantly 
worse in chronic pain patients (p < 0.001). Adolescents felt they had less personal 
control over the cardiac conditions than did the colorectal cancer screening patients (p 
< 0.001) and the chronic (P < 0.01) and acute pain patients (p < 0.001), but ratings 
were similar to those of cervical cancer screening patients.
Adolescents were similar to colorectal screening patients in how much they felt 
treatment could control the conditions. They perceived treatment to be better than did 
chronic pain patients (P < 0.001). However, both cervical cancer patients (p < 0.001) 
and acute pain patients (p < 0.05) both felt that treatment was better at controlling the 
conditions as compared to adolescents’ perceptions of cardiac conditions. The way 
adolescents represented these conditions emotionally was similar to acute pain 
patients. It was significantly different to the cervical cancer (p < 0.001) and colorectal 
cancer screening settings (p < 0.01) and chronic pain patients (p < 0.001) who were all 
much more concerned about these conditions. Although adolescents had a similar 
understanding (illness coherence) of cardiac conditions to that of cervical cancer 
screening patients, they had more understanding than those in the colorectal cancer 
screening (p < 0.001) and the patients experiencing both chronic (p < 0.01) and acute 
pain (p < 0.001). The illness coherence scores of acute pain patients were particularly 
poor.
All the comparison conditions in Table 11.4 involved adults, so respondents were better 
matched to the adult cardiac testing group than the adolescents. Adults undergoing 
cardiac testing felt the conditions were more chronic (p < 0.005) and others, such that
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they were similar to the beliefs of chronic pain patients. They believed the conditions 
had greater consequences than the problems being investigated in the cervical and 
colorectal screening conditions (p < 0.01), although still not as high as the chronic pain 
patients. Adults had stronger emotional representations than adolescents(p < 0.005), 
more similar to those of the cancer screening groups. They had similar levels of 
understanding to adolescents, as well as perceptions of treatment and personal 
control.
11.3.2 Interrelationships o f  IPQ-R factors
Table 11.5 Correlations between IPQ-R scales in adolescents
Timeline Consequ’s Treatment Personal Illness Emotional Psych. External
control control coherence reps causes causes
Consequences .175***
Treatment control -.033 .025
Personal control .024 _ 2 0 4 *** -.088
Illness coherence .126* -.132* .173*** -.028
Emotional Reps -.034 .241*** -.060 . 0 0 0 -.158**
Psychological -.094 .051 .038 _ 144** -.038 .054
causes
External causes -.095 .131* .017 -.063 -.046 .1 1 0 ’
Lifestyle causes -.018 .154** .164** -.268*** .043 . 0 2 2
*** p < 0.001, ** p < 0.01, * p < 0.05 , N = 354-359
Some of the interrelationships were as expected when I compared this study of 
adolescents to the relationships reported by Hagger and Orbell (2005) (in the context of 
cervical cancer screening) and the original results reported of the IPQ-R by Moss- 
Morris etal., (2002). However, the majority of the relationships previously observed 
were not significant.
As expected, consequences were significantly and positively correlated with both 
timeline and emotional representations. People who felt that there were worse
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consequences felt the conditions were more chronic and were more likely to be worried 
about them. Furthermore, illness coherence was negatively associated with both 
consequences and emotional representations, and positively associated with treatment 
control. When people had less of an understanding of the conditions they worried more 
about them, perceived greater consequences and thought that treatments were less 
able to help control the condition.
Both previous studies showed that beliefs about timeline of the illness were negatively 
associated with illness coherence, personal control and treatment control and positively 
associated with emotional representations. In those studies, people who believed that 
the illness would last a long time also understood the condition less, felt they could not 
control it (either personally or with treatment) and were more worried about the 
conditions. In the present study, beliefs about timeline were positively related to illness 
coherence, as opposed to negatively, and not associated with personal control, 
treatment control or emotional representations.
Unlike the other studies treatment control was not negatively associated with either 
consequences or emotional representations, and not positively associated with 
personal control. Furthermore there was not the positive association between illness 
coherence and personal control in this study that was seen in previous studies.
Personal control was negatively correlated with consequences, whereby more personal 
control was felt over the conditions when the consequences were perceived less 
severe. This was similar to the findings of Moss Morris et al., although this relationship 
was not significant in Hagger and Orbell’s study. Furthermore, the lack of association 
between personal control and emotional representations was similar to the results of 
Hagger and Orbell, although Moss Morris et al., did find these factors to be negatively 
associated.
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The causal attributions are more difficult to evaluate as they were presented as a single 
factor by Hagger and Orbell. However, there was a degree of consistency with the 
other studies within the causal dimensions, with them all positively intercorrelating. 
There is also a reasonable degree of consistency in the interrelationships between the 
causal items and the other factors in this study compared to Moss- Morris et al., with 
the exception of personal control, where the relationships were significant but inverted.
11.3.3 Factors associated with IPQ-R scores in adolescents
I also compared the mean scores of the adolescent IPQ-R dimensions in boys and 
girls, participants with and without cardiac symptoms, and the school and community s 
study groups. Personal control was significantly higher in girls than boys (P = 0.014). 
Beliefs in psychological causes was greater in the symptomatic group (p = 0.014), 
compared to the asymptomatic group. Personal control and treatment control were 
both significantly higher in the community screenings compared to the school 
screenings. None of the other differences were significant. In view of the fact that 32 
different comparisons were made, the observation of 4 significant differences is not 
impressive, and suggests that at least some of these may be down to chance.
11.4 Discussion of the modified IPQ-R and causal scales
The majority of items in the illness cognition scales loaded as expected, and most of 
the scales had either high or satisfactory levels of internal reliability. I carried out a 
separate factor analysis on just the adolescent sample with similar findings (appendix 
VI). This provides confirmation of the potential value in the screening context of the 
theoretically derived factors presented in the IPQ-R. However, the personal control, 
treatment control and consequences scales were less consistent than the others, so 
should be treated with caution.
The psychological and lifestyle cause scales also had a satisfactory level of internal 
reliability. The developers of the IPQ-R stressed that the causal scales should be
157
modified to suit particular illnesses. When adding items it is essential that there is no 
ambiguity in interpretation, such as the case of the item “exercise”. It was expected that 
people may have less clear causal interpretations of illness prior to any diagnosis or 
reason for concern. However, even in this context it is clear that young people have 
coherent views about what causes cardiac conditions.
Although not all of the interrelationships were as expected, some were consistent with 
previous studies. One of the key differences between this study and Moss-Morris et 
a/’s., findings is that emotional representations were significantly correlated with each 
of the other factors tested in their study, whereas this was not the case in the 
adolescent sample where only consequences and illness coherence and external 
causes correlated significantly. In their study personal control, treatment control and 
timeline were also related to emotional representations. This was similar to the cancer 
screening sample (Hagger and Orbell, 2006), although there was no relationship 
between emotional representations and personal control. The data in the present study 
was collected at a time when the adolescents had not yet been tested, so it is 
reasonable to expect that the only factors that would be associated with emotional 
representations in this context are consequences and their understanding of the 
conditions. The other factors would play a role in emotions once a person was 
diagnosed or considered at greater risk.
The important role of illness coherence in this screening context, prior to any abnormal 
results, is highlighted by the similar pattern of relationships as compared to the other 
studies. Although there was no association between personal control and illness 
coherence, and the relationship with timeline was in the opposite direction, the pattern 
with consequences, treatment control and emotional representations was the same.
Although, it is important to note the different provision of information to the participants 
and its potential influence on developing illness representations, this did not appear to
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have any effect on the participants as there were either no differences or negligible 
differences (Personal control and treatment control (p = 0.03) between the study 
groups or within the school samples (Millfield and the Western Isles).
The comparisons of means for each of the IPQ-R dimensions with the chronic pain and 
cancer screening samples was interesting, considering adolescents perceived these 
conditions to have greater consequences than those in the colorectal and cervical 
screening groups. These conditions were also perceived to be more chronic than the 
conditions being appraised by both the cervical and colorectal cancer screening 
samples. This is a surprising finding considering firstly most people are aware of 
cancer and the impact that a diagnosis would have. Secondly, the samples in both the 
pain and cancer screening contexts were adults and may be expected to have stronger 
representations than the adolescents. This is because the acute and chronic pain 
patients actually have an illness. In the case of the cancer screening, this is because 
the data has been collected at a second phase of screening, after an initial abnormality 
had been identified. There is also the possibility that adolescents would have a more 
positive outlook on illness than adults. In this study, adults did have more negative 
perceptions of consequences and felt the conditions were more chronic than the 
adolescents. Therefore, the differences between the groups on some factors were 
even stronger when comparing adults in this study.
Adolescents and the adults in this study had lower sense of personal control than the 
colorectal cancer screening patients and the chronic and acute pain patients. This may 
have been due to their understanding of the genetic aspect of these conditions, and 
that they are not caused by lifestyle factors. However, the scores were similar to the 
cervical cancer screening patients. Hagger and Orbell (2006) noted that perceptions of 
personal and treatment control were not related to distress in the cervical cancer 
screening sample, whereas high personal control and attributions to personal 
behaviour causes were related to lower distress amongst the colorectal sample,
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suggesting that when clear advice is feasible regarding personal means of lowering the 
risk of disease, this may have an impact of levels of distress. Although adolescents had 
a positive perception that treatments would help to control the conditions if diagnosed, 
this was much stronger in the cervical cancer screening participants. Even though the 
adults worried more about these conditions than the adolescents, people were still 
more worried in the cancer screenings. This is probably due to the greater risk 
introduced by a detected abnormality rather than a direct comparison between 
conditions.
One of the difficulties in these comparisons is understanding exactly what patients 
were evaluating in the Hagger and Orbell (2006) study of patients who had had positive 
smear and FOBT tests. These individuals were undergoing additional tests for cancer, 
but it is not clear whether their illness representations related to cancer or to beliefs 
they had about some other cause of their positive smear or FOBT. Other literature 
indicates that the majority of patients with positive results on these tests do not assume 
that they have cancer, but believe there is another explanation of their test results.
This may account for the relatively low ratings they gave on average on issues such as 
timeline and consequences. However, some patients may have feared a more serious 
outcome. The wording of the IPQ-R in this study makes it difficult to be certain what 
illness is being represented in the questionnaire. The present study was less 
ambiguous in this respect, since participants were asked about having ‘a heart 
condition’, with the definite understanding that what they were rating was what they 
would feel like if they had a positive diagnosis.
11.5 The relationship between illness cognitions and anxiety in adolescents
The aim of these analyses was to determine whether illness cognitions predicted 
anxiety at time 1 (invitation to testing), time 2 (immediately prior to the test), and time 3 
(after a normal result has been received). Before conducting these analyses, I
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checked whether anxiety scores differed in participants who did and did not complete 
the IPQ-R. There were no significant differences at any time point.
11.5.1 Regressions on anxiety at time 1 for adolescents
A series of hierarchical regressions were carried out to determine if illness 
representations independently predicted anxiety at time 1 after age, gender, symptoms 
and study group had been taken into account. These factors were included on step 1, 
and as can be seen in Table 11.6, they accounted for 17.5 % of the variance
Table 11.6 Step 1 - Multiple regression on anxiety at time 1
Step 1 B 
Model
Std.
Error
Beta t Sig. R*F change S ig f
change
1 (Constant) 2.762 1.940 1.424 .155 .175 29.563 . 0 0 0
Age .014 . 1 1 2 .005 . 1 2 1 .904
Gender 1.534 .269 .223 5.700 . 0 0 0
Symptoms .926 .113 .319 8.187 . 0 0 0
Study groups -.468 .288 -.063 -1.629 .104
Each of the illness representation scales and causal factors was then entered in a
separate regression on anxiety. The results are shown in table 11.7.
Table 11.7 Step 2 - Hierarchical regressions on anxiety time 1
Step 2 
Model
B Std.
Error
Beta t Sig. R* Additional
R2
3 Treatment control -.309 .406 -.039 -.761 .447 .167 .0 0 1
4 Emotional representations .927 .200 .228 4.633 .000 .216 .051
5 Illness coherence -.411 .219 -.095 -1.874 .062 .174 .009
6  Consequences .618 .329 .095 1.880 .061 .175 .009
7 Timeline -.226 .333 -.034 -.679 .498 .167 . 0 0 1
8  Personal control -.243 .226 -.055 -1.075 .283 .169 .003
9 Lifestyle causes .523 .330 .080 1.583 .114 .173 .006
10 External causes .435 .312 .071 1.395 .164 .171 .005
11 Psychological causes .292 .302 .049 .967 .334 .169 . 0 0 2
12 Genetic w orry .632 .168 .187 3.759 .000 .191 .034
Only one of the illness representations -  emotional representations -  predicted time 1 
anxiety, accounting for an additional 5.1% of the variance. In addition, I tested the 
possible role of genetic worries, using the single item described in section 7.6.1. This 
was also an independent predictor of time 1 anxiety, accounting for 3.4% of the 
variance.
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So as to discover whether genetic worries and emotional representations are 
independent of one another, both were entered into a multiple regression. The results, 
summarized in table 11.8, indicate that they are independent of one another, and of the 
background factors included in the models. Altogether, 23.7% of the variance in time 1 
anxiety was accounted for by these factors.
Table 11.8 Hierarchical regression on anxiety at time 1
Model B Std. Beta t sig R* F Sig R* sH
Error change change change
(Constant) 2.483 2.707 .917 .360 .237 14.769 . 0 0 0 .07
Age -.221 .155 -.070 -1.430 .154
Gender 1.338 .337 .199 3.968 .000 0.037
Symptoms .788 .133 .292 5.922 .000 0.082
Study Groups .146 .425 .017 .344 .731
Genetic Worry .459 .170 .136 2.706 .007 0.017
Emotional Representations .799 .204 .197 3.912 .000 0.036
The strongest predictor of anxiety at time 1 was how many symptoms they reported. 
Those with more symptoms were more anxious. Women were more likely to be 
anxious at time 1. Participants with more negative emotional representations of cardiac 
conditions were more anxious at time 1 as well as those who were concerned about 
the genetic aspects of these conditions.
11.5.2 Predictors of anxiety at time 2
A similar set of analyses was carried out to predict anxiety at time 2. However, this time 
anxiety at time 1 was included at step 1 along with gender, symptom groups, age 
groups and study type. As can be seen in table 11.9, these factors together accounted 
for 52.9% of the variance in time 2 anxiety, with anxiety at time 1, study group and
gender being particularly important.
Table 11.9 Multiple regression on anxiety at time 2
Step 1 
Model
B Std.
Error
Beta t Sig. R2 F 
change
Sig. F 
change
1 (Constant) 2.840 1.432 1.984 .048 .529 100.358 . 0 0 0
age -.045 .082 -.018 -.550 .583
gender .431 . 2 1 0 .070 2.056 .040
Symptoms .094 .089 .037 1.056 .291
Study groups -.581 .208 -.092 -2.798 .005
anxiety time 1 .599 .032 .679 18.953 .000
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On the second step, each of the illness cognitions (plus genetic worry) was entered in a 
separate regression analysis. The results are summarized in table 11.10. As with time 
1 anxiety, only emotional representations and worry about genetic factors predicted 
time 2 anxiety independently of step 1 variables.
Table 11.10 Step 2 - Hierarchical regression on anxiety time 2
Step 2 B 
Model
Std. Error Beta t sig Rz Additional
R2
2 Genetic worry .380 .133 .133 2.870 .004 .017
3 Treatment control -.241 .301 -.037 -.799 .425 . 0 0 1
4 Emotional Representations .451 .158 .132 2.858 .005 .016
5 Illness coherence -.313 .173 -.084 -1.813 .071 .007
6  Consequences .157 .257 .028 .612 .541 . 0 0 1
7 Timeline -.181 .265 -.031 -.681 .496 . 0 0 1
8  Personal control -.224 .173 -.060 -1.294 .197 .003
9 Lifestyle causes -.384 .258 -.068 -1.491 .137 .005
10 External causes .177 .247 .033 .718 .474 . 0 0 1
11 Psychological causes .087 .231 .017 .376 .707 . 0 0 0
An additional regression analysis was therefore carried out that included both 
emotional representations and worry about genetic factors at step 2. The results are
shown in table 11.11.
Table 11.11 Hierarchical regression on anxiety at time 2
Model B Std. Beta t sig F SIG F R" sr2
Error change change change
2 (Constant) .685 2.105 .326 .745 .537 6.490 .002 .026
Age .029 . 1 2 0 . 0 1 1 .244 .807
Gender -.247 .278 -.043 -.889 .375
Symptoms .231 .108 .103 2.143 .033 0.009
Study Groups -.443 .308 -.066 -1.437 .152
Anxiety time 1 .534 .043 .640 12.547 .000 0.317
Genetic Worry .287 .136 .101 2.108 .036 0.009
Emotional Representations .375 .164 .110 2.283 .023 0 . 0 1 0
At step 1, 51% of the variance in anxiety levels at time 2 was predicted by the scores 
on these 5 variables. At step 2, the two cognitive variables contributed significantly to 
prediction of anxiety; genetic worry (sr^.OOQ) and emotional representations (sr^.OI). 
The final model accounted for 53.7% of the variance
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11.5.3 Predictors of anxiety at time 3
The same analyses were carried out to predict anxiety at time 3 for those with negative 
cardiac testing results. Once again, anxiety at time 1 was included at step 1 with 
gender, symptoms, age and study type.
Table 11.12 Step 1 - Multiple regression of on anxiety at time 3
Step 1 B Std. Beta 
Model Error
t Sig. R* F 
change
Sig. F 
change
(Constant) .370 2.298 .161 .872
age . 0 1 0 .133 .004 .081 .935
gender .760 .316 . 1 2 0 2.404 .017
Symptoms .302 .138 .108 2.178 .030
Study groups -.262 .326 -.039 -.804 .422
anxiety time 1 .563 .049 .587 11.386 . 0 0 0
46.0% of the variance in time 3 anxiety was accounted for by the step 1 factors, with 
time 1 anxiety, gender and symptom group being particularly important (see table 
11.12). When the illness cognition variables were entered in separate regressions on 
step 2, a different pattern of results emerged by comparison with anxiety and times 1 
and 2 (table 11.13). Instead of worry about genetics and emotional representations 
emerging as significant predictors, it was beliefs in lifestyle causes that were important, 
being negatively associated with anxiety. This factor accounted for 2.5% of the 
variance over and above the step 1 variables.
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Table 11.13 Step 2 - Hierarchical regression on anxiety time 3
Step 2 
Model
B Std. Error Beta t Sig Additional
R2
4 Genetic worry .156 .213 .047 .735 .464 . 0 0 2
5 Treatment control .025 .475 .003 .053 .958 . 0 0 0
6  Emotional Representations .460 .253 . 1 2 0 1.815 .072 . 0 1 2
7 Illness coherence -.056 .241 -.014 -.231 .818 . 0 0 0
8  Consequences -.028 .368 -.005 -.076 .940 . 0 0 0
9 Timeline .487 .388 .077 1.256 . 2 1 1 .006
10 Personal control -.171 .258 -.041 -.661 .510 . 0 0 2
11 Lifestyle causes -.964 .365 -.162 -2.638 .009 .025
12 External causes .540 .362 .095 1.491 .138 .008
13 Psychological causes .439 .338 .080 1.297 .197 .006
11.6 Factors associated with anxiety at time 3 in participants with positive test 
results
Only 23 adolescents who completed the modified IPQ-R had positive test results. Of 
these, only 14 returned anxiety ratings at time 3 (following receipt of the positive 
results). Since it is generally agreed that there should be ten times as many cases as 
variables in a multiple regression, it was not possible to carry out similar analyses on 
the positive test cases as was done for those with negative results. Instead, simple 
product-moment correlations were conducted to discover whether illness perception 
variables were associated with anxiety responses.
Individuals with positive test results were treated exactly the same as other participants 
at times 1 and 2, and only differently at time 3 when test results were sent to them. I 
therefore analysed factors associated with time 3 anxiety in this small group of 
adolescents with positive cardiac testing results. Two sets of correlations were carried 
out: simple product-moment correlations, and partial correlations controlling for time 1 
anxiety. The results are shown in Table 11.14 and 11.15.
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Table 11.14 Product-moment correlations for adolescents with positive results
anxiety time 3
Timeline .551*
Consequences -.264
Treatment control -.051
Personal control .084
Illness coherence .197
Emotional Representations .180
Psychological causes -.254
External causes -.498
Lifestyle causes .223
Genetic worry .339
* p> 0.05, N=14
In the simple product moment correlations timeline was the only cognitive 
representation that was correlated with anxiety at time 3 (r2 = 0.55, p < 0.05). The more 
chronic the participant believed the condition to be, the more anxious the person was. 
After controlling for anxiety at time 1, the strength of the association between timeline 
and anxiety increased. There was also the negative association between a belief in 
external causes and anxiety (r2 = -0.68, p < 0.05). Participants were less anxious if 
they felt the conditions were caused by external factors such as a germ or virus.
Table 11.15 Partial correlations for anxiety time 3
Controlling for time 1 anxiety
Timeline External
causes
Anxiety time 3 .6238 -.6812
(1 1 ) (1 1 )
p=.023 P=.010
11.7 Cognitive factors associated with emotional representations
Emotional representation was the most important component of the IPQ-R as far as 
anxiety responses were concerned. Cognitive components of the illness 
representation model did not contribute. However, it is possible that cognitive factors 
are related to emotional representations. As noted in the intercorrelation between IPQ- 
R scales (table 11.5), emotional representation scores were positively associated with 
consequences and beliefs in external causes, and negatively with illness coherence. I 
therefore carried out a series of hierarchical regressions to determine whether cognitive 
factors were associated with emotional representations independently of gender,
symptoms, age, and study type. Step 1 of the models is shown in table 11.16. The 
background factors together accounted for 1.8% of the variance in emotional 
representations, with gender being particularly important.
Table 11.16 Step 1 - Multiple regression on emotional representations
Step 1 
Model
B Std.
Error
Beta t sig R* F 
change
Sig.
1 (Constant) 2.001 .725 2.761 .006 .018 1.546 .189
age .014 .042 .018 .328 .743
Gender . 2 0 0 .091 .121 2.189 .029
Symptoms -.009 .036 -.014 -.252 .801
Study groups .168 .117 .078 1.431 .153
The results from Step 2 are shown in table 11.17. Illness coherence was negatively 
associated with emotional representations, and scores on the consequences and 
external cause scales positively related. Additionally, participants with higher ratings of 
worry about genetics also had greater emotional representation scores.
Table 11.17 Step 2 - Hierarchical regressions on emotional representations
Step 2 
Model
B Std. Error Beta t Sig. R
change
2 Treatment control -.166 .107 -.085 -1.554 . 1 2 1 .007
3 Illness coherence -.210 .057 -.197 -3.662 .000 .038
4 Consequences .420 .084 .264 4.989 .000 .068
5 Timeline -.096 .087 -.060 -1.098 .273 .004
6  Personal control -.033 .060 -.030 -.548 .584 . 0 0 1
7 Cause Lifestyle .047 .088 .029 .538 .591 . 0 0 1
8  Cause External .267 .082 .177 3.270 .001 .031
9 Cause Psychological Stress .136 .080 .094 1.703 .090 .008
Finally, a regression analysis was run in which illness coherence, consequences and 
external cause factors were entered simultaneously, along with the control variables 
gender, symptoms, study type, age. The results shown in table 11.18 indicate that all 
three were independently associated with emotional representations. The complete 
model accounted for 13.4% of the variance, indicating that the cognitive factors did 
contribute substantially to emotional representations
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Table 11.18 Regression on emotional representations
B
Model
Std. Beta 
Error
R F 
square change
Sig f 
change
R sq 
change
sr*
(Constant) .773 .816 .948 .344.134 14.799 .000 .116
Age .002 .040 .003 .060 .952
Gender .257 .087 .155 2.957 .003 0.023
Symptoms .007 .034 .010 .202 .840
Study groups .191 .112 .089 1.702 .090
Cause External .224 .079 .148 2.841 .005 0.021
Consequences .358 .084 .224 4.276 .000 0.048
Illness coherence -.180 .056 .168 -3.234 .001 0.027
The strongest correlate of emotional representations was how participants perceived 
the consequences of being diagnosed with a cardiac condition, with more negative 
consequences being predictive of more negative emotional representations. Believing 
the cause was external was also associated with more negative emotional 
representations of these conditions. A better understanding of these conditions (greater 
illness coherence) was associated with more positive emotional representations (less 
worry) of these conditions. Women had more negative emotional representations of 
cardiac conditions.
11.8 Factors associated with reassurance for adolescents
The reassurance scale was comprised of three items that loaded on a single factor in 
Varimax factor analysis accounting for 23.9% of the variance, reliability analysis 
indicated a =0.70. For adolescents the mean (SD) score for this scale was 4.55 (.59) 
identifying a positive reaction to the screening process. 97.3% of the 110 participants 
who completed this measure felt reassured, wanted to recommend this to others and 
have the test again in the future. Only one participant felt negatively towards the 
process. Girls were more reassured than boys (P < 0.05), but there were no significant 
differences between study types of symptom groups.
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I carried out a series of hierarchical regressions to determine which illness 
representations independently predicted reassurance at time 3 after age, gender, 
symptoms, and study group had been taken into account.
Step 1 of the models is shown in table 11.19. The background factors together 
accounted for 4.3% of the variance in reassurance.
Table 11.19 Step 1 - Multiple regression on reassurance
Step 1 B Std. Beta T sig R* F Sig.
Model Error change
(Constant) 4.704 .988 4.762 .000
Age -.024 .060 -.041 -.390 .698
Gender .221 .120 .206 1.840 .069
Symptoms -.002 .047 -.006 -.052 .958
Study groups -.039 .133 -.031 -.289 .773
Anxiety time 1 -.002 .019 -.009 -.079 .937
The results from Step 2 are shown in table 11.20. Emotional representations was 
positively associated with reassurance and accounted for 7.9% of the variance over 
and above the step 1 variables.
Table 11.20 Step 2 - Hierarchical regressions on reassurance
Step 2 
Model
B Std. Error Beta t Sig. R* R* 
change
2 Treatment control .242 .122 .208 1.981 .051 .040
3 Emotional representations .191 .067 .299 2.838 .006 .079
4 Illness coherence .080 .068 .122 1.178 .242 .015
5 Consequences -.080 .106 -.080 -.756 .452 .006
6 Timeline .090 .110 .090 .819 .415 .007
7 Personal control .040 .070 .063 .584 .561 .004
8 Cause Lifestyle -.070 .102 -.074 -.680 .498 .005
9 Cause External .136 .102 .143 1.341 .183 .019
10 Cause Psychological Stress .017 .097 .019 .175 .862 .000
11 Genetic worry .040 .061 .069 .644 .521 .005
Participants who had greater emotional representation scores prior to the testing,
indicating more worry about cardiac conditions, were more reassured after the testing.
11.9 Discussion of illness representation results
This chapter examined the relationship between cognitive and emotional 
representations of cardiac conditions and anxiety levels throughout the cardiac testing.
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These analyses are important for increasing our understanding of the role of illness 
representations in responses to participation in testing.
11.9.1 Factors associated with anxiety
The main hypothesis driving the analyses in this chapter was that illness 
representations would predict levels of anxiety throughout the testing, and would 
predict anxiety levels at later stages of the testing independently of the factors already 
shown in Chapter 8 to be relevant (gender, age, symptom levels and study type). The 
results in general did not confirm this hypothesis. None of the cognitive scales on the 
IPQ-R predicted anxiety either at time 1 or time 2 after control variables had been 
taken into account (tables 11.5 and 11.8). One single cognitive factor (belief in lifestyle 
causes) predicted anxiety at time 3 (table 11.10). However, this was the only one 
positive result out of more than 30 independent regressions, so might have been a 
chance effect.
It is surprising that illness consequences do not play an important role in independently 
explaining anxiety levels since the representation of consequences reflects an 
individual’s evaluation of the potential seriousness that a positive screening result may 
have (Wardle and Pope, 1992). This dimension is described as reflecting the 
importance that a participant gives to the condition being tested (Hagger and Orbell, 
2006).
The most likely explanation for the failure of the more cognitive components of the 
illness perception model from being predictors is that adolescents did not have well 
formed cognitive representations of the cardiac conditions for which they were being 
tested. Almost all the knowledge they had of these conditions was likely to have come 
from the brief description of the reasons for testing outlined in the letter of invitation, 
and from informal sources in school or the community. They had very little information 
about the nature of the conditions, their controllability or consequences. Although they
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generated internally coherent representations (as reflected in the scales that were 
constructed), the scores may not have borne much relationship with their personal 
experience of the testing programme.
By contrast, emotional representations were consistently associated with anxiety at 
both time points prior to a negative test result. Similarly, worry about the genetic 
aspects of cardiac conditions were related to anxiety. Both these factors are directly 
related to worry -  indeed, three of the six items on the emotional representation scale 
mention worry, anxiety and upset. It could therefore be argued that the emotional 
representation and worry about genetics scales tap specific forms of anxiety. Specific 
anxieties typically correlate with general anxiety measures such as the HAD scale, and 
may contribute to generalized anxiety levels. The measures have common method 
variance, so the strength of these associations is perhaps not surprising.
However, it is notable that emotional representations and worry about genetic causes 
were related to time 2 anxiety (immediately before testing) independently of time 1 
(invitation) anxiety. This indicates that these anxieties about cardiac conditions and 
their causes played an independent role in predicting pretest anxiety. The fact that 
they were no longer significant predictors at time 3 (after a negative test result had 
been received) suggests that these fears were not trait effects, but dependent on the 
state of uncertainty that participants experienced at times 1 and 2. Additionally, 
emotional representations predicted ratings of reassurance at the end of the procedure 
independently of anxiety (section 11.7). So the effects are substantive and not merely 
secondary to trait anxiety.
The independent relationship of genetic worry also suggests that the emotional 
representation scale may not be sensitive to some of the specific illness concerns that 
are present when screening for genetic conditions. This highlights an important 
consideration when investigating these cognitive processes within a screening context.
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11.9.2 Factors associated with emotional representations and reassurance
As cognitive representations at no point in time predicted anxiety, emotional 
representations did not play a mediating role between the cognitive representations 
and anxiety. However, gender, perceptions of consequences, illness coherence and 
perceptions that the conditions were caused by external influences were associated 
with emotional representations. The greater the perceived consequences the more 
negative the emotional representation of the conditions. Emotional representations 
were also influenced by how strongly it was felt that the cause of cardiac conditions 
was external, and those who understood less about the conditions had more negative 
emotional representations. The negative relationship between emotional 
representations and illness coherence supports the important role of informed consent, 
and giving participants quality information to ensure they correctly understand the 
medical procedures they are participating in.
Emotional representations were the only predictors of reassurance after the testing, 
with those who were more concerned being more reassured later. Contrary to the 
results described by Donkin et al., (2006) none of the cognitive representations were 
associated with reassurance. There were however similarities with Donkin’s results in 
that anxiety was not associated with reassurance. This finding goes further to support 
the position that there were concerns which were independent of trait or state anxiety, 
but dependent on the state of uncertainty that participants experienced prior to the 
negative test result.
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Chapter 12. Qualitative analysis of the responses for those 
requiring follow up tests after an abnormal ECG was detected 
at the first stage of testing.
Although cardiac abnormalities were identified in all of the screening studies at time 3, 
it was only possible to gain data after a final diagnosis was confirmed (at time 4) in the 
Western Isles sample. 22 of the 289 (pN=210) people who participated in the Western 
Isles testing required further tests to confirm their cardiac status. 18 of these were 
cleared at time 4 after having a further ECG, ECHO and consultation with the 
cardiologist, 4 required further cardiac tests. 12 (5 Female, 7 Male) of the 22, who 
required follow up tests, completed at least one of the questionnaires at time 1-4. 11 of 
which completed the 4th and final questionnaire (time 4). In this questionnaire a number 
of open-ended questions (completed by 9 participants) were asked with the aim of 
understanding initial thoughts when being called back for further tests, how they felt 
after having the tests and how the process could be improved.
Eleven of the participants completed at least one anxiety measure between time 1-4. 
The mean score for anxiety was 4.56(1.51) before the testing, 5.4(2.3) immediately 
prior the testing, 3.5(3.02) after the first abnormal ECG result and 5.18(2.68) after the 
final result.
Table 12.1 Descriptive Statistics for anxiety and self rated scores 
for participants with abnormal ECG results at time 3
N Mean SD
anxiety time 1 9 4.56 1.51
anxiety time 2 5 5.40 2.30
anxiety time 3 8 3.50 3.02
anxiety time 4 11 5.18 2.68
self rated health time 1 9 2.89 .93
self rated health time 2 5 2.40 .89
self rated health time 3 8 2.75 1.04
self rated health time 4 11 2.55 .82
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The results in Table 12.1, although similar to the scores of adolescents reported in 
chapter 8, are not particularly informative. This is primarily due to the missing data that 
has had a significant impact on the means. I have therefore included a case by case 
report in Table 12.2.
After the initial letter of recall, about half of the participants felt that this did not raise 
anxiety, stressing that they were not too worried. The others expressed some concern 
about being called back for further tests. None of these participants were ‘probable’ 
anxiety cases at any time during the testing. Indeed, only one person was a ‘possible’ 
anxiety case at time 2 and one at time 3. Three were ‘possible’ anxiety cases at time 4. 
However, only one of these completed a questionnaire at time 1, 2 or 3. Table 12.2. 
also shows that in the majority of cases, scores either decreased at time 3 and 4, or 
stayed relatively stable throughout. This is surprising, as the prospect of requiring 
further tests, after the letter of recall, may have acted to raise anxiety levels (at time 3). 
It may be that young people do not respond to health threats in the same way as 
adults, with adolescents showing less concern. Alternatively, they may have had a 
good understanding of the follow up procedure and realised that although there was a 
chance that something might be found, a positive diagnosis was not imminent.
Table 12.2 Case summaries of anxiety levels 
throughout the testing
Time 1 Time 2 Time 3 Time 4
1 5 7 6
2 4 5 2 4
3 7 9 4 5
4 4 1 3
5 3 4 3 3
6 3 3
7 7 6 9 8
8 4 1 3
9 4 3 1 3
10 9
11 10
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The scores for self rated health throughout the testing, are also presented in table 12.1, 
with means of 2.89(.93) before the testing, 2.4(.89) immediately prior the testing, 
2.75(1.04) after the first abnormal ECG result and 2.55(.82) after the final result. These 
results are similar to the findings of adolescents in chapter 9 at time 1 and 3, but worse 
at time 2 (and 4). As with the anxiety results the means are not that informative due to 
the impact of the missing data. Once again, I have included the case reports 
throughout the testing in table 12.3. This shows that none of the participants requiring 
further testing had a “poor” perception of health at any time in the testing. Only one 
person reported a “fair” self rated health throughout and this was not affected in any 
way by the testing procedure or being called back for further tests. In the remaining 
participants, the results are positive with no noticeable positive or negative trends.
Table 12.3 Case Summaries for self rated health at time 1-4 for those 
abnormal ECG results
time 1 time 2 time 3 time 4
1 Very Good Good Good
2 Very Good Very Good Very Good Very Good
3 Excellent Good Excellent Good
4 Good Very Good Very Good
5 Fair Fair Fair Fair
6 Excellent Excellent
7 Very Good Very Good Very Good Good
8 Very Good Good Very Good
9 Very Good Very Good Excellent Very Good
10 Very Good
11 Good
After they received a final negative diagnosis at time 4 they were asked about their 
thoughts on being called back for further tests. One participant stated, they were ‘a little 
bit worried but happy it was going to be checked out. Four participants were less 
concerned with the follow up tests making the following comments, 7 thought it was 
because my heart might be bigger because of the exercise I do or it might be slower. I 
wasn't scared as I am very confident there is nothing seriously wrong’, 7 was quite 
relaxed and curious, I didn't think something would be wrong but I was trying to look on 
the positive side’, 7 wasn't really all that worried’, 7 personally wasn't too worried. I
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didn't think anything was wrong with me, but I still knew that didn't mean I might not be 
ill’.
The other 4 of the participants clearly stated concerns about being called back with the 
comments 7 was concerned that there was something seriously wrong with my heart', 
‘What's wrong with me?’ 7 was worried’, and 7 wondered why I was being called back - 
was there something abnormal to worry about’.
It is important to note that although a number of participants reported they were not 
initially overly concerned about being called back for further tests, when asked how 
they felt having had the tests and received an all clear (at time 4), one said they felt 
‘very relieved’, another ‘reassured’, and another ‘reassured a little about my health’. 
From this it would appear that there were initial concerns that may not have been 
clearly identified in the earlier comments. This is a problem when conducting a 
retrospective study. However, there is qualitative evidence to support the position that 
being called back for further tests causes some concern that will be relieved once a 
negative diagnosis is confirmed.
This was not the case for all participants. One of the participants was asked how he felt 
having had the test, he stated, 7 felt happy after the test because I felt that everything 
was well. I was told that there was no problem with my heart. Now I am being told that 
there is a minor fault and I feel angry and confused’. This illustrates a break down in 
communication of information and the potential problems this can cause. The 
participant’s parents had also shown considerable concerns after their son was initially 
called back for further tests, and did not understand that the ECG was not diagnostic. It 
provides evidence of the importance of conveying clear information of what a ‘minor 
fault’ is and the ability to distinguish this from a potentially life threatening condition.
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The importance of informing the participant is further supported in another case where 
a question was raised in regard to her final result: ‘From my second screening process 
I received a letter to myself which said no abnormality had been found and also one 
sent to my doctor which stated that the ECG revealed a resting sinus tachycardia - 1 
would appreciate information on this - i f  it in any way affects my health’. When there is 
inconsistency in the diagnostic message, or a lack of information conveyed to the 
patient, there is a potential problem of causing concerns about their perception of 
health by introducing a degree of uncertainty.
Once a negative diagnosis was confirmed, the participant’s responses suggest that 
they were happy to have had the tests with no prolonged anxiety felt. There was only 
one instance in which a participant reported dissatisfaction, but his discontent appears 
to be attributed to the misunderstanding of the diagnostic information. It may be 
important to identify in the initial invitation letter that minor abnormalities may be found 
and clarify what these may be to avoid unnecessary anxiety.
In general these participants were satisfied with the information they were provided, 
anxiety was not a problem and there was a positive outlook on the screening process. 
They would recommend the test to their friends and felt it was important.
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Chapter 13. Final discussion
The research described in this thesis was carried out in the context of a cardiac testing 
programme for young people carried out through the charity Cardiac Risk in the Young 
(CRY). There were two testing settings -  school-based programmes and community 
programmes. This allowed a number of hypotheses to be tested in this thesis, the 
results of which I have discussed in the previous chapters.
13.1 Summary of results
I predicted that participants’ anxiety levels would decrease from before to after 
screening in those with negative results. Also that participants in the community group 
(recruited through public advertisement following a death in the community) would have 
higher levels of anxiety at baseline before testing than those recruited through school- 
based programmes. Furthermore, that participants presenting with symptoms 
consistent with cardiac conditions would have significantly higher levels of anxiety than 
those without symptoms.
Anxiety levels decreased after the testing and those with one or more symptom were 
more anxious before, during and after the screening compared to those not reporting 
symptoms. However, the type of study did not appear to affect the way participants 
responded to the screening. Participants in this study probably had lower levels of 
anxiety than those who did not participate. Non-participants may have responded to the 
screening differently, especially as it would be reasonable to expect them to be more 
anxious in general.
Although most previous research evaluating the psychological impact of screening has
focused on anxiety, the inclusion of self rated health into this evaluation is important for
us to understand other aspects of the experience and to have a general perception of
health as a marker of impact as well as an emotional / psychological one. This is the
first time that self rated health has been utilized in studies evaluating the psychological
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impact of a screening programme in adolescents. It is reasonable to think that self 
rated health may have been influenced by the vulnerability that a person feels when 
introduced to a risk.
I predicted participants’ self rated health would improve from before to after screening 
in those with negative results. Participants in the community group would have poorer 
levels of self rated health at baseline before testing than those recruited through school 
based programmes. Furthermore that participants presenting with symptoms consistent 
with cardiac conditions would have significantly lower levels of self rated health than 
those without symptoms.
There was an improvement in self rated health after receiving a negative test result 
although the degree of improvement was quite small. Similar to the anxiety responses, 
there were no differences between the two types of testing and participants who 
reported one or more symptom, most importantly breathlessness, had worse self rated 
health.
Prior to the screening illness perceptions were evaluated enabling an important 
theoretical insight into how people respond to a threatening health message. I 
predicted that illness representations would predict levels of anxiety throughout the 
testing, and would predict anxiety levels at later stages of the testing independently of 
other factors (gender, age, symptoms level, study type and anxiety). The results in 
general did not confirm this hypothesis. The only time that a cognitive factor predicted 
anxiety was probably a chance effect at time 3, with belief in lifestyle causes predicting 
anxiety.
Emotional representations and worry about genetic causes were important predictors 
of anxiety at time 1 and 2 with anxieties about cardiac conditions and their causes 
playing an independent role in predicting pretest anxiety. These fears were not trait
effects, but dependent on the state of uncertainty that participants experienced at times 
1 and 2 . 1 also expected for participants’ with more negative representations of the 
cardiac conditions to be more reassured following the negative test result.
Emotional representations predicted ratings of reassurance following the testing, 
independently of anxiety. So the effects of emotional representations on anxiety were 
substantive and not merely secondary to trait anxiety.
When the emotional representation scale was developed by Moss-Morris et a/., (2002) 
the authors took care not to develop a measure that was merely a proxy indicator of 
patients’ general mood, but instead an assessment of the emotional response 
generated by the illness. As emotional representations and anxiety did not completely 
overlap, my results not only support the use of this as a valid measure, but also 
highlight the important role of this dimension in explaining the anxiety responses. 
Although I did not report the findings of the illness representation regressions on self 
rated health in this thesis, it is interesting to note that none of the dimensions were 
associated with self rated health at any time in the testing.
The levels of anxiety at time 1 and 2 are associated with worse emotional 
representations, however, it is not clear if this has been caused by the offer of 
screening, or if the participants responses were similar to those who have not 
participated. In requesting for people to articulate their thoughts about these conditions, 
opinions may have been formed which had simply not been developed before the offer. 
The basic information about the conditions that was provided along side the specific 
questions within the IPQ-R was probably enough for people to generate coherent 
opinions. Alternatively, it may be that a significant proportion of the population already 
had concerns about these conditions, which were already conscious and well formed. It 
may have been that the testing gave them the opportunity to alleviate some of their 
concerns.
180
I did not report the regression analysis for adults in this thesis due to a lack of sufficient 
sample size. However, there was an interesting difference between adults and 
adolescents in that emotional representations and genetic worries only predicted 
anxiety at time 1 in adults, where as in adolescents it also predicted anxiety at time 2, 
after controlling for prior levels of anxiety. In adults there was a decrease between time 
1 and 2 anxiety levels, which then stayed stable at time 3. This decrease at time 2 
corresponds with a lack of association between emotional representations and anxiety 
at time 2. Although the lack of association at time 2 may be due to the mediating role of 
prior anxiety levels, it would appear, as with adolescents, that emotional 
representations play an important role in understanding changes in anxiety levels.
13.2 Importance of this research
It was important to carry out the research that was presented in this thesis for a number 
of reasons. Primarily, opinions appear to be divided on the benefits of screening 
programmes in general. This debate gets subdivided into different conditions i.e. 
cancer or cardiac screening, and then further subdivided into specific types of each 
condition, i.e. breast screening or cervical screening. Often advocates or critics speak 
in general terms using phrases like “screening can seriously damage your health” 
(Stewart-Brown and Farmer, 1997). However, the important issues that guide decision 
making, as set out by the National Screening Committee, are often highly specific. Both 
the advocates and critics of screening programmes are influenced by evidence that is 
unsubstantiated, or taken out of context. Having said that there would appear to be a 
general trend in the literature, although there are limitations within the research, that 
screening does not have a significant negative psychological impact.
The results of this study help to inform the debate about cardiac screening within 
adolescents. The strengths are that data were collected in a systematic manner with a 
well validated anxiety measure, a standard measure of self rated health, and a robust 
quantatative assessment of illness representations.
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Apart from informing the debate around the psychological impact of the evaluated 
programme, the data from this research is also useful within the context of 
understanding the development of illness representations. Clearly coherent 
representations already exist prior to any diagnosis. This has important implications for 
understanding the impact that chronic conditions have on quality of life.
Although cognitive representations do not have any association with anxiety levels in 
this study, this association does occur in other studies. In the case of specific chronic 
conditions such as cancer, factors such as consequences are often associated with 
anxiety. It is likely that this association with anxiety is due to a more acute sense of 
personal importance that the representation takes once a level of threat is increased. In 
the case of cancer screening where consequences, amongst other factors, were 
associated with anxiety, even after emotional representations were accounted for, 
patients had already had an initial abnormal result (Hagger and Orbell, 2006). In my 
study I did gain some data on those with abnormal results. Although, the sample size 
was small and the results should be treated cautiously, consequences ratings were still 
not associated with anxiety, but both timeline and external causes were associated. 
Whether this was due to consequences playing a less significant role in adolescents, 
as compared to adults, as some previous research has suggested (Michie, Bobrow, 
and Marteau, 2001) or due to other reasons such as consequences being estimated on 
the basis of limited information is difficult to tell from this research. It is definitely not 
because the consequences dimension was underscored in this context, as adults 
reported higher levels than those reported for cancer, and adolescents’ ratings were 
also similar or greater than those reported in cancer. So, not only do participants have 
coherent views of illness representations leading into the screening, but the majority of 
them are also strongly pronounced and worse than those perceptions held by patients 
about cancer in a cancer screening context. Furthermore, many of the cognitive 
representations were stronger than expected as compared to cancer. The perception
was that cardiac conditions were more chronic, there was less personal control, less 
treatment control, less understanding of the conditions and yet fewer concerns were 
reported about the conditions.
From a theoretical perspective it would appear plausible to suggest that the role of the 
cognitive representations in predicting anxiety is minimal until a time when the threat is 
considered strong enough for those representations to have a direct psychological 
impact. But although there is no direct association with anxiety, cognitive 
representations and concerns about the conditions being tested for, such as being 
genetic, have an indirect effect on emotional responses through their relationship with 
emotional representations.
A small number of participants had positive results in response to screening, and their 
experiences were also tracked. False positive results are an inevitable but serious 
concern for any screening programme, and efforts must be made to minimize the 
number of people being called back for further tests. Having said this, in general those 
who were called back were not overly anxious, they felt reassured after the final result, 
had a positive outlook on the screening process and would recommend it to their 
friends.
There has been little research that incorporates a theoretical position when drawing 
conclusions on the psychological impact. I feel this study has made some inroads into 
improving our understanding of the issues surrounding the psychological impact of a 
screening programme in adolescents.
Currently screening is not available on the NHS, but provided by charitable, or private 
health care providers. It is prudent to evaluate a screening programme for its 
psychological impact, regardless of the governmental policy position, and identify any 
negative outcomes as well as means of minimizing psychological harm for participants.
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Anxiety is often regarded as responsible for inducing irrational and maladaptive 
responses in threatening situations. However, the emotional system evolved as an 
adaptive set of mechanisms for promoting survival (Cameron, 2003) and it should be 
acknowledged that anxiety plays a crucial role in motivating goal related behaviours 
(Carver and Sheirer, 1998). It is reasonable to suggest that an elevated level of anxiety 
prior to the testing is important and inevitable if people are to be motivated to engage in 
health promoting behaviours. However, the discussion of the degree of increase of 
anxiety due to the testing and its ongoing impact is central to the debate surrounding 
the psychological impact of screening programmes. Had the results at time 3 been a 
significant increase in anxiety then I would be drawing different conclusions at the end 
of the thesis.
13.3 Limitations
There were a number of limitations in this study some of which have already been 
discussed in earlier chapters. There was a lack of consistent initial information about 
the testing across the different study types. I have already mentioned that the 
community screenings were usually advertised through the local media. An example of 
the type of article is in appendix V. An invitation to be screened that is related to the 
story of a death of a fit and healthy young person is likely to have an impact on both the 
emotional representations and perception of illness consequences. In all the 
community screenings, funds to pay for the testing had been raised in memory of a 
person who had died, and there was an increased awareness within the community. 
This also occurred in the Western Isles but not in Millfield. Ideally all information letters 
would have contained the same information. Furthermore, an evaluation of the 
methods used by the media to raise awareness of the events may have been helpful. 
Having said this, there were no significant differences between the scores of the 
cognitive and emotional representations for the different groups. The only difference 
between Millfield and the Western Isles was for lifestyle causes and this is was unlikely
184
to be due to something that was read within this study. It is unlikely that the different 
circumstances surrounding the different testing events had an impact on the 
perceptions of those participating.
As noted in section 7.1, the design of the study was constrained by the format of the 
screening programme, and the precise timing of completing measures at times 1 and 3 
is not known. I could have gained a better understanding of the data had I 
incorporated questions in which the person reported the date they received the 
informed consent and the date they actually completed the questionnaire (time 1). 
Similarly, a question about when the results letter was received and when they 
completed the anxiety measures should have been included. The final measure (after 
the results) is potentially most problematic, as it is difficult to know what effect of 
variations in timing could have had on the anxiety measure. Nevertheless, in the vast 
majority of cases, the questionnaires were completed within 2 weeks.
In an ideal scenario I would have liked to measure anxiety at a later date, perhaps 6-9 
after testing. This would have given me a better understanding of whether the 
reduction in anxiety at time 3 was (as Rothman suggests) a feeling of reassurance and 
well being, or alternatively, a temporary relief from anxiety. Although the former would 
appear to be the correct presumption with the majority of participants reporting high 
levels of reassurance after the testing, to know this with certainty would have been 
advantageous. But although a 6-9 month follow up would have been helpful, it would 
have suffered from inevitable drop out of respondents. Considering the number of non­
respondents at time 3 already, a 6-9 month follow up would undoubtedly have been 
very problematic.
Understanding the trend in responses was also complicated by the considerable 
difficulties in gaining accurate baselines measures. Obtaining a measure of anxiety 
prior to any offer of testing, while obtaining appropriate informed consent, is
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problematic. In the community screening this would have been impossible, because the 
method of enrolment, advertised in local communities, entailed a basic knowledge of 
the procedure before any contact was made with the administrator. In the school 
screening I would have had to administer the measures prior to the offer of screening, 
informed consent and first medical questionnaire. In essence this would have meant 
me initially misleading the participants at the first stage, then having to clarify with them 
why they had been mislead in the first instance while offering them the testing. This 
was not a course of action I intended to take, settling for an adequate alternative, 
namely a matched sample comparison group recruited from another school.
The wording of the time 3 anxiety HADS measure was a potential limitation of the study 
design. Ideally I would have requested for the participants to wait a week after 
receiving their result, before completing the anxiety measure. This would have given 
the most accurate comparison of the anxiety measure throughout, as the introductory 
wording to the scale would have been consistent across all time intervals. However, I 
felt this could have an impact on non-respondents, and it was necessary to be less 
prescriptive. The anxiety measure I used at time 3 aimed to reflect a response to the 
testing result, as was seen in this study.
The possibility should also be considered that one reason for not finding adverse 
effects of participating in this screening programme is that the methods were 
insufficiently sensitive or the sample size too small to detect a difference. As can be 
seen in Figure 8.3 (page 108), there was a small increase in anxiety between the 
invitation (T1) and pre-screening (T2) assessments. It is possible that with a larger 
sample, this effect would have become significant. I therefore tested the sensitivity of 
the results by carrying out power calculations to estimate the sample size that would 
have been necessary to detect significant effects. The effect size was very small 
(0.035), so the number of participants needed to detect significant differences was 
6490. Such a number is large, but is certainly conceivable in the context of a screening
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programme. However, the effect size suggests that the difference may not be very 
meaningful.
The alternative possibility is that the anxiety measure was not appropriate. A number of 
other measures were considered including the State Trait Anxiety Inventory (STAI), 
because the state scale can assess anxiety over short periods, rather than how a 
person had felt over the previous week. However, it was important in this study to use a 
measure that had been validated with adolescents and had comparison data, both of 
which are true of the HADS. The HADS scale is shorter than the full versions of other 
established emasures of anxiety. Most importantly, the HADS anxiety scale was 
constructed to be used with medical patients, so is relatively independent of somatic 
symptoms. The STAI contains a number of somatic symptoms. This is also true of the 
best established short-form of the STAI, Marteau and Becker’s (1992) 6 item version. 
This was not designed to assess specific modes of anxiety, and indeed correlated 
poorly with cognitive anxiety in one study (Withers and Deane, 1995). Furthermore as I 
had used the HADS measure in previous research in hypertrophic cardiomyopathy, 
these data had the potential to be useful in comparing anxiety levels of people prior to 
diagnosis after diagnosis and how this equates with the long-term experience of those 
with the condition reported in this earlier research.
I would also have liked to have measured symptoms in the comparison group. Clearly 
symptoms have an independent association with anxiety, and throughout the repeated 
measures there were significant differences between the levels of anxiety and 
perceptions of self rated health that the two symptom groups reported. The conclusions 
that I drew through evaluating the differences between these data and the comparison 
group data were sufficient. However, there is the chance that the comparison group 
was either more or less symptomatic than the cardiac testing group. Unfortunately, it 
was not acceptable to incorporate symptom questions into the comparison group data 
without raising the issue of screening. Had any person reported symptoms that could
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benefit from cardiac screening I would have been compromised both ethically and 
legally if I had not passed on that important information. In essence, any attempt to 
gain baseline symptom data is a first step towards a screening test, as is the case 
throughout the US where it is called the pre-participatory questionnaire. In a similar 
vain, it would have been interesting to see how people perceived these conditions if 
they decided not to participate. Although they were asked to complete the 
questionnaires even if they did not agree to be tested, I had a highly successful 0% 
response rate for this. I imagine there were many reasons for this lack of participation 
including that they never received or read the questionnaires or just felt no desire to 
participate at all.
Although I have raised a couple of issues with regard to when the measures were 
taken, it is important to point out that there is only one study to my knowledge that has 
been able to take a more accurate baseline measure. This was the study by Walker et 
a/., (1994) on cancer screening and was made possible because the HADS test was 
circulated in a general practice clinic prior to any knowledge of an impending offer of 
screening. They found that for most women with normal results the screening was not 
stressful. With the exception of this study, my study is a significant improvement on the 
majority of other studies of the psychological impact of screening programmes.
Ideally I would have liked to obtain data on illness perceptions after participants 
received their results. This would have provided a better understanding of whether they 
changed during the testing, and would have improved the analysis of anxiety levels at 
time 3. However, within the preliminary phase of the research when I was distributing a 
short questionnaire at time 3, including the HADS and self rated health measure, there 
was already a considerable group of non responders / missing data. I felt that including 
too many questions such as the IPQ-R would be a significant addition to the time 3 
assessment, and would increase the rate of non-response beyond acceptable levels.
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Furthermore a considerable amount of missing data in the Western Isles screening 
occurred at time 2 when only half of the questionnaires were given to the students to 
complete immediately prior to the ECG. It was an administrative oversight that I was 
only aware of after the event had been completed and therefore it was not possible to 
send out a reminder. This resulted in significant amount of missing cases in the 
repeated measures analysis of the Western Isles data.
Although there were no differences between anxiety at any time point in the samples 
when data was complete, compared with those with one or more missing time point, 
the number of dropouts in this study reached almost 60%. It would have been 
preferable if there had been a greater response rate at time 3 and I had been able to 
gain data on all of the people who were called back for further tests after the initial 
abnormal ECG result.
13.4 Policy and future research
An evaluation of a screening programme does not occur in a political vacuum. Already 
there are career paths or professions that either mandate or recommend cardiac 
screening as part of their protocol. Although, there are strong critics of screening 
programmes in the US, and the American Heart Association (AHA) has rejected the 
European Society of Cardiology (ESC) guidelines that recommend ECG testings prior 
to competitive sports participation, the US is also setting its own standards in 
professional sport. The National Basketball Association (NBA) has recently mandated 
standardized screening for all players on an annual basis with echocardiography and 
ECGs. The National Football League (NFL) has a system more similar to the ESC 
recommendations in which teams undergo ECGs (Maron et al., 2007). There are many 
universities in the US that also require all their athletes to be screened. In the UK 
screening is required to join the military. It is also a mandate of the Football 
Association. There are other European countries that have similar policies to those in 
Italy, who would expect their athletes to be tested prior to participation. In the case of
the US (Maron et al., 2007) there is an acknowledgement that the size of population 
has an impact on the policy decision, and therefore a policy could not be recommended 
until the infrastructure is in place to carry out that service. A more constructive stance 
may highlight the need for more investment in the skills and services required to start to 
put the infrastructure in place.
Without focusing too much on sport, it is also important to note that the current 
International Olympic Committee’s recommendations that all Olympic participants in 
2012 have had cardiac testing highlights the importance of when to test. These 
guidelines inadvertently highlight a fundamental problem with the current screening 
strategies that are being implemented. Namely that it is only at the penultimate moment 
in a career that you are tested to see if you can continue. The reality is that some will 
have cardiac conditions that may prevent them from playing competitive sport. It 
becomes highly debatable that this information is only given to them when they are 
about to reap the rewards of a considerable investment of time and money in that 
career path. A more ethical, although costly, approach is to identify those at risk at an 
earlier stage, prior to personal and financial commitments, at a time when other options 
in life are still available.
Sport is clearly enveloped within its own debate about screening with a difference of 
opinion between the European and American perspectives. However, the vast majority 
of the young sudden cardiac deaths occur outside of sport. A recent editorial in the 
European Heart Journal raises the important question of who should be tested and 
supports the position that these tests should not be limited to sport. This editorial also 
opens the important debate of when testing should happen (Nistri et al., 2007).This 
later point is where my results can also help to guide the debate. Clearly the 
adolescents appeared to be less anxious than the adults, they also had less 
pronounced perceptions of the consequences of the conditions, less worries about the 
conditions, and did not perceive the conditions to be as chronic. If we are considering
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when to implement screening programmes, and a critical aspect of implementation is 
minimizing the psychological impact, then it would appear that the adolescent period is 
a good time, or at least better than post adolescents. As many of the deaths occur in 
adolescents it is reasonable to suggest that the earlier it is conducted the more people 
will be identified prior to sudden death, although this is balanced by the position that 
the earlier the screening is carried out the more likely it is that some conditions (i.e 
some cases of HCM) may not have presented.
As I have already said earlier in this thesis there are many times when a person may 
benefit from the knowledge of an underlying asymptomatic cardiac condition. This is 
relevant to the National Screening Committee’s question of how ethical is the 
screening. In a society where prevention of disease is becoming ever more important, 
an evaluation of the ethical standing of a screening programme can be turned on its 
head to question whether it is ethical not to provide testing to those who request it. This 
is with the knowledge that often proactive testing is the only way that a person will 
know if they are at risk, prior to sudden death. If screening is not provided, society is 
fundamentally accepting that many people will die, since many preventable fatalities 
occur in people with no prior symptoms.
13.5 Conclusions
This research provides strong evidence that the tests were acceptable to the 
participants. They were reassured after the testing; satisfied with the information they 
received; reported qualitative responses that were positive; and showed they had 
understood the process that they were engaged in.
The conclusions from this study are that the levels of anxiety reported in this study, and 
the impact on self rated health, are not excessive. However, this is not to say, that 
these results can be applied as a blanket for all screening programmes in adolescents 
or cardiac conditions. This programme has been devised within an environment where
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there is sensitivity to the issue of the potential psychological impact of screening 
programmes. The national screening guidelines stress the importance of identifying the 
potential harm of any screening programme. It is essential to be vigilant in identifying 
any potential threats within such a programme, as well as evaluating changes to the 
programme when they are made.
These results suggest that screening apparently healthy young people for potentially 
serious cardiac conditions does not have adverse psychological effects, and should not 
stand in the way of introducing screening on a large scale.
With the development of new technologies and a better understanding of genetics we 
are moving into an age where preventive medicine, instead of reactive medicine, will 
become increasingly available. With this shift towards preventive medicine, we need to 
evaluate the impact this will have on people’s perceptions of health and the best 
methods for implementing health promotion strategies. The screening that has been 
evaluated is central to this debate as it is not only seeking to identify genetic conditions, 
but also conditions that have an immediate danger if not treated.
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Appendix I
Medical Questionnaire
Spring/Summer 2003 — ECG Testing Health Questionnaire Eton College PLEASE COMPLETE CLEARLY IN BLACK INK
NAME of CLIENT Name of Parent/Guardian
Age Sex Date of Birth Height -  metric Weight - metric Date/s of event
Your FULL HOME Address + Postcode: Dr’s Name & FULL Address +Postcode Have you had an ECG Test before? Yes 1 No
Where were you tested?
When were you tested?
Postcode: Postcode: Are you taking any medication? Yes / No
Tel. No: Tel No:
Please circle the correct response If YES, please describe the circumstances
1. Have you ever fainted? During Exercise Yes / No
Following Exercise Yes / No
Unrelated to Exercise Yes / No
2. Do you experience dizzy turns? During Exercise Yes / No
Following Exercise Yes / No
Unrelated to Exercise Yes / No
3. Do you experience palpitations (i.e. heavy, 
rapid or irregular heartbeat)?
Yes / No
4. Do you experience chest pain, heaviness During Exercise Yes / No
or tightness?
Following Exercise Yes / No
K»ml*© Unrelated to Exercise Yes / No
Cardiac Risk in the Young -  web site www.c-r-y.org.uk 1
Spring/Summer 2003 — ECG Testing Health Questionnaire_______  Eton College PLEASE COMPLETE CLEARLY IN BLACK INK
5. Do you feel that you get more breathless or more easily 
tired than your team mates?
Yes / No If YES, which
6. Is there a history of heart disease in your family? Yes / No If YES, what
7. Are you aware of any history of sudden cardiac death in 
your family?
Yes / No If YES, who and what age
8. Please tick one box to show which of these best describes you?
1 am.... □ White □ Black -  Caribbean □ Black -African □ Black - other (write in) ..................................................
□ Indian □ Pakistani □ Bangladeshi □ Chinese □ Any other group (write in) .....................................................
9. Are you involved in reaular exercise or trainina? Please comolete even if vou do not 
exercise regularly.
Distance Number of 
Sessions / week
Total hours/ 
week
A Name main Exercise or Sport:
B1 Swimming (specify distance / duration of sessions)
B2 Cycling (specify distance / duration of sessions)
B3 Running (specify distance / duration of sessions) Jogging and/or sprinting
B4 Weight Training (please specify heavy/light weights)
B5 Other (describe)r:
B6 Other (describe):
Total B Training
Total ‘A’ & ‘B’ Training
N>
Cardiac Risk in the Youna -  web site www.c-r-y.org.uk 2
Appendix II
Consent form and information 
Consent form and information 
Consent form and information
community screening 
school screening (Millfield) 
school screening (Western Isles)
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CRY
CARDIAC RISK IN THE YOUNG
Unit 7, Epsom Downs Metro Centre, Waterfield, Tadworth, Surrey, KT20 5LR United Kingdom 
Telephone: +44(0) 01737 363 222 Facsimile +44(0) 01737 363 444 
e-mail crv@c-r-v.org.uk web site www.c-r-v.orq.uk
CONSENT FORM
We are delighted to bring facilities for Mobile Cardiac Screening to your 
area. We aim to evaluate the heart muscle by using the following tests.
1. The Electrocardiogram:
This is a simple test which checks electrical activity of the heart. Small stickers known as electrodes are 
strategically placed onto the chest of the client. Leads are attached to the stickers which are connected 
to an ECG Recorder. A printout of cardiac electrical activity is then obtained for evaluation by the 
Technician or Cardiologist. This procedure is non-invasive, painless, easy to reproduce and very reliable. 
The client should remain still during the test, which lasts a matter of minutes.
2. The Echocardiogram:
This is an ultrasound scan (similar to that now offered to pregnant women) which looks at the structure of 
the heart. From the scan, Technicians are able to take measurements of the heart chambers and 
thickness of the heart muscle. Again, this test is painless and non-invasive, but takes approximately 15- 
20 minutes to perform. Please note that for both tests, clients will need to be undressed to the waist.
These tests are carried out by fully trained ECG/ECHO Technicians or Cardiologists who are legally obliged to operate 
within Hospital Guidelines. All medical personnel who give their time to CRY are required to provide details of their 
training, work experience and current CV. This information is verified and approved by Professor WJ McKenna, a 
Professor of Cardiac Medicine with a special interest in heart muscle disease.
If you would like to be tested, would you please sign below, indicating your consent to these procedures. Please note 
that if a cardiac condition is diagnosed and confirmed, like many other conditions (such as diabetes or high blood 
pressure) it may have implications when applying for Life Insurance (i.e. higher premiums) and Mortgage Applications. 
CRY’s screening service cannot detect every known cardiac condition, but it is able to identify the hidden cardiac 
conditions that are most likely to occur in young people and is potentially a life saving test. Clients should avoid 
strenuous exercise for approximately 1 hour prior to being tested. On the screening day, clients are requested to avoid 
using body lotion or cream prior to their given appointment time.
VENUE:
SCREENING DATES:)
NAME OF CLIENT (Printed).......................................................................................
CLIENT SIGNATURE..................................................TEL NO....................................
PARENTS SIGNATURE............................................................DATE........................
(Required if individual is under 16 years of age)
It is essential that this form, together with the CRY Health Questionnaire is completed and returned to
............................ no later than...............
For further information contact CRY’s Administrator on 
020 8 725 5098.
Patrons: Rob Andrew MBE Jeremy Bates Mark Cox MBE Nick Gillingham MBE 
Professor WJ McKenna Sir Steven Redgrave CBE
Administrator address and contact details
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CRY Mobile Cardiac Screening
Saturday, 27th and Sunday 28th October 2001 at - 
Aughton Village Hall, Aughton, Nr Ormskirk, West Lancashire L39 5DJ
In Memory of Andrew Blow
(Cardiac Risk in the Young) will be holding a Mobile Cardiac Screening in conjunction with the 
CRY Medical team. This open letter is being forwarded for your interest and perusal and provides 
some background on the charity, events around the screening and what happens after the 
screening has taken place.
CRY (Cardiac Risk in the Young) was established in 1995 by Alison Cox. The Charity’s remit is:
• To raise interest both locally and nationally for ECG Testing and Mobile Cardiac Screenings
• To highlight the symptoms of undetected heart conditions and emphasis how much can be 
done should a diagnosis be confirmed
• To support medical research into Sudden Death Syndrome
• To offer counselling and support to families affected by the loss of an apparently healthy 
child/young person due to an undetected heart condition.
Overleaf is some information giving a comprehensive idea of what CRY can offer the local 
community. The Protocol for our Screening Programme has been devised and approved with the 
Cardiological Sciences medical team of St George’s Hospital Medical School based in Tooting, 
London. The team is headed up by Professor McKenna, who is a Consultant Cardiologist with a 
special interest in heart muscle disease and one of CRY’s Patrons.
In the majority of cases, 12 lead ECG has proved the most accurate tool in diagnosing hidden 
heart conditions, with follow up on 2 D ECHO. This Mobile Cardiac Screening is offered to young 
people with their understanding and consent to the processes involved and any possible 
implications.
The screening is held in memory of Andrew Blow. He was a very active young man who loved 
sport, particularly football. Andrew died, aged just 20, of a rare heart condition (Dilated 
Cardiomyopathy) whilst playing football for his Hall of Residence Team. He attended Hull 
University where he was a second year business student.
Dr Sam Firoozi, a British Heart Foundation Fellow, will be responsible for the clinical procedures
on the day. Also in attendance will be the ECG and ECHO team, M s  , and....................Mr
 will be the CRY Screening Manager for this event. He will be happy to speak with
clients/parents regarding the screening session. The screening will be held between 9.30am- 
5.00pm on Saturday 27th October and 9.45am-1.15pm on Sunday 28th October.
Jan Smith, CRY Administrator can be contacted on Tel No: 020 8 725 5098
Mr and Mrs Blow can be contacted on Tel No: xxxx
If you would like to know more about CRY’s work, further information can be 
obtained from CRY’s Website. www.c-r-y.org.uk___________
Patrons: Rob Andrew MBE Jeremy Bates Mark Cox MBE Nick Gillingham MBE Professor WJ McKenna
Sir Steven Redgrave CBE
A Company Limited by Guarantee. Registered in England No. 3052965
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The ECG and ECHO Test -  “What happens?”
A 12 lead Electrocardiogram machine is used to take a reading of electrical activity in the heart. 
The process is quick, non-invasive and painless. It should be noted that skin creams and body 
lotions should be not be used prior to the test being taken. The ECG print-out is reviewed by an 
appropriate clinician, who then takes an ultrasound scan of the heart. We are particularly looking 
at the structure of the heart, checking measurement of the heart chambers and thickness of the 
heart muscle. The ECG and ECHO are reviewed on site, and once more at St George’s. Each 
client (and their GP) will be notified of the results within 15 working days. No results are provided 
on the day. If an abnormality is detected, your GP will be contacted with a request to provide us 
with a referral letter and follow-up investigations will be offered at St George’s. If required, 
treatment will be offered at St George’s, or arranged through GP referral with the appropriate local 
hospital. You can discuss any concerns with CRY staff, either at Head Office, or at St George’s.
In the event that a previously undetected cardiac condition is diagnosed, like other medical 
conditions, such as high blood pressure or diabetes, there is a possibility it may affect a number of 
life issues. It could potentially affect a chosen career, i.e. Fire Fighter or the ability to take out 
particular types of life insurance and mortgages. This seems to vary greatly from one area to 
another. Some people may be affected, whilst others with a similar condition are not. However, it 
must be stressed that undetected heart conditions are rare, and these are potentially life saving 
tests.
CRY Health Questionnaires and Consent Forms will be distributed with this letter, but it should be 
noted that young people wishing to attend who are under the age sixteen, must seek written 
permission from a parent/guardian. If you intend to take part in the screening you must sign and
return a CRY Consent Form and the Health Questionnaires to .............. -  address is on the
Consent Form). If the Consent Form is not returned prior to the screening, the CRY team will not 
be able to screen you. Please also ensure that you provide us with your GP’s name and surgery 
address details in full.
Background information on CRY (Cardiac Risk in the Young)
CRY’s remit is to raise awareness of undetected cardiac abnormalities in young, apparently 
healthy individuals. Although accurate statistics are not available, experts believe that 4 young 
people die each week in the UK from undiagnosed cardiac conditions. It is important to stress 
that the majority of these deaths are preventable. Problems are more likely to occur in sporty, 
young people because the heart is put under greater strain. Sudden cardiac death can also 
occur after exertion or during rest.
Our normal testing and screening age range is 1 4 - 3 5  years. Anyone who receives an ECG 
prior to their fourteenth birthday should be made aware that this test is not conclusive, since 
the heart muscle is generally still developing at a fast rate. Tests performed on pre-pubescent 
teenagers should also be repeated at a later date.
Information concerning appointments: The CRY Health Questionnaires and Consent Form 
must be completed and returned to your CRY contact no later than Friday,12th October. This 
way we can ensure that everyone receives an appointment in good time. Your appointment 
time will be provided by your CRY contact. We try to keep to our schedule but, due to the 
nature of our work, it is not always possible to keep within the timeframe allowed. 
Occasionally, we need more time with a particular client to rule out a possible problem, and 
consequently, this does alter appointment times. We hope that you will see the value of this 
screening, and bear with us if your appointment has been affected. This is a rare opportunity, 
so if you cannot keep your appointment, please remember to notify Mrs Blow by 19h October, 
so the place can be offered to another person. Your co-operation is very much appreciated.
Thank you for your interest in CRY
Patrons: Rob Andrew MBE Jeremy Bates Mark Cox MBE Nick Gillingham MBE Professor WJ McKenna
Sir Steven Redgrave CBE
A Company Limited by Guarantee. Registered in England No. 3052965
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CRY ECG Testing Session -  May 2002 
at Millfield School, Street, Somerset
Consent Form
W e are delighted to bring facilities for ECG  Testing to Millfield School 
Our aim is to evaluate the heart muscle by using the following test
The Electrocardiogram:
This is a simple test, which checks electrical activity of the heart. Small stickers, known as electrodes 
are strategically placed onto the chest of the client. Leads are attached to the stickers, which are 
connected to an ECG Recorder. A print-out of cardiac electrical activity is then obtained for 
evaluation by the Technician/Cardiologist. This procedure is non-invasive, painless, easy to 
reproduce and very reliable. The client should remain still during the test, which lasts a matter of 
minutes. Please note that tests are carried out in private, by female technician. If you wish, a 
chaperone or friend can come in with you during the test. No results will be issued at the time of 
testing, and all paperwork is thoroughly reviewed by our Cardiologists based at CRY’s supporting 
hospitals. In the event that a follow-up test is recommended we will ask that clients are referred to 
one of our supporting hospitals for a full cardiac evaluation. There are no extra charges relating to 
further tests. We anticipate that 1 in a 100 may require further testing but stress that follow up tests 
are often employed to rule out a possible problem.
These tests are carried out by fully trained ECG Technicians, who are legally obliged to operate within Hospital Guidelines. 
All medical personnel who give their time to CRY are required to provide evidence of their work experience, training, 
current post and an up-to-date CV. This information is verified and approved by Professor WJ McKenna, a Professor of 
Cardiac Medicine with a special interest in heart muscle disease.
If you would like to be tested, would you please sign below, indicating your consent to these procedures. Please note that if 
a cardiac condition is diagnosed and confirmed, like many other medical conditions (such as high blood pressure or 
diabetes) it may have implications when applying for Life Insurance (i.e. higher premiums) and certain types of Mortgage 
Applications. However, there is no set pattern of response from the Finance Industry to such results and each case is 
reviewed on an individual basis. It must be stressed however, that this is potentially, a life saving test. CRY’s ECG testing 
service cannot detect every known cardiac condition, but it is able to identify approximately 95% of the hidden cardiac 
conditions that are most likely to occur in young people.
VENUE: Millfield School, Street, Somerset (under the direction of the Medical Officer)
NAME OF CLIENT (Printed)...............................................................................................
CLIENT SIGNATURE..................................................Contact Tel No..............................
PARENTS SIGNATURE............................................................DATE...............................
(Required if individual is under 16 years of age)
For further information on CRY you can dial into our web site www.c-r-v.orq.uk or contact CRY’s Administrator, 
Jan Smith, on Tel No: 020 8 725 5098
Patrons: Rob Andrew MBE Jeremy Bates Mark Cox MBE Nick Gillingham MBE Professor WJ McKenna Sir Steve Redgrave CBE 
Ian Botham OBE -  Honorary President of the CRY Centre for Sports Cardiology 
A Company Limited by Guarantee. Registered in England No. 3052965 
Registered Office 35 -  37 Grosvenor Gardens, London SW1 0BY Registered Charity No. 1050845
“What happens at an ECG test?”
You will need to set aside approximately 10-12 minutes for the appointment. Firstly, your details will be checked and your height and 
weight confirmed. You will be asked to remove your shoes to gain an accurate height reading. You will then be called to have an ECG 
taken. A piece of equipment called a 12 lead Electrocardiogram is used to take a reading of electrical activity in the heart. The 
process is quick, non-invasive and painless. Small stickers are placed at strategic points across the chest wall. Flexible leads are 
attached to these stickers and the leads are then attached to the ECG machine. The electrical rhythm of the heart is recorded and 
printed out on two sheets of a special type of paper. This actual process takes about 5-7 minutes to perform. To obtain an accurate 
printout, you will need to allow the Technician access to your chest. The ECG printout is then put with your client information, and 
returned to St George’s for review.
The ECG is reviewed at St George’s. Each client (and their GP) will be notified of the results within 15 working days of the test. No
results are provided on the day. If our Cardiologists want to rule out a 
potential problem, or detect a possible problem, your GP will be contacted 
with a request to provide us with a referral letter and follow-up investigations 
will be offered at one of our supporting Hospitals, or offered through GP 
referral with the appropriate local hospital. You can discuss any concerns 
with CRY staff, either at Head Office, or at St George’s.
In the rare event that a previously undetected cardiac condition is diagnosed, 
like other medical conditions, such as high blood pressure or diabetes, there 
is a possibility it may affect a number of life issues. However, it must be 
stressed that undetected heart conditions are rare, and these are potentially 
life saving tests and the majority of conditions are managed by appropriate 
treatments.
CRY Health Questionnaires and Consent Forms will be distributed with this letter, but it should be noted that young people 
wishing to attend who are under the age sixteen, must seek written permission from a parent/guardian. If you intend to take part 
in the testing session you must sign and return the CRY Consent Form and Health Questionnaires to Dr Hugh Sharp at 
Millfield School in the envelope provided.
If you do not intend to take part in the testing session, we would appreciate it if you would you still complete our questionnaires 
and return to Dr Sharp in the envelope provided -  but mark the outside of the envelope NOT TAKING PART IN ECG TEST. 
You will not need to sign the Consent Form or provide your doctors details. Your co-operation is very much appreciated.
Information concerning appointments: The CRY Health Questionnaire and Consent Form must be completed and returned to 
Dr Sharp by 26th April 2002. This way we can ensure that everyone receives an appointment in good time. Your appointment 
time will be provided by the School in due course. Please note that our testing dates are 8th and 9th May.
Background information on CRY (C ard iac Risk in the Young)
CRY’s remit is to raise awareness of undetected cardiac abnormalities in young, apparently healthy individuals. Although 
accurate statistics are not available, experts believe that 4-8 young people die each week in the UK from undiagnosed cardiac 
conditions. It is important to stress that the majority of these deaths are preventable. Problems are more likely to occur in active, 
young people because the heart is put under greater strain. Sudden cardiac death can also occur after exertion or during rest.
Our normal testing and screening age range is 1 4 - 3 5  years. Anyone who receives an ECG test prior to their fourteenth 
birthday should be made aware that this test is not conclusive, since the heart muscle is generally still developing at a fast rate. 
Tests performed on pre-pubescent teenagers should be repeated at a later date.
Thank you for your interest in CRY
Patrons: Rob Andrew MBE Jeremy Bates Mark Cox MBE Nick Gillingham MBE Professor WJ McKenna Sir Steve Redgrave CBE 
Ian Botham OBE -  Honorary President of the CRY Centre for Sports Cardiology 
A Company Limited by Guarantee. Registered in England No. 3052965 
Registered Office 35 -  37 Grosvenor Gardens, London SW1 0BY Registered Charity No. 1050845
ECG Testing in process -  Printed with kind permission
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CRY ECG Testing Session -  Spring 2002
Consent Form
W e are delighted to bring facilities for ECG  Testing to the Western Isles of Scotland 
Our aim is to evaluate the heart muscle by using the following test
The Electrocardiogram:
This is a simple test which checks electrical activity of the heart. Small stickers, known as electrodes 
are strategically placed onto the chest of the client. Leads are attached to the stickers which are 
connected to an ECG Recorder. A print-out of cardiac electrical activity is then obtained for 
evaluation by the Technician or Cardiologist. This procedure is non-invasive, painless, easy to 
reproduce and very reliable. The client should remain still during the test, which lasts a matter of 
minutes. Please note that tests are carried out in private, and usually by female technicians. A 
chaperone or friend can come in with you during the test if you wish. No results will be issued at the 
time of testing, and all paperwork is thoroughly reviewed by our Cardiologists based at our 
supporting hospitals. In the event that a follow up test is recommended we will be making 
subsequent arrangements to visit the Western Isles Hospital where an Echocardiogram will be 
offered. There are no extra charges relating to further tests. We anticipate that 1 in a 100 may require 
further testing but stress that follow up tests are often employed to rule out a possible problem.
These tests are carried out by fully trained ECG Technicians, who are legally obliged to operate 
within Hospital Guidelines. All medical personnel who give up their time to CRY are approved by the 
Western Isles Health Board and by Professor WJ McKenna, a Professor of Cardiac Medicine with a 
special interest in heart muscle disease.
If you would like to be tested in Stornoway, would you please sign below indicating your consent to
these procedures. CRY’s ECG Testing service cannot detect every known cardiac condition, but it is
able to identify at least 95% of the hidden cardiac conditions that are most likely to occur in young 
people. We feel this test is potentially a life saving test. Please note that if a cardiac condition is 
diagnosed and confirmed, (like many other medical conditions such as high blood pressure or 
diabetes) that treatment and advice can be given to control the situation.
VENUE: ..................................................................................... Please state name of School/College
NAME OF CLIENT (Printed)...............................................................................................
CLIENT SIGNATURE..................................................Contact Tel No.............................
PARENTS SIGNATURE.............................................. DATE............................................
(Required if individual is under 16 years of age)
This completed form, together with the CRY Health Questionnaire should be returned to Mr George 
Moody in the addressed envelope provided by 25th March 2002. The Psychological Questionnaire 
should be returned as per instructions in the letter from Mr Steve Cox.
For further information on CRY you can dial into our web site www.c-r-v.orq.uk or contact CRY’s Administrator, Jan Smith, 
on Tel No: 020 8 725 5098
Patrons: Rob Andrew MBE Jeremy Bates Mark Cox MBE Nick Gillingham MBE Professor WJ McKenna Sir Steven Redgrave CBE 
Ian Botham OBE - Honorary President o f the CRY Centre for Sports Cardiology 
A Company Limited by Guarantee. Registered in England No. 3052965 
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CRY ECG Testing Session
Students Information Letter 
Spring 2002
In Memory of Joanne F. Fotherinqham
This open letter is being forwarded for your interest and perusal and provides some background on the 
charity, events around the ECG Testing Session and what happens after the testing has taken place.
CRY (Cardiac Risk in the Young) was established in 1995. The Charity’s remit is:
• To raise interest both locally and nationally for ECG Testing and Mobile Cardiac Screenings
• To highlight the symptoms of undetected heart conditions and emphasis how much can be done should 
a diagnosis be confirmed
• To support medical research into Sudden Cardiac Death (SCD)
• To offer counselling and support to families affected by the loss of an apparently healthy child/young 
person due to an undetected heart condition.
Overleaf is some information giving a comprehensive idea of what CRY can offer through ECG Testing. The 
Protocol for our Testing Programme has been devised and approved with the Cardiological Sciences 
medical team of St George’s Hospital Medical School based in Tooting, London. The team is headed up by 
Professor WJ McKenna, who is a Consultant Cardiologist with a special interest in heart muscle disease and 
one of CRY’s Patrons.
In the majority of cases, 12 lead ECG has proved the most accurate tool in diagnosing hidden heart 
conditions, with follow up on 2 D ECHO where necessary. This ECG Testing session will offer young people 
an opportunity to be involved in a pro-active cardiac health test.
This event is held in memory of Joanne F. Fotheringham, who died of an undetected heart condition. 
Joanne was a teacher at Bayble School on the Isle of Lewis. She was fit, active and involved in many 
aspects of life. There was no family history of heart problems nor had she experienced cardiac symptoms 
herself. This testing event has been made possible by the hard work of Joanne’s parents, Mr and Mrs 
Fotheringham and their incredible supporters, who are based all over the Western Isles.
Final dates and times of the testing sessions will be organised and sent to you in due course.
Mr Moody, Volunteer Project Administrator for the Western Isles can be contacted on: 01851 703593
Jan Smith, CRY Administrator can be contacted on: 020 8 725 5098
If you would like to know more about CRY’s work, further information can be obtained from
CRY’s Website. www.c-r-y.org.uk_______________________
Patrons: Rob Andrew MBE Jeremy Bates Mark Cox MBE Nick Gillingham MBE Professor WJ McKenna Sir Steve Redgrave CBE 
Ian Botham OBE -  Honorary President of the C R Y Centre for Sports Cardiology 
A Company Limited by Guarantee. Registered in England No. 3052965 
Registered Office 35 -  37 Grosvenor Gardens, London SW1 0BY Registered Charity No. 1050845
“What happens at an ECG test?”
You will need to set aside approximately 10-12 minutes for the appointment. Firstly, your details will be checked and your height and 
weight confirmed. You will be asked to remove your shoes to gain an accurate height reading. You will then be called to have an 
ECG taken. A piece of equipment called a 12 lead Electrocardiogram is used to take a reading of electrical activity in the heart. The 
process is quick, non-invasive and painless. Small stickers are placed at strategic points across the chest wall. Flexible leads are
attached to these stickers and the leads are then attached to the ECG machine. The electrical rhythm of the heart is recorded and
printed out on two sheets of paper. This process takes about 5-7 minutes to perform. To obtain an accurate printout, you will need to
allow the Technician access to your chest. The ECG printout is then put with your client information, and returned to St George’s for
review.
The ECG is reviewed at St George’s. Each client (and their GP) will be notified of the results within 15 working days of the test. No
results are provided on the day. If an abnormality is detected, your GP will 
be contacted with a request to provide us with a referral letter and follow- 
up investigations will be arranged locally on a set number of days 
(depending on need). If required, treatment will be offered at one of our 
supporting Hospitals, or offered through GP referral with the appropriate 
local hospital. You can discuss any concerns with CRY staff, either at 
Head Office, or at St George’s.
In the rare event that a previously undetected cardiac condition is 
diagnosed, like other medical conditions, such as high blood pressure or 
diabetes, there is a possibility it may affect a number of life issues. 
However, it must be stressed that undetected heart conditions are rare, 
and these are potentially life saving tests.
CRY Health Questionnaires and Consent Forms will be distributed with this letter, but it should be noted that young people wishing 
to attend who are under the age sixteen, must seek written permission from a parent/guardian. If you intend to take part in the 
testing session you must sign and return a CRY Consent Form and Health Questionnaire to Mr George Moody at the Nicolson 
Institute in the envelope provided. Please also ensure that you provide us with your GP’s name and surgery address details in full.
If you do not intend to take part in the testing session, it would be very much appreciated if you would still complete our 
questionnaires and return to CRY in the Freepost envelope provided.
Information concerning appointments: The CRY Health Questionnaire and Consent Form must be completed and returned to Mr 
Moody, by 25th March 2002. This way we can ensure that everyone receives an appointment in good time. Your appointment time 
and date will be provided by your School in due course.
Your co-operation is very much appreciated.
Background information on CRY (C ard iac R isk in the Young)
CRY’s remit is to raise awareness of undetected cardiac abnormalities in young, apparently healthy individuals. Although accurate 
statistics are not available, experts believe that 4-8 young people die each week in the UK from undiagnosed cardiac conditions. It is 
important to stress that the majority of these deaths are preventable. Problems are more likely to occur in active, young people 
because the heart is put under greater strain. Sudden cardiac death can also occur after exertion or during rest.
Our normal testing and screening age range is 1 4 - 3 5  years. Anyone who receives an ECG test prior to their fourteenth birthday 
should be made aware that this test is not conclusive, since the heart muscle is generally still developing at a fast rate. Tests 
performed on pre-pubescent teenagers should be repeated at a later date.
Thank you for your interest in CRY
Patrons: Rob Andrew MBE Jeremy Bates Mark Cox MBE Nick Gillingham MBE Professor WJ McKenna Sir Steve Redgrave CBE 
Ian Botham OBE -  Honorary President of the CRY Centre for Sports Cardiology 
A Company Limited by Guarantee. Registered in England No. 3052965 
Registered Office 35 -  37 Grosvenor Gardens, London SW1 OBY Registered Charity No. 1050845
ECG Testing in process -  Printed with kind permission
Appendix III
Psychology questionnaires and cover letters 
Cover letter - time 1 community screening 
Cover letter - time 1 school screening 
Questionnaire - time 1 (school and community)
Questionnaire - time 2 (school and community)
Questionnaire - time 3 and cover letter (school and community) 
Questionnaire - time 4 and cover letter (western Isles only)
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RESEARCH INTO THE PSYCHOLOGICAL IMPACT OF CARDIAC TESTING
I am working on this project to improve our understanding of your feelings about the testing process and 
your thoughts about heart conditions in general. It is important to know if the test raises concerns with 
any of the people taking part in this testing, even when no heart complications are found. I am carrying 
out this project in consultation with Professor Andrew Steptoe from University College London, who is 
an expert on studying psychological factors in relation to health.
This study will involve completing three short Questionnaires. The first of these three Questionnaires is 
attached and must be filled in when you complete the Consent Form. The second Questionnaire will be 
given to you on the day. It is shorter and needs to be filled in immediately before you have the ECG test. 
A final Questionnaire needs to be completed after you have received the final result, and sent back to 
CRY in the addressed envelope provided.
Some of the questions are repeated in each questionnaire to see how, or if, your feelings change so 
please do not attempt to remember your previous responses. Please respond as honestly as you can 
and be reassured that your responses will remain confidential and be used for research purposes only.
CRY would like to emphasise that your co-operation will contribute to the way undiagnosed heart 
conditions are tested for and help to develop a fuller understanding of the impact of these conditions. 
Please feel free at any time to write comments on the Questionnaires about your experience of the 
testing process.
I would like to stress that your involvement in this study is voluntary and will not affect your decision to 
have the ECG test.
If you have any queries feel free to contact me between 10 a.m. and 6 p.m., Monday to Friday, on 
01737 363 222 at Cardiac Risk in the Young, or go to the CRY website at crv@c-r-v.orq.uk
Thank you for your time, it is much appreciated.
Yours sincerely
Steve Cox
Research and Education
PATRONS
Rob Andrew MBE Jeremy Bates Mark Cox MBE Nick Gillingham MBE Professor William McKenna Sir Steve Redgrave CBE 
Ian Botham OBE -  Honorary President of the CRY Centre for Sports Cardiology 
A Company Limited by Guarantee. Registered in England No. 3052965Registered Office 35 -  37 Grosvenor Gardens, London
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Tel: +44(0)1737 363222 Fax: +44(0)1737 363444 Web Site: www.c-r-y.org.uk e-mail cry@c-r-y.org.uk
RESEARCH INTO THE PSYCHOLOGICAL IMPACT OF CARDIAC TESTING
If, after reading the following information you intend to take part in the...................ECG Testing
Session, please return the questionnaires in the envelope provided addressed to M r..............
Please DO NOT send the questionnaires back in the freepost envelope addressed to CRY.
If, after reading the following information you decide NOT to take part in the ........................
ECG Testing session, please complete and return all the questionnaires in the freepost envelope 
addressed to CRY, there is no need to put a stamp on the envelope. It is very important that we 
hear from everyone who has been contacted regarding this project.
I am working on this project to improve our understanding of your feelings about the testing process and 
your thoughts about heart conditions in general. It is important to know if the test raises concerns with 
any of the people taking part in this testing, even when no heart complications are found. I am carrying 
out this project in consultation with Professor Andrew Steptoe from University College London, who is 
an expert on studying psychological factors in relation to health.
This study will involve completing three short Questionnaires. The first of these three Questionnaires is 
attached and must be filled in when you complete the Consent Form. The second Questionnaire will be 
given to you on the day. It is shorter and needs to be filled in immediately before you have the ECG test. 
A final Questionnaire needs to be completed after you have received the final result, and sent back to 
CRY in the addressed envelope provided.
Some of the questions are repeated in each questionnaire to see how, or if, your feelings change so 
please do not attempt to remember your previous responses. Please respond as honestly as you can 
and be reassured that your responses will remain confidential and be used for research purposes only.
CRY would like to emphasise that your co-operation will contribute to the way undiagnosed heart 
conditions are tested for and help to develop a fuller understanding of the impact of these conditions. 
Please feel free at any time to write comments on the Questionnaires about your experience of the 
testing process.
I would like to stress that your involvement in this study is voluntary and will not affect your decision to 
have the ECG test.
If you have any queries feel free to contact me between 10 a.m. and 6 p.m., Monday to Friday, on 
01737 363 222 at Cardiac Risk in the Young, or go to the CRY website at crv@c-r-y.org.uk
Thank you for your time, it is much appreciated.
Yours sincerely
Steve Cox
Research and Education
PATRONS
Rob Andrew MBE Jeremy Bates Mark Cox MBE Nick Gillingham MBE Professor William McKenna Sir Steve Redgrave CBE 
Ian Botham OBE -  Honorary President of the CRY Centre for Sports Cardiology 
A Company Limited by Guarantee. Registered in England No. 3052965Registered Office 35 -  37 Grosvenor Gardens, London
SW1 OBY Registered Charity No. 1050845
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Section 1
Name............................................................
Instructions: This survey asks for your views about your health and feelings.
Answer every question by marking the answer as indicated. If you are unsure about how to 
answer a question, please give the best answer you can.
In general how would you say your health is: (Please circle one only)
Excellent Very good Good Fair Poor
This part of the questionnaire is designed to help the clinician to know how you feel. Read each 
item and underline the reply which comes closest to how you have been feeling in the past 
week. Don't take too long over your replies; your immediate reaction to each item will probably 
be more accurate than a long thought-out response.
I feel tense or 'wound up1: Most of the time
A lot of the time
From time to time, occasionally
Not at all
I get a sort of frightened feeling as if 
something awful is about to happen:
Very definitely and quite badly 
Yes, but not too badly 
A little, but it doesn't worry me 
Not at all
Worrying thoughts go through my 
mind:
I can sit at ease and feel relaxed:
A great deal of the time 
A lot of the time
From time to time but not too often 
Only occasionally
Definitely 
Usually 
Not often 
Not at all
I get a sort of frightened feeling like 
'butterflies' in the stomach:
I feel restless as if I have to be on 
the move:
Not at all 
Occasionally 
Quite often 
Very often
Very much indeed 
Quite a lot 
Not very much 
Not at all
I get sudden feelings of panic: Very often indeed 
Quite often 
Not very often 
Not at all
Please turn over
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We are interested in your own personal views of how you see heart conditions. Please indicate how 
much you agree or disagree with the following statements about heart conditions.
Please circle one number on each line
Statements about heart conditions: Strongly
Agree
Agree Don’t
Know
Disagree Strongly
Disagree
1 A person with a heart condition can lead 
a fully satisfying life 1 2 3 4 5
2 The genetic (inherited) aspects of some 
heart conditions worry me 1 2 3
4 5
3 I think I would have difficulty adjusting to 
being told I had a heart condition 1 2 3
4 5
4 I like to take an active role in any 
treatment I receive 1 2 3
4 5
6 The fact that some heart conditions can 
put my life at risk worries me
1 2 3 4 5
7 I do not expect to be told I have a heart 
condition
1 2 3 4 5
8 All people are at risk from heart disease 1 2 3 4 5
9 It is important for a person with 
symptoms (chest pain, breathless ness, 
palpitations, passing out) to be screened
1 2 3 4 5
10 It is important for all people with or 
without symptoms to be screened 1 2 3 4 5
11 It is necessary for you to have a 
symptom such as (chest pain, breathless 
ness, palpitations, passing out) for you to 
have a heart condition
1 2 3 4 5
12 The more exercise I do the healthier I will 
be
1 2 3 4 5
13 There is a chance I may have a heart 
condition
1 2 3 4 5
14 A heart condition will last a short time 1 2 3 4 5
15 A heart condition is likely to be 
permanent rather than temporary
1 2 3 4 5
16 A heart condition will last for a long time 1 2 3 4 5
17 A heart condition will improve in time 1 2 3 4 5
18 A heart condition will pass quickly 1 2 3 4 5
19 A heart condition would last a lifetime 1 2 3 4 5
20 Heart conditions are serious 1 2 3 4 5
21 Having a heart condition would have 
major consequences on my life
1 2 3 4 5
22 A heart condition would not have much 
effect upon my life
1 2 3 4 5
23 Having a heart condition would strongly 
affect the way others see me
1 2 3 4 5
24 Having a heart condition would have 
serious financial consequences
1 2 3 4 5
25 Having a heart condition would cause 
difficulties for those who are close to me
1 2 3 4 5
Please turn ove?
State
cont
aments about heart conditions 
inued:
Strongly II Agree 
Agree
Don’t
Know
Disagree S trong ly !
Disagree
26 Having a heart condition would depend on 
the way I live my life 1 II 2 3 4 5
27 Having a heart condition would depend on 
me 1 2 3 4 5
28 I am taking part in this screening because 
I feel it is important 1 2 3 4 5
29 I will not get a heart condition if I eat a 
healthy diet 1 2 3 4 5
30 I am more likely to have a heart condition 
L if I smoke
1 2 3 4 5
31 I am less likely to have a heart condition if 
I do regular exercise
1 2 3 4 5
32 Nothing I do will affect if I have a heart 
condition
1 2 3 4 5
33 I am taking part in this screening because 
my parents/guardian encouraged me
1 2 3 4 5
34 A heart condition will improve in time 1 2 3 4 5
35 There is very little that can be done if I 
have a heart condition
1 2 3 4 5
36 Treatment will be effective in curing a 
heart condition
1 2 3 4 5
37 The negative effects of a heart condition 
can be prevented (avoided) by treatment
1 2 3 4 5
38 Treatment can control the symptoms of a 
heart condition.
1 2 3 4 5
39 There is nothing which can help those 
with heart conditions.
1 2 3 4 5
40 The symptoms of heart conditions are 
puzzling to me
1 2 3 4 5
41 Heart conditions are a mystery to me 1 2 3 4 5
42 I don’t understand heart conditions 1 2 3 4 5
43 Having a heart condition doesn’t make 
any sense to me
1 2 3 4 5
44 I have a clear picture or understanding of 
heart conditions
1 2 3 4 5
45 I get depressed when thinking about 
having  ^a heart condition
1 2 3 4 5
46 When I think about having a heart 
condition I get upset
1 2 3 4 5
47 The thought of having a heart condition 
makes me feel angry
1 2 3 4 5
48 When I think about having a heart 
condition I get worried
1 2 3 4 5
49 The thought of having a heart condition 
makes me feel anxious
1 2 3 4 5
50 The thought of having a heart condition 
makes me feel afraid
1 2 3 4 5
51 The thought of having a heart condition 
has no effect on me
1 2 3 4 5
Please turn over 
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The following questions look at what you consider to cause heart conditions. Please indicate how much 
you agree or disagree that the cause may lead to a heart condition
Please circle one number on each line
Cause of heart conditions: Strongly
Agree
Agree Don’t
Know
Disagree Strongly
Disagree
52 Stress or worry 1 2 3 4 5
53 Hereditary -  it runs in the family 1 2 3 4 5
54 A germ or virus 1 2 3 4 5
55 Diet or eating habits 1 2 3 4 5
56 Chance or bad luck 1 2 3 4 5
57 Poor medical care in my past 1 2 3 4 5
58 Pollution in the environment 1 2 3 4 5
59 Behaviour and lifestyle 1 2 3 4 5
60 Mental attitude e.g. thinking about life 
negatively
1 2 3 4 5
61 Overwork 1 2 3 4 5
62 Emotional state e.g. feeling down, lonely, 
anxious, empty
1 2 3 4 5
63 Alcohol 1 2 3 4 5
64 Smoking 1 2 3 4 5
65 Accident or injury 1 2 3 4 5
66 Personality 1 2 3 4 5
67 Exercise 1 2 3 4 5
IN the table below please list in rank order the three most important factors that you believe may cause 
heart conditions. You may use any of the items from the box above, or you may have additional ideas 
of your own.
What is most likely to cause a heart condition:
1
2
3
Do you know of any young person or adult (under (please circle one)
the age of 35) who has suffered a sudden death - Yes I No
If yes. What was your relationship to that person (ie. friend, brother, friend of a friend, read about it in 
a paper etc....) and what did they die of?
Please turn ov&27
The following questions are about activities you might do during a typical day.
Does vour health now limit vou in these activities? If so how much?
Please circle one number on each line |
Activities Yes, Limited Yes, Limited No, Not
A Lot A Little limited At All
a Vigorous activities, such as running, 
lifting heavy objects, participating in 
strenuous sports
1 2
3
b Moderate activities, such as moving a 
table, pushing a vacuum cleaner, 
bowling, or playing golf
1 2 3
c Lifting or carrying groceries 1 2 3
d Climbing several flights of stairs 1 2 3
e Climbing one flight of stairs 1 2 3
f Bending, kneeling, or stooping 1 2 3
9 Walking^more than a mile 1 2 3
h Walking half a mile 1 2 3
i Walking one hundred^ards 1 2 3
i Bathing or dressing yourself 1 2 3
How often do you drink or eat any of the following?
Please circle one number on each line |
Foods/ Drinks More than 
once a day
Once 
a day
At least once a 
week but not daily
Rarely Never I
1 Coffee 1 2 3 4 5
2 Fruit 1 2 3 4 5
3 Coke or other fizzy drinks 1 2 3 4 5
4 Sweets 1 2 3 4 5
5 Raw vegetables or salad 1 2 3 4 5
6 Cooked vegetable 1 2 3 4 5
7 Peanuts 1 2 3 4 5
8 Crisps 1 2 3 4 5
9 Chips/ fried potatoes 1 2 3 4 5
10 Hamburgers or hot dogs 1 2 3 4 5
11 Sausages 1 2 3 4 5
12 Meat Pies 1 2 3 4 5
13 Skimmed or semi-skimmed milk 1 2 3 4 5
14 Ordinary milk (full fat) 1 2 3 4 5
15 Low fat yoghurt or fromage frais 1 2 3 4 5
16 Fish (including fish fingers) 1 2 3 4 5
17 White bread 1 2 3 4 5
18 Brown bread/chapattis 1 2 3 4 5
19 Cakes or biscuits 1 2 3 4 5
20 Chocolate 1 2 3 4 5
21 Pasta or rice 1 2 3 4 5
Please turn ov#28
22 Apart form your main meals (for example, breakfast, lunch, tea/dinner) how many times did you 
have a snack yesterday? Include things like chocolate, crisps, cake biscuits and peanuts.
Please tick one box
None----------------------- □
Once----------------------- □
Twice---------------------- □
Three times--------------  □
More than three times - □
23 Are you on a diet to lose weight?
Please tick one box
Yes-----------------------------------------------  □
No, because my weight is fine---------- □
No, but I do need to lose weight  □
24 Now read all the following sentences carefully and tick the box next to the one which you think
you are the most like? Please tick one box
I have never smoked -------------------------------------------- □
I have only smoked once or twice------------------------------- □
I sometimes smoke, but I don’t smoke every week □
I smoke every day----------------------------------------------------□
25 Thinking just about alcoholic drinks, which of these best describes your drinking habits?
Please tick one box
I do not drink alcohol at all-------------------□
I drink a little alcohol--------------------------□
I drink at least once a week----------------- □
I drink every day.------------------------------- □
Please indicate how much you agree or disagree with the following statements about food.
Please circle one number on each line
Statements about food: Strongly
Agree
Agree Don’t
Know
Disagree Strongly
Disagree
26 People of my age don’t need to worry 
about the food they eat
1 2 3 4 5
27 Experts never agree which foods are 
good for you
1 2 3 4 5
28 I find healthy foods too boring 1 2 3 4 5
29 I am always trying to diet 1 2 3 4 5
30 As long as you are reasonably active you 
can eat what you like
1 2 3 4 5
31 I don’t know enough about which foods 
are good for you
1 2 3 4 5
32 I just eat the food I like and I don’t worry 
about whether it’s healthy or not
1 2 3 4 5
What is you sex Male / Female
What is you date of birth Day_________Month_____________Year_
Thank you for completing this questionnaire, 
your tim e is much appreciated
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Section 2
Nam e................................................................  Date of birth........................................
Instructions: This survey asks for your views about your health and feelings.
Answer every question by marking the answer as indicated. If you are unsure about how to 
answer a question, please give the best answer you can.
In general how would you say your health is: (Please circle one only)
Excellent Very good Good Fair Poor
This part of the questionnaire is designed to help the clinician to know how you feel. Read 
each item and underline the reply which comes closest to how you have been feeling in the 
past week. Don't take too long over your replies; your immediate reaction to each item will 
probably be more accurate than a long thought-out response.
I feel tense or 'wound up': Most of the time
A lot of the time
From time to time, occasionally
Not at all
I get a sort of frightened feeling as if 
something awful is about to happen:
Very definitely and quite badly 
Yes, but not too badly 
A little, but it doesn't worry me 
Not at all
Worrying thoughts go through my 
mind:
A great deal of the time 
A lot of the time
From time to time but not too often 
Only occasionally
I can sit at ease and feel relaxed: Definitely 
Usually 
Not often 
Not at all
I get a sort of frightened feeling like 
'butterflies' in the stomach:
Not at all 
Occasionally 
Quite often 
Very often
I feel restless as if I have to be on 
the move:
Very much indeed 
Quite a lot 
Not very much 
Not at all
I get sudden feelings of panic: Very often indeed 
Quite often 
Not very often 
Not at all 230
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RESEARCH INTO THE PSYCHOLOGICAL IMPACT OF CARDIAC TESTING
You will probably remember the cardiac test you had a number of weeks ago and the two 
questionnaires you kindly gave up your time to complete.
I would be very grateful if you could also complete this final questionnaire and I hope it will 
not take more than just a few more minutes of your time.
The questions are once again repeated to see how, or if, your feelings have changed so 
please do not attempt to remember your previous responses. Although it may seem 
repetitive it is an important part of this psychological questionnaire to ask the same 
questions at these three different time intervals to establish any changes. Please respond 
as honestly as you can and be reassured that your responses will remain confidential and 
be used for research purposes only.
Once you have filled in this final questionnaire please return it to the CRY office in the 
addressed envelope provided.
I am working on this project to improve our understanding of your feelings about the testing 
process. It is important to know if the test raises concerns with any of the people taking part 
in this testing, even when no heart complications are found. I am carrying out this project in 
consultation with Professor Andrew Steptoe from University College London, who is an 
expert on studying psychological factors in relation to health.
I would like to emphasise that your co-operation in this final part will contribute to the way 
undiagnosed heart conditions are tested for and help to develop a fuller understanding of 
the impact of these conditions. Please feel free at any time to write comments on the 
Questionnaires about your experience of the testing process.
If you have any queries feel free to contact me between 10 a.m. and 5 p.m., Monday to 
Friday, on 01737 363 222 at Cardiac Risk in the Young, go to the CRY website at www.c-r- 
y.org.uk or email me at crv@c-r-v.orq.uk
I would like to take this opportunity of again thanking you for your time in contributing to this 
very important study.
Yours sincerely
Steve Cox 
CRY Manager 
Research and Education
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Section 3
Name
The following questions will look at how you have been feeling having received the result of 
the cardiac test.
Answer every question by marking the answer as indicated. If you are unsure about how to 
answer a question, please give the best answer you can.
In general how would you say your health is:
(Please circle one only)
Excellent Very good Good Fair Poor
The following questions are about activities you might do during a typical day. 
Does your health now limit you in these activities? If so how much?
(circle one number on each line)
Activities
Yes, 
Limited 
A Lot
Yes, 
Limited 
A Little
No, Not 
limited 
At All
a Vigorous activities, such as running, lifting 
heavy objects, participating in strenuous 
sports
1 2 3
b Moderate activities, such as moving a 
table, pushing a vacuum cleaner, bowling, or 
playing golf
1 2 3
c Lifting or carrying groceries 1 2 3
d Climbing several flights of stairs 1 2 3
e Climbing one flight of stairs 1 2 3
f Bending, kneeling, or stooping 1 2 3
9 Walking more than a mile 1 2 3
h Walking half a mile 1 2 3
i Walking one hundred yards 1 2 3
j Bathing or dressing yourself 1 2 3
Please turn over
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This part of the questionnaire is designed to help the clinician to know how you feel. Read 
each item and underline the reply which comes closest to how you have been feeling having 
received the result of the cardiac test.
Don't take too long over your replies; your immediate reaction to each item will probably be 
more accurate than a long thought-out response.
I feel tense or 'wound up': Most of the time
A lot of the time
From time to time, occasionally
Not at all
I get a sort of frightened feeling as if 
something awful is about to happen:
Worrying thoughts go through my 
mind:
I can sit at ease and feel relaxed:
I get a sort of frightened feeling like 
'butterflies' in the stomach:
I feel restless as if I have to be on 
the move:
I get sudden feelings of panic:
Very definitely and quite badly 
Yes, but not too badly 
A little, but it doesn't worry me 
Not at all
A great deal of the time 
A lot of the time
From time to time but not too often 
Only occasionally
Definitely 
Usually 
Not often 
Not at all
Not at all 
Occasionally 
Quite often 
Very often
Very much indeed 
Quite a lot 
Not very much 
Not at all
Very often indeed 
Quite often 
Not very often 
Not at all
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The following questions look at the information you have received at the screening, how well you 
have understood what you have been told, and how satisfied you are with the information you have 
been given.
Answer every question by marking the answer as indicated. If you are unsure about how to answer a 
question, please give the best answer you can.
(circle one number on each line)
Strongly
Agree
Agree Don’t
Know
Disagree Strongly
Disagree
1 I remember all the information I was told. 1 2 3 4 5
2 I was provided with all the information I 
asked for.
1 2 3 4 5
3 I was able to understand all the 
information that was presented to me.
1 2 3 4 5
4 I would have liked to ask medical staff 
more questions.
1 2 3 4 5
5 I was satisfied with the amount of 
information I received.
1 2 3 4 5
6 I would have liked to ask members of CRY 
more questions.
1 2 3 4 5
7 I feel reassured now I have had this 
cardiac test.
1 2 3 4 5
8 I would recommend to my friends to have 
this cardiac test.
1 2 3 4 5
9 I would like to have this cardiac test again 
in the future.
1 2 3 4 5
Do you feel that your level of anxiety has changed since the cardiac testing? Has it:
(circle one number)
Increased a lot  1
Increased slightly ............................................................2
Stayed about the same ............................................................3
Decreased slightly ........................................................... 4
Decreased a lot  5
Do you feel that your understanding of the importance of a healthy lifestyle has changed since the 
cardiac testing? Has it:
(circle one number)
Increased a lot  1
Increased slightly ........................................................... 2
Stayed about the same ........................................................... 3
Decreased slightly ........................................................... 4
Decreased a lot  5
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How did you initially find out about this testing?
Why did you decide to be tested?
Was the testing as you imagined?.
Any Further comments:
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RESEARCH INTO THE PSYCHOLOGICAL IMPACT OF CARDIAC TESTING
Dear
A number of you were called back for further cardiac tests on September 7th. Although 
there were three questionnaires in the general study, it is very important that all those with 
follow up tests fill in this final questionnaire.
As part of the group that were called back for further test your input will be of great 
importance and your co-operation will make a significant contribution to the way 
undiagnosed heart conditions are tested for especially when follow up tests are needed.
Please feel free at any time to write comments on the Questionnaires about your 
experience of the testing process.
I hope this will not take more than just a few more minutes of your time.
The questions are once again repeated to see how, or if, your feelings have changed so 
please do not attempt to remember your previous responses.
Please respond as honestly as you can and be reassured that your responses will remain 
confidential and be used for research purposes only.
Once you have filled in this final questionnaire please return it to the CRY office in the 
addressed envelope provided.
If you have any queries feel free to contact me between 10 a.m. and 5 p.m., Monday to 
Friday, on 01737 363 222 at Cardiac Risk in the Young, go to the CRY website at www.c-r- 
y.org.uk or email me at crv@c-r-v.orq.uk
I would like to take this opportunity of again thanking you for your time in contributing to this 
very important study.
On a personal note I thoroughly enjoyed my time in the Western Isles and meeting with you 
on the day and I hope you have found the experience valuable.
Yours sincerely
Steve Cox 
CRY Manager 
Research and Education
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Section 4
Name
Instructions: This survey asks for your views about your health and feelings. This 
information will help keep track of how well you are able to do your usual activities.
Answer every question by marking the answer as indicated. If you are unsure about how to 
answer a question, please give the best answer you can.
In general how would you say your health is:
(Please circle one only)
Excellent Very good Good Fair Poor
The following questions are about activities you might do during a typical day. 
Does your health now limit you in these activities? If so how much?
(circle one number on each line)
Activities
Yes, 
Limited 
A Lot
Yes, 
Limited 
A Little
No, Not 
limited 
At All
a Vigorous activities, such as running, lifting 
heavy objects, participating in strenuous 
sports
1 2 3
b Moderate activities, such as moving a 
table, pushing a vacuum cleaner, bowling, or 
playing golf
1 2 3
c Lifting or carrying groceries 1 2 3
d Climbing several flights of stairs 1 2 3
e Climbing one flight of stairs 1 2 3
f Bending, kneeling, or stooping 1 2 3
g Walking more than a mile 1 2 3
h Walking half a mile 1 2 3
i Walking one hundred yards 1 2 3
j Bathing or dressing yourself 1 2 3
Please turn over
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This part of the questionnaire is designed to help the clinician to know how you feel. Read 
each item and underline the reply which comes closest to how you have been feeling in the 
past week.
Don't take too long over your replies; your immediate reaction to each item will probably be 
more accurate than a long thought-out response.
I feel tense or 'wound up': Most of the time
A lot of the time
From time to time, occasionally
Not at all
I get a sort of frightened feeling as if 
something awful is about to happen:
Worrying thoughts go through my 
mind:
I can sit at ease and feel relaxed:
I get a sort of frightened feeling like 
'butterflies' in the stomach:
I feel restless as if I have to be on 
the move:
I get sudden feelings of panic:
Very definitely and quite badly 
Yes, but not too badly 
A little, but it doesn't worry me 
Not at all
A great deal of the time 
A lot of the time
From time to time but not too often 
Only occasionally
Definitely 
Usually 
Not often 
Not at all
Not at all 
Occasionally 
Quite often 
Very often
Very much indeed 
Quite a lot 
Not very much 
Not at all
Very often indeed 
Quite often 
Not very often 
Not at all
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The following questions look at the information you have received at the screening, how well you 
have understood what you have been told, and how satisfied you are with the information you have 
been given.
Answer every question by marking the answer as indicated. If you are unsure about how to answer a 
question, please give the best answer you can.
(circle one number on each line)
Strongly
Agree
Agree Don’t
Know
Disagree Strongly
Disagree
1 I remember all the information I was told. 1 2 3 4 5
2 I was provided with all the information I 
asked for.
1 2 3 4 5
3 I was able to understand all the 
information that was presented to me.
1 2 3 4 5
4 I would have liked to ask medical staff 
more questions.
1 2 3 4 5
5 I was satisfied with the amount of 
information I received.
1 2 3 4 5
6 I would have liked to ask members of 
CRY more questions.
1 2 3 4 5
7 I feel reassured now I have had this 
cardiac test.
1 2 3 4 5
8 I would recommend to my friends to have 
this cardiac test.
1 2 3 4 5
9 I would like to have this cardiac test again 
in the future.
1 2 3 4 5
10 It is important for a person with symptoms 
(chest pain, breathlessness, palpitations, 
passing out) to be screened.
1 2 3 4 5
11 It is important for all people with or without 
symptoms to be screened
1 2 3 4 5
What were your thoughts when you were called back for further tests?
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How do you feel now you have had the tests?
Have you sought further information about cardiac conditions in other sources, e’g’ on the internet/ in 
a library? If Yes, Where?_________ ____________________________________________________
In your opinion is there anything that either the charity CRY or the medical staff could have done 
better throughout the screening programme? If Yes, What?______________________________
Any Further comments:
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Appendix IV
Cover letter and questionnaire -  comparison group study
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Anxiety and perceptions of health in schools
Dear participant
I am a researcher from Cardiac Risk in the Young working on a project in collaboration with Professor 
Andrew Steptoe from University College London, who is an expert on studying psychological factors in 
relation to health.
We are aiming to gain insight into your perceptions of health in general. This is an important piece of 
research that will enable a better understanding of how you feel about your health and feelings in general.
This study will involve completing a short Questionnaire and sending it back to CRY in the pre paid 
addressed envelope provided. Please turn over to complete the questionnaire; it should take no more than 
5 minutes.
Please respond as honestly as you can and be reassured that your responses will remain confidential and 
be used for research purposes only. Your participation in this project is voluntary.
If you have any queries feel free to contact me between 10 a.m. and 5 p.m., Monday to Friday, on 01737 
363 222
Thank you for your time, it is much appreciated.
Yours sincerely
Steve Cox 
CRY Manager
PATRONS
Rob Andrew MBE Jeremy Bates Mark Cox MBE Nick Gillingham MBE Professor William McKenna Sir Steve Redgrave CBE 
Ian Botham OBE -  Honorary President o f the CRY Centre for Spoils Cardiology 
A Company Limited by Guarantee. Registered in England No. 3052965Registered Office 35 -  37 Grosvenor Gardens, London SW1
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Name
Gender...Male / Female Date of birth Day_____Month__________________Year_
Instructions: This survey asks for your views about your health and feelings.
Answer every question by marking the answer as indicated. If you are unsure about how to 
answer a question, please give the best answer you can.
In general how would you say your health is: (Please circle one only)
Excellent Very good Good Fair Poor
This part of the questionnaire is designed to help us know how you feel. Read each item and 
underline the reply which comes closest to how you have been feeling in the past week. Don't 
take too long over your replies; your immediate reaction to each item will probably be more 
accurate than a long thought-out response.
I feel tense or 'wound up': Most of the time
A lot of the time
From time to time, occasionally
Not at all
I get a sort of frightened feeling as if 
something awful is about to happen:
Worrying thoughts go through my 
mind:
I can sit at ease and feel relaxed:
I get a sort of frightened feeling like 
'butterflies' in the stomach:
I feel restless as if I have to be on 
the move:
I get sudden feelings of panic:
Very definitely and quite badly 
Yes, but not too badly 
A little, but it doesn't worry me 
Not at all
A great deal of the time 
A lot of the time
From time to time but not too often 
Only occasionally
Definitely 
Usually 
Not often 
Not at all
Not at all 
Occasionally 
Quite often 
Very often
Very much indeed 
Quite a lot 
Not very much 
Not at all
Very often indeed 
Quite often 
Not very often 
Not at all
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Appendix V
Newspaper article advertising community screening events
Printed with permission
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Appendix VI
Factor analysis of the modified IPQ-R in adolescents
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Table 11.1. Principal components analysis of the modified IPQ-R in adolescents; Varimax rotation
Component
1
46 When I think about having a heart condition I get upset .852
50 The thought of having a heart condition makes me feel afraid .823
48 When I think about having a heart conditions I get worried .822
49 The thought of having a heart condition makes me feel anxious .802
45 I get depressed when thinking about having a heart condition .753
47 The thought of having a heart condition makes me feel angry .736
41 Heart conditions are a mystery to me .851
42 I don't understand heart conditions .846
43 Having a heart condition doesn't make any sense to me .772
44 I have a clear picture or understanding of heart conditions -.734
40 The symptoms of heart conditions are puzzling to me .717
16 A heart condition will last a long time .860
15 A heart condition is likely to be permanent rather than temporary .758
19 A heart condition would last a lifetime .679
18 A heart condition will pass quickly -.666
14 A heart condition will last a short time -.649
39 There is nothing which can help those with heart conditions .746
'Xl’&Tn 38 Treatment can control the symptoms of a heart condition -.602
[uOGNCn] ^  There is very little that can be done if I have a heart condition .545
25 Having a heart condition would cause difficulties for those who are .716 
close to me
23 Having a heart condition would strongly affect the way others see me .683
24 Having a heart condition would have serious financial consequences .639
36 Treatment will be effective in curing a heart condition .681
37 The negative effects of a heart condition can be prevented by treatment .630
34 A heart condition will improve in time .552
27 Having a heart condition would depend on me .817
26 Having a heart condition would depend on the way I live my life .799
20 Heart conditions are serious .735
21 Having a heart condition would have major consequences on my life .710
22 A heart condition would not have much effect upon my life 
£  32 Nothing I do will affect if I have a heart condition .481
